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Abstract  
Musculoskeletal conditions are prevalent worldwide and are associated with pain, 
disability and impaired quality of life (QoL). Osteoarthritis (OA) is a common, costly and 
disabling musculoskeletal condition. Lower limb OA research has focussed on the hip and 
knee and, as a consequence, impairments characterising ankle OA are not well understood. 
This thesis aims to advance our understanding of the physical, functional and psychological 
impairments and associated disability in individuals with persistent ankle symptoms and in 
those with radiographic evidence of ankle OA. 
Study 1: A systematic literature review and meta-analysis was conducted to synthesise 
and appraise the quality of studies investigating physical impairments in ankle OA. The review 
identified eight studies, three of which were included in the meta-analyses. Meta-analyses 
revealed large impairments of ankle sagittal plane range of motion (ROM) on the affected 
compared to the unaffected side and less sagittal plane torque in ankle OA compared to 
controls. Evidence from single studies indicated deficits in frontal plane ROM and strength, 
talar translation and rotation, balance, electromyography of ankle muscles, abnormal bony 
alignments and greater fatty infiltrate in all calf muscle compartments in individuals with 
ankle OA. Critical appraisal of the literature revealed limitations surrounding assessor 
blinding, measurement validity, and lack of generalization. 
Study 2: A cross-sectional laboratory study of 96 participants compared physical 
measures of function, strength, ROM and posture and patient-reported outcomes in 1) 
individuals with symptoms and radiographic evidence of ankle OA to asymptomatic 
individuals; and 2) asymptomatic individuals with and without radiographic evidence of ankle 
OA. Those with symptomatic OA reported greater pain, disability, instability, kinesiophobia, 
lower function and QoL, and exhibited significant deficits in muscle strength, ROM and 
ambulatory function compared to asymptomatic individuals. Most patient-reported and 
physical outcomes were similar between asymptomatic individuals with and without 
radiographic OA. Stair function times were significantly associated with QoL and self-reported 
function. 
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Study 3: A cross-sectional exploratory survey (n=394) was conducted to compare self-
reported daily living and sports function, ankle pain and disability, physical activity, ankle 
instability, and QoL between individuals with and without persistent ankle pain and stiffness, 
and to explore factors associated with QoL. Individuals with ankle symptoms reported worse 
scores for all measures, except self-reported physical activity. Daily living function and age 
explained 66% of the variance in QoL. 
Study 4: Individuals with and without persistent ankle pain and stiffness (n= 231) 
participated in an online survey to obtain data about pain severity, pain self-efficacy, anxiety, 
depression, kinesiophobia, pain catastrophizing, and function. Individuals with persistent 
ankle pain reported higher pain and depressive symptoms, and lower function than controls. 
Higher pain self-efficacy and lower levels of ankle pain and kinesiophobia were associated 
with a better function in the symptomatic group. 
Study 5: Using the same sample in study 4, work limitation, function, and psychological 
features were compared between working individuals with and without persistent ankle 
symptoms and between working and non-working individuals with persistent ankle 
symptoms. Working individuals with ankle symptoms reported higher pain levels, work 
limitation, and lower function than working controls. Among the symptomatic group, 
individuals who remained in the workplace were significantly younger with less pain in the 
ankle and in other body sites, and at a lower risk of clinical catastrophising than individuals 
who were not working. Working individuals also reported higher function and pain self-
efficacy compared to non-working symptomatic individuals. Total psychological stress, 
depression and catastrophizing were significantly lower among the working than non-working 
symptomatic individuals. Higher levels of depression and kinesiophobia and lower pain self-
efficacy were associated with greater work limitation.  
Study 6: Data on number of falls and associated injuries/hospitalization in the past 12 
months, balance confidence, falls efficacy, function, and comorbidities associated with risk of 
falling were collected in individuals with and without persistent ankle pain and stiffness using 
an online survey (n=226). Individuals with persistent ankle pain and stiffness reported more 
falls, greater fear of falling, more fall-related injuries, lower function and balance confidence 
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when compared to controls. The number of falls was associated with fear of falling and 
severity of ankle pain.  
This thesis has demonstrated that individuals with symptomatic ankle OA present with 
impairments in ambulation, ROM, muscle strength and endurance compared to 
asymptomatic individuals. Interestingly, there were minimal differences in these outcomes 
between individuals with and without radiographic OA who did not have ankle symptoms. 
This suggests the presence of ankle pain and stiffness has a greater influence on function and 
impairments than radiographic OA at the ankle. Further, our data indicate that persistent 
ankle pain and stiffness negatively impacts QoL and function and is associated with limitations 
at work, increased falls and psychological impairment. Further research is needed to better 
understand the mediators of the poorer physical impairments in ankle OA, psychological 
distress, and QoL in those with persistent ankle pain and stiffness. This would plausibly lead to 
more directed investigations of the effect of interventions for ankle OA. 
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Chapter 1 Introduction  
Musculoskeletal conditions represent the second leading cause of disability 
worldwide, affecting between one in three and one in five individuals 1. Chronic 
musculoskeletal conditions at the ankle affect nearly 20% of Australian adults 2. Other 
reported estimates for the prevalence of ankle pain range from 9%-15% of adults 3-5.  
One of the most common and disabling musculoskeletal conditions is osteoarthritis 
(OA) 1. Osteoarthritis is one of the most prevalent joint diseases 6 and is expected to become 
the fourth leading cause of disability worldwide by the year 2020 7. As per the international 
classification of disease (ICD-10) diagnosis Codes 8, OA is classified into primary, secondary 
and post-traumatic OA based on the underlying cause for the cartilage breakdown. Traumatic 
injuries to joints, which often occur in young adults, place the injured joint at risk for post-
traumatic OA. Although OA is generally considered to be multifactorial in nature 9,10-12, it is 
agreed that OA at the ankle is associated with trauma to the joint such as ankle sprains 13,14 or 
fractures 15,16. Over 80% of ankle OA is thought to be of post-traumatic origin 15. Due to the 
post-traumatic origin of ankle OA, it affects a younger population than OA of other joints, 
which is most commonly primary, non-traumatic, in nature 15,17,18.  
Pain and physical impairments related to musculoskeletal conditions are associated 
with negative impacts on social functioning, mental health, and quality of life (QoL) 7. As such, 
assessment of impairment and disability is important to understand the overall impact of a 
health condition. The International Classification of Functioning, Disability, and Health (ICF) 19 
is a biopsychosocial framework defined by the World Health Organization for classifying 
health and disability into three components: impairment, activity limitation and participation 
restriction. Osteoarthritis affects all of the components of the ICF. For example, joint stiffness 
and pain constitute impairments in body structure, mobility and gait limitation affect activity, 
and difficulty in maintaining social activities and work relates to restrictions on participation. 
Research (mostly on hip and knee) has shown that OA is associated with pain, joint 
stiffness, reduced joint motion, joint malalignment, psychological distress, increased risk of 
fall, limited societal interaction, a decline in wellbeing and impaired work ability 20-23. In light 
of the population affected by ankle OA, and the often long-lasting disability associated with 
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OA, ankle OA will likely be a major problem with the medical burden and the socioeconomic 
impact that extend to affect work participation and family commitments. Nonetheless, there 
is a scarcity of scientific data in the area of ankle OA. Much of the research focus on ankle OA 
is related to the technical and clinical success of ankle surgical intervention 24-29. Further, most 
studies to date have focused on people during the latter stage of the OA. 
In order to understand the specific impact of ankle OA on both the individual and 
society and optimize the management of this condition, an essential first step is to improve 
our understanding of the impairments associated with the condition in its clinical 
presentation. The aim of this thesis is to promote a better understanding of the physical and 
psychological impairments and associated disability of individuals with ankle pain and OA. The 
outcomes of this thesis may be used to inform management and identify therapeutic targets 
for people with ankle OA.
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Chapter 2 Background  
This chapter includes a synthesis of relevant background literature. In particular, the 
chapter explores the role of injury in the aetiology of ankle OA and introduces the International 
Classification of Functioning, Disability, and Health (ICF) as a conceptual framework to 
illustrate disability in OA. The gaps in the existing literature that will be addressed in this thesis 
are also highlighted. Finally, the specific aims and structure of this thesis are outlined. 
2.1 Osteoarthritis  
2.1.1 Magnitude of osteoarthritis 
Osteoarthritis is a chronic pathology characterised by articular cartilage and 
subchondral bone degeneration. Osteoarthritis is one of the most prevalent joint diseases 6, 
affecting up to 9.6% and 18% of adult men and women respectively 6. In 2012, approximately 
33% of the English population over the age of 45 sought treatment related to OA 30, and 9.5% 
of Australian adults aged 35-64 years were diagnosed with OA 31. 
Osteoarthritis has major personal, societal, psychological, and economic impacts 
including pain, stiffness, reduced joint motion, deformity, disability, loss of independence, 
limited societal interaction, and a decline in QoL 20,21. It is the third-largest contributor to life-
years lost due to disability in Australia 32; and is expected by 2020 to become the fourth 
leading cause of disability worldwide 7. Osteoarthritis is the second most common cause of 
missed work in developed countries 33; and is associated with significant activity and work 
limitations 23,34-36. In 2007, $2 billion of Australian health system funding was allocated for OA 
management 37. 
Osteoarthritis is most common in weight-bearing joints of the lower limb 38. The 
prevalence of radiographic hip and knee OA among adults in the United States has been 
reported at 27% and 27.8% respectively 39. While there is limited data on ankle OA, 
conservative estimates report a prevalence of 1% of the world’s adult population 
(approximately 7.6 million individuals worldwide) 40-42. However, other data suggests that the 
actual prevalence is likely much higher. In 2013, it was reported that 7% of UK adults aged 45 
years and over (approximately 1.77 million individuals) sought treatment for ankle or foot OA 
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43. Similarly, a recent community-based cohort study of 864 individuals identified the 
presence of radiographic ankle OA (defined as a Kellgren-Lawrence grade ≥ 2) in 7% of their 
study population 44. Among cadaveric studies, degenerative changes at the ankle range 
between 2% and 18% 45-48. Thus, data suggest the population with ankle OA is not trivial and 
warrants investigation. 
2.1.2 Definition of OA 
Osteoarthritis is diagnosed either radiographically or clinically 49. Not all cases of 
radiographic OA is associated with clinical symptoms 50,51. Previous research on the knee 
found only 15% of individuals who had evidence of radiographic knee OA presented with knee 
pain 50. On the other hand, radiographic OA was found to occur more frequently in individuals 
with persistent knee joint pain >3 months in the past 12 months or >90 days in the past 6 
months 52.  
Plain radiographs (x-ray) are the most commonly used radiographic tool to define OA. 
The definition of radiographic joint degeneration is the presence of articular cartilage loss 
(inferred by joint-space narrowing), osteophytes and/or increased sub-chondral bone density 
and cysts 53. A number of ankle radiographic grading systems exist with slightly variable 
criteria to determine the presence and severity of ankle OA. For example, The Morrey and 
Wiedeman 54 which is three-stage grading and the modified Takakura 55 a five-stage grading 
have similar early stage (1 and 2) OA (e.g., early sclerosis, minimum narrowing and 
osteophyte formation). The modified Takakura grading has an intermediate stage 3 OA that 
further differentiates the extent of joint space narrowing and subchondral bone contact. The 
advanced stage OA is similar in both classification (e.g., gross deformity, ankyloses, no joint 
space and bone contact). Other radiographic grading systems include the Kannus 56 and the 
venDijk 57 grading schemes, both consider the presence of cysts, subchondral sclerosis, 
osteophytes and joint space narrowing to determine OA severity. 
The Kellgren-Lawrence (KL) grading scheme 58, which is extensively used for the 
diagnosis of OA in joints around the body, has good inter-observer reliability at the ankle and 
elsewhere 59. In the ankle, mortise (an AP-view) and lateral radiographic views are used to 
determine the presence and grade of OA using the modified KL scale (Table 2.1) validated as a 
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tool for defining ankle OA severity 60. It quantifies ankle OA into five grades (levels of severity) 
and similar to KL criteria used for the hip and knee, KL criteria for the ankle relies heavily on 
the presence of osteophytes as a discriminating factor between OA and non-OA.  
Table 2.1: Radiographic grades of severity of ankle OA 
KL Grade Description 
0 No radiographic findings of OA 
1 Minute osteophytes of doubtful clinical significance 
2 Definite osteophytes with mild joint space narrowing 
3 Definite osteophytes with moderate joint space narrowing  
4 Definite osteophytes with severe joint space narrowing 
 
Osteoarthritis can also be diagnosed clinically. Clinically, OA is characterised by joint 
aching or pain, stiffness, reduced joint motion, crepitus, and variable levels of localised 
inflammation/effusion 7,53. There is evidence from research on hip OA indicating a diagnostic 
accuracy of hip clinical examination in predicting the presence of radiographic hip OA 61. 
Individuals are classified as having symptomatic OA if they have both radiographic signs of 
joint degeneration and clinical symptoms 62,63. It is becoming apparent that radiographic 
evidence of OA does not correlate well with symptoms, or impairments, as symptoms appear 
to be the relevant determinant of impairments 64-66. For example, previous research identified 
knee muscle weakness in individuals with knee pain but no radiographic knee OA, and no 
direct association between muscle strength and signs/severity of radiographic degeneration 
67. Further, individuals with chronic knee pain have been shown to have lower strength on the 
painful than the pain-free side, despite the same radiographic stage bilaterally 68. Whether 
there is a relationship between radiographic evidence of OA and QoL is less clear, due to 
inconsistent research findings. Some studies have reported cross-sectional associations 
between radiographic OA and QoL 69,70; whereas, other research on hip and knee pain 
reported strong associations between pain and QoL, but not radiographic OA 71. The relation 
between radiographic evidence of OA, symptoms and impairments, and the clinical and 
radiographic OA assessments have not been investigated at the ankle. 
6 
 
2.1.3 Classification of OA 
Osteoarthritis is classified based on the underlying mechanism for the cartilage 
breakdown. The International Statistical Classification of Diseases and Related Health 
Problems (ICD), is an international medical classification published by the World Health 
Organization (WHO) that is used to classify diseases, signs and symptoms, abnormal findings, 
complaints, social circumstances, and external causes of injury or disease 8. In this 
classification (ICD-10 Diagnosis Codes), OA is classified as primary (M19.0), secondary 
(M19.2), and posttraumatic (M19.1). Primary OA features erosive cartilage changes in the 
absence of an identifiable cause or underlying abnormality and is most commonly associated 
with aging 45,72,73. Secondary OA results from another disease or condition, such as obesity, 
congenital abnormalities, gout, rheumatoid arthritis (RA), or hormone disorders including 
diabetes. Finally, post-traumatic OA is a consequence of injury, repeated trauma or surgery to 
the joint 45. Compared to the hip and knee joints, the ankle is nine times less susceptible to 
primary OA 47. Valderrabano 45 undertook a large cohort study of 390 patients with ankle OA 
and found that 78% of the ankle OA cases were posttraumatic, 13% were secondary and only 
9% were primary OA. This incidence is similar to the suggestion that 80% of ankle OA cases in 
the United States are thought to be post-traumatic, compared to only approximately 2% of 
the hip and 10% of the knee 15.  
2.2 The Ankle joint  
2.2.1 Anatomy and composition 
Although the talo-crural joint is often considered “the ankle joint,” it is important to 
consider that the ankle comprises three articulations from a functional perspective: the talo-
crural joint, the subtalar joint, and the distal tibiofibular syndesmosis 74.  
The talo-crural joint also referred to as the tibiotalar joint or ankle mortise, is a 
uniaxial, modified hinge, synovial joint comprised of the tibia (tibial plafond and medial 
malleolus), fibular (lateral malleolus) and talus 75. Together, the medial malleolus, which 
extends to the midpoint of the talus, and the lateral malleolus, which nearly extends to the 
level of the subtalar joint, form a mortise. The saddle shape of the talus allows it to remain in 
close contact with the articular surface of the mortise 76. This intimate contact is thought to 
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be important for an even distribution of load at the ankle. The talo-crural joint is stabilized by 
the congruency of the bony articulation and the ligamentous complexes (the inferior 
tibiofibular complex and the collateral ligament complexes).  
The subtalar joint is a synovial plane (condyloid) joint 77 made up of anterior, middle 
and posterior articulations 78. The subtalar joint has congruent osseous anatomy and strong 
lateral ligamentous support from calcaneo-fibular, lateral talo-calcaneal, cervical and 
interosseous talocalcaneal ligaments 79. The deltoid ligament medially also contributes to the 
stability to the posterior aspect of the subtalar joint.  
The inferior tibiofibular joint, also known as the tibiofibular syndesmosis, is a 
syndesmotic joint formed by the convex facet of the fibula and the concave facet of the tibia. 
The fibular part of the joint is congruent with its tibial counterpart. The joint is stabilised by 
the distal anterior and posterior tibiofibular ligaments, the transverse ligament and the 
interosseous ligament 80. The inferior tibiofibular joint is important for the stability of the 
mortise of the talo-crural joint.  
2.2.2 Cartilage characteristics of the ankle 
To comprehend ankle OA, this section briefly reviews the basics of ankle articular 
cartilage owing to its importance in the development of OA. The degeneration of articular 
cartilage is a hallmark of OA. Adult articular cartilage (hyaline) is an avascular, aneural and 
alymphatic connective tissue that is 2 to 4 mm thick 81,82. The thickness of articular cartilage 
varies depending on the joint congruency 83. The principal functions of articular cartilage are 
to provide a low-friction gliding surface for joint articulation, act as a shock absorber and to 
facilitate the load transmission to subchondral bones.  
The articular cartilage at the ankle is different from that of other synovial weight-
bearing joints. It is thought that differences in ankle joint anatomy and cartilage properties 
may protect the ankle from primary degenerative changes 62,84. Ankle articular cartilage has 
been shown to be thinner than that of the hip and knee 83,85 but also stiffer and more 
resistant to indentation 86. The contact area of the ankle joint is smaller than that of the hip or 
knee 87 which means that a greater compressive force per unit area is exhibited over the 
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ankle joint cartilage 87. Nonetheless, the joint congruity at the ankle is thought to protect the 
articular cartilage from high stress and secondary degeneration 83,88.  
Further, the bio-molecular composition of talar articular cartilage is denser and has a 
higher turnover of matrix material in response to stress than tibiofemoral joint articular 
cartilage 89,90. The varying capabilities of articular cartilage to react to stimuli was further 
confirmed when same injurious compression protocol applied to the tibiofemoral and ankle 
cartilage induced damage to 6% of ankle cartilage disk compared to 46 % of the knee cartilage 
disk with similar peak stresses 91. Altogether, these unique features of ankle articular cartilage 
and the congruity of the ankle joint may explain the reduced prevalence of primary ankle OA 
(compared to hip and knee), which in turn is likely why ankle OA has received so little 
attention compared to hip and knee OA.  
2.3 Aetiology of ankle OA 
The aetiology of OA at the ankle, like that at other joints, is multifactorial. However, 
there is a consensus in the literature that ankle OA is predominantly a result of previous injury 
or trauma 13-15,17,44, such as ligament injury or fracture. Other factors associated with ankle OA 
include age 44, female sex 92, malalignment 13, malalignment with ligament insufficiency 93, age 
30 years or older at the time of injury 91, and increased body mass index (BMI) 44,94. 
2.3.1 Ankle sprains and instability 
While an ankle sprain is often perceived as a minor injury, both mild and severe 
sprains increase the risk of ankle OA. In a large cohort study (n=247), Valderrabano 13 found 
that 55% of ankle OA cases were associated with previous ligamentous injury, with 85% of 
those cases associated with a lateral ankle sprain. Consistent with those observations, an 
anatomic study of elderly cadavers found degenerative changes in the talo-crural joint 
cartilage in 79% of ankles with previous talofibular ligament injuries 14. The time between the 
development of ankle OA and initial injury is thought to be related to the severity of cartilage 
trauma 95,96. As such, a severe ankle sprain is associated with a reduced time from the injury 
until the development of symptomatic end-stage ankle OA compared to recurrent sprains of 
less severity (25.7 vs 38.0 years) 13.  
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Chronic ankle instability (CAI), which is a common sequella of ankle sprains 
characterised by recurrent sprains, giving way and instability at the ankle 97,98, is also 
associated with ankle OA 18,99,100. Arthroscopic findings suggest that 55% of individuals with 
CAI have cartilage lesions to the talus 101, and pre-surgical assessments have found talar 
cartilage fibrillation and cartilage defect in 25% and 14% of CAI patients, respectively 102. In 
addition to probable cartilage damage at the time of the sprain(s), it has been suggested that 
altered load distribution at the ankle joint may also contribute to ankle OA development in 
this population 18,103,104.  
 2.3.2 Ankle fractures 
Ankle fractures are an increasingly prevalent health care problem 105,106. It is estimated 
that 62% of ankle OA occurs subsequent to an ankle fracture 45. Malleolar, tibial plafond 95 
and talar fractures 107,108 are frequently associated with the development of post-traumatic 
ankle OA 95.  
The type and severity of ankle fracture, associated articular surface incongruity/mal-
alignment, instability and healing complications are reported to correlate with post-traumatic 
ankle OA. The prevalence of posttraumatic OA increased with the increasing severity of 
fracture and pattern for example; fractures that resulted in malleolar fragments were 
considered a severe pattern of fracture and correlated with a higher prevalence of OA 92,109. 
In high-energy injuries, such as skiing and motor vehicle accidents, acute loading can result in 
overwhelming injury to the articular cartilage and joint degeneration can occur relatively 
rapidly. Within two years of an ankle fracture or joint injury, post-trauma radiographs can 
show evidence of degenerative joint changes 92,110,111. Joint incongruency reduces the joint 
contact area which could lead to mechanical loading that exceeds the capacity of the articular 
cartilage cells and matrix to repair 112,113. Individuals with complications during fracture 
healing (e.g. osseous disturbance, infections, osteomyelitis, osteonecrosis, development of 
arthrofibrosis, and complex regional pain syndrome) have been shown to develop ankle OA 
earlier than those with uncomplicated fracture-healing 114,115. 
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2.3.3 Hindfoot malalignment  
Individuals with ankle OA often present with concomitant hindfoot deformity, most 
commonly a varus deformity 55,116. Varus or valgus angulation is defined by the angle between 
the anatomical axis of the tibia and a line perpendicular to the articular surface of the talar 
dome 117-119. An angle of <10° varus or valgus is considered a neutral ankle alignment, while 
an angle of ≥10° is considered to be varus or valgus malalignment deformity 118. 
Valgus and varus hindfoot malalignment can be caused by neurological conditions, 
trauma (such as tibial fractures 120), genetics and other unknown factors 121. A longitudinal 
prospective study of individuals with malalignment following a tibial fracture found a direct 
correlation between the degree of tibial malalignment and ankle joint degeneration 120. 
Deviations from normal hindfoot or tibial alignment are thought to reduce the ankle joint 
contact area 122,123 and tibiotalar force transmission 121. Any shift from neutral joint alignment 
moves the normal load-bearing regions of the ankle joint to areas less well adapted to 
withstand load and asymmetrical load distribution across the joint. This subsequently 
predisposes the joint to asymmetric ankle OA. 
2.4 A possible increasing risk of ankle OA 
In light of increases in sports participation and injuries, it is likely that the incidence of 
ankle OA is also on the rise. Over the past decade, the number of individuals who participate 
in sports has increased. For instance, in the United Kingdom, the number of individuals 
participating in a sporting activity at least once a week rose by 750,000 from 2011 to 2012 124. 
Perhaps unsurprisingly, the incidence of sports-related injuries, particularly to the lower limbs 
has also increased 125,126. The ankle joint is among the most commonly injured joints 127. 
Research has shown that acute ankle injury was the second most common career ending 
acute injury after the knee among 185 retired English professional soccer players 128. Ankle 
sprains are the most common injury seen in US emergency departments 129, with over 3.1 
million sprains occurring between 2002 and 2006 129, 50% of which were due to sport-related 
injuries 129,130.  
Ankle sprains are most common among individuals in the second to third decade of 
life 131. As the majority of ankle OA is post-traumatic in nature and ankle sprains are 
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associated with the development of OA in 25.7 to 38.0 years 13, it is likely that ankle OA is or 
will be affecting individuals of a relatively young age. This is consistent with data suggesting 
that ankle OA occurs earlier in life than that of other joints15,17,18. The onset of ankle OA at a 
time of life where individuals have high work and family demands and are typically active in 
sporting and recreational pursuits will likely have a significant impact on QoL. Further, the 
impact of OA will be felt for a longer period of time than individuals of more advanced age. 
2.5 Impairments and disability 
2.5.1 The International Classification of Functioning, Disability and Health (ICF) 
The World Health Organization (WHO) International Classification of Functioning, 
Disability, and Health (ICF) has been used to systematically describe the impairments and 
limitations in functioning (disability) encountered by individuals with a health condition. The 
ICF is a biopsychosocial model that considers biological, environmental and social 
perspectives and interactions 19. Information in the ICF model are arranged into two different 
domains, 1) functioning and disability and 2) contextual factors. The ICF domain of functioning 
and disability is composed of three parts 1) body function and structures, and 2) activities and 
3) participation.  
Impairments are part of the “disease process” and refer to problems of body functions 
and structures associated with a health condition. Body function and structures refer to the 
physiological aspects of the affected anatomical body part or system; and describes the 
impairment experienced at the physical level as a consequence of a health condition/disease 
process. Activities refer to the consequences of impairments of body function and structures 
that affect the execution and performance of particular functional tasks, such as walking or 
stair negotiation. A bidirectional relationship exists between body function and structures and 
activities, in that a limitation in one domain contributes to a limitation in the other. 
Participation is involvement in an activity with individual meaning and relevance, such as 
sports, employment or shopping. The relationship between activities and participation is also 
bidirectional; limitation in activities affects participation and vice versa. Disability is a 
collective term that encompasses impairments, activity limitations and participation 
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restrictions 132 that limit an individual’s ability to perform or undertake a task in the same way 
as a non-disabled person 132,133. 
The contextual factors domain of the ICF includes the two contexts, environmental 
(physical and social) and personal (such as age, sex, social status, coping and behaviour 
patterns), that either facilitate or hinder an individual’s functioning within the context of the 
health condition.  
Interactions between the different domains of the ICF have the potential to influence 
an individual’s QoL 134 (Figure 2.1). Thus, understanding impairments at the level of body 
function and structure, activities and participation, with consideration of environmental and 
personal factors, is important to understand the influence of a health condition on QoL.  
 
Figure 2. 1: Illustrative interaction between the different components of ICF 
 
2.6 Impairments and disability in OA 
Research on impairments and disability in ankle OA is limited and existing studies 
often do not compare findings to healthy controls 135,136, or combined the results for ankle OA 
and rheumatoid arthritis (RA) 137-144. The few studies that have considered ankle OA 
separately have used modest sample sizes, which raise questions about their power and 
generalizability 145-148. These methodological considerations limit the interpretation of existing 
data. The following section will use elements of the ICF model to describe impairments 
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associated with ankle OA. Characteristic impairments that warrant consideration during OA 
assessment, development and application of management plans and outcomes assessment 
will be highlighted. In light of the limited research in ankle OA population, studies on the 
characteristic impairments in OA of other weight-bearing joints (i.e. the hip and knee) will also 
be presented. 
2.6.1 Body function and structure in OA 
The body structure and function component of OA relates to both degeneration of 
articular cartilage and subchondral bone, and impairments such as pain, muscle weakness, 
and deficits in range of motion (ROM). While damage to cartilage and subchondral bone may 
be non-modifiable in management, other impairments may be able to be addressed with 
targeted treatment. 
Musculoskeletal pain is the main reason for seeking medical care 149. Pain is a cardinal 
symptom 150 and a key determinant of disability in individuals with musculoskeletal conditions 
and OA 151. Research on retired soccer players showed that ankle joint pain on daily activities 
was reported by 17.2% of retired players while 9% reported pain on walking 128. Pain also has 
a detrimental effect on QoL 152. Research on a small sample of individuals with ankle OA (n=5) 
and healthy controls (n=5) showed that those with OA group presented with significantly 
higher pain scores 26 ± 7.6 on the Short Form health survey (SF-36; 54.2 ± 3.7 vs 87.6 ± 17.2) 
and Ankle Osteoarthritis Scale (AOS; 26 ± 7.6 vs 1.8 ± 4) 153. Both of these tools (i.e. SF-36 and 
AOS) have pain sub-scales commonly used to evaluate pain in clinical and general 
populations.  
Muscle weakness is a common impairment in individuals with OA in weight-bearing 
joints 154. There is some evidence from small studies of ankle muscle weakness in ankle OA 
compared to controls 145,146,155. Similarly, hip and knee muscle weakness has been identified 
in individuals with hip 156 and knee OA 157-159 compared to controls.  
Reduced joint mobility and stiffness are common clinical features of OA. Individuals 
with ankle OA have reduced total ankle dorsiflexion-plantarflexion ROM 160,161,162-164. This is 
important because reduced ankle dorsiflexion has been associated with compromised 
balance and function 165,166-169. However, it is not clear whether the limitation is in 
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dorsiflexion, plantarflexion or both. There is also evidence of decreased inversion-eversion 
ROM from one study 145. Most participants in studies that have investigated ankle ROM have 
been awaiting surgery with end-stage ankle, which limits the generalisability of findings. 
Reduced hip and knee joint mobility has been reported in hip and knee OA 22. 
2.6.2 Activities and participation in OA 
The impact of OA on activities and participation can be measured using self-report or 
performance-based measures. Osteoarthritis has been linked with a progressive deterioration 
in function 112,170. In 2009, 592,000 Australians reported having a disability related to arthritis 
171. The WHO estimates that 80% of individuals with OA present with movement limitation 
and 25% are unable to perform major daily activities 172.  
There has been limited research on functional limitations in ankle OA. A small pilot 
study (with five participants per group) found that individuals with ankle OA reported higher 
disability compared to age-matched controls 147. Comparisons between the end-stage ankle 
and hip OA showed similar levels of physical disability between groups 173. However, as both 
the ankle and hip OA groups had end-stage OA and were awaiting surgery, a poor function 
would be expected. Research exploring function in earlier stages of ankle OA is warranted. 
Pain can influence participation in meaningful activities, as such, it can initiate 
avoidance as cognitive (avoiding painful experience) or behavioural (avoiding activities) 174 
reaction which can, in turn, lead to a range of consequences including activity restriction, 
muscle deconditioning, impaired balance, more pain, limited participation and disability 
175,176. While participation in meaningful activities such as work and recreation has not 
specifically been investigated in ankle OA, research on individuals with arthritis (OA, 
rheumatoid arthritis, gout, lupus, or fibromyalgia) indicate that they do not meet the 
recommended level of activity for arthritis 177,178 (30 minutes of moderate-intensity physical 
activity at least 3 days per week) 179. There is evidence that OA limits work participation 23,34-36 
and those limitations are reported to be 3-5 times higher in individuals with OA compared to 
individuals without OA 180,181.  
Participation in meaningful activities can be influenced by fear of fall and falling. 
Research suggests that individuals with OA have an increased risk of falls 182-184. Pain is also 
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associated with fear of falling 185 which has been linked to restriction of activities 186. Granting 
that OA related impairments including pain, decreased muscle strength and reduced joint 
motion, have been suggested to increase the risk of falls in older adults 168,187-191, it is possible 
that individuals with ankle OA may be at risk of falls which warrant investigation. 
2.6.3 Contextual factors in OA 
Considering OA from other areas of the body, due to lack of research at the ankle, sex, 
age, BMI, cognitive factors such as pain beliefs, self-efficacy, fear of movement and 
psychological distress (anxiety and depression) are contextual factors that have been shown 
to relate to functioning and disability in OA. Women with OA experience higher disability and 
functional decline than men with OA 192-194. Psychological distress is greater in younger, 
compared to older, individuals with OA 195. In light of ankle OA affecting a younger population 
than that of other joints, this may be a concern in ankle OA 15,17,18. High BMI is a key 
determinant of disability in knee OA 64.  
There are many psychosocial considerations that are likely to affects the functioning in 
chronic pain and OA. Research has reported that 20% of individuals with OA experience 
symptoms of depression and anxiety 196, and that depression is associated with decreased 
physical activity participation 197,198. Higher fear of movement, anxiety, depression, 
catastrophizing 199 and lower pain self-efficacy 200 are all associated with pain 201, and related 
to disability 200,202. Low levels of self-efficacy have been linked to higher disability in 
individuals with OA of the knee and hip 203. It remains unclear whether these findings extend 
to individuals with ankle OA.  
2.6.4 Health-related QoL in OA 
Quality of life is a product of the interaction between the functioning/disability and 
contextual factors components of the ICF and is an important goal of the management of 
health conditions. Individuals with musculoskeletal disorders report lower QoL compared to 
individuals without musculoskeletal disorders 204, and those with OA report poorer QoL than 
healthy individuals 205. According to the 2014–15 National Health Survey 206, Australians aged 
18 and over with OA were 4.3 times more likely to report very severe pain, and 2.3 times 
more likely to report poor health status as compared with those without OA.  
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The majority of research investigating QoL in OA involves the hip and knee joints. 
Studies have shown that hip and knee OA has a negative effect on QoL 207-209 and 
psychological health 210-213. However, comparatively little is known about the experience of 
individuals with ankle OA. Saltzman et al 214 used the SF-36 to compare the physical and 
mental component summary scores between individuals with ankle OA and controls and 
found mental component scores in ankle OA significantly lower than that of the controls. 
Further, the physical component scores in individuals with ankle OA were similar to 
populations with severely disabling medical conditions such as end-stage renal disease, 
radiculopathy and congestive heart failure 214.  
2.7 What is missing? 
In the previous section, the ICF served as a system to describe OA across the different 
domains of health. While there is evidence of the impact of hip and knee OA on disability 207-
209, participation in daily living activities (ADL) 215 and QoL 204, little is known about the impact 
of ankle OA on these and other elements of activities, participation, and QoL. Further, the few 
studies that investigated impairments in body structure and function in ankle OA have used 
small sample sizes and/or populations with end-stage OA awaiting surgery. Thus, impairment 
characteristics of the early stage of ankle OA are not known. Furthermore, no study has 
focused on examining the extent to which age, ankle pain, self-efficacy or anxiety contribute 
to disability in individuals with ankle OA.  
Since little is known about the key impairments to body structure and function, or the 
impact of ankle OA on activities, participation and QoL, it is difficult to design and 
appropriately assess the impact of treatment programs for individuals with ankle OA. It is 
therefore important to identify specific impairments associated with ankle OA to guide 
management of this condition. Understanding disability and factors related to the disability in 
ankle OA will help identify key outcomes to determine the impact of an intervention which 
will, in turn, guide the development of evidence-based practice guidelines in the management 
of ankle OA.  
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2.8 Thesis aims and objectives 
The aim of this thesis is to promote a better understanding of the physical 
impairments and associated disability of individuals with ankle pain and OA. The studies in this 
thesis include a systematic review to synthesise the existing literature on physical 
impairments in ankle OA, a cross-sectional laboratory study to assess physical and functional 
impairments in ankle OA, and cross-sectional online surveys to explore the impact of ankle 
symptoms on pain, disability, physical activity, psychosocial factors, falls, work ability and QoL.  
Specific objectives of this thesis were to: 
1. Systematically review available evidence of physical impairments in individuals with ankle 
OA (Chapter 3); 
2. Compare physical measures (ambulatory function, ankle muscle strength and endurance, 
ROM, ankle-subtalar joint laxity, foot mobility and posture) and patient-reported 
outcomes (QoL, perceived function, pain, disability, kinesiophobia and physical activity) 
between 1) individuals with symptomatic ankle OA and asymptomatic controls, and 
between 2) asymptomatic individuals with and without evidence of ankle OA, and to 
explore the relation between QoL, patient-reported outcomes and physical impairments 
(Chapter 5); 
3. Compare pain, stiffness and patient-reported outcomes (QoL, perceived function, 
disability, kinesiophobia and physical activity) between individuals with persistent ankle 
symptoms and asymptomatic controls (Chapter 6); 
4. Identify whether the psychological characteristics of individuals with ankle symptoms 
differ from that of asymptomatic controls, and to assess the association between 
psychological characteristics and 1) pain, and 2) self-reported function (Chapter 7); 
5. Assess work limitations experienced by individuals with and without ankle symptoms, 
compare function and psychological features between working and non-working 
individuals with ankle symptoms, and to explore factors associated with work limitation 
in the symptomatic group (Chapter 8); 
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6. Compare the self-reported history of falls, balance confidence and falls self-efficacy 
between individuals with ankle symptoms and asymptomatic controls, and to identify 
factors associated with the frequency of falls in individuals with ankle symptoms (Chapter 
9). 
2.9 Overview of thesis structure  
This thesis is presented with a series of chapters to address the thesis objectives 
identified above. Traditional thesis format was selected for The Background (Chapter 2), The 
Methodology (Chapter 4), and the Discussion and Conclusion (Chapter 10). These three 
chapters indorse the thesis context with supplementary details not provided in other chapters 
prepared for publication in peer review journals. 
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Chapter 3 Physical impairments in adults with ankle osteoarthritis: A 
systematic review and meta-analysis. 
3.1 Introduction 
Osteoarthritis is one of the most prevalent and costly 216,217 health conditions and 
causes of disability 15,16,95. The World Health Organisation estimates that 80% of people with 
OA are limited in their movement, and 25% are unable to perform many daily activities 218. 
Ankle OA affects approximately 70 million people worldwide 217. It is predominantly 
associated with previous ankle trauma, including ankle sprains 14, and fractures15,17,18. Given 
that ankle sprains are the most common injury among sportspeople 129,130 and the most 
common injury seen in US emergency departments 131, the incidence of ankle OA is a 
considerable health concern. There is evidence that individuals with post-traumatic ankle OA 
report higher levels of disability, measured by the ankle osteoarthritis scale relative to age-
matched controls 147. Studies investigating the QoL indicate that mental and physical disability 
associated with ankle OA is similar to that of individuals with end-stage hip OA 173, renal 
disease, radiculopathy and congestive heart failure 214. Due to the post-traumatic origin of 
ankle OA, it affects a younger population than OA of other joints 15,17. The disability associated 
with ankle OA may negatively impact earning potential and the ability to meet familial 
obligations. 
In contrast to hip and knee OA, management options for ankle OA are limited with 
lower success rates and less favorable long-term outcomes following surgical intervention 219-
222,236. Physical therapy is frequently used to manage pain and disability associated with OA 
223. The goals of intervention are often achieved by addressing physical impairments, such as 
low muscle strength/ endurance, limited range of motion (ROM) and poor balance 224-226, 
which improve pain and function 224,227,228. Recent International Ankle Consortium 
recommendations highlighted the need to address and raise awareness and understanding of 
the consequence of lateral ankle sprain 229, of which ankle OA is one. At the moment, it is 
challenging to determine which impairment(s) should take priority as a therapeutic target(s) 
for patients with ankle OA. Consistent with International Ankle Consortium 
recommendations, an improved understanding of the scope and extent of physical 
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impairments in individuals with ankle OA is required. Further, understanding key impairments 
in ankle OA will inform the selection of outcomes measures, and development of non-surgical 
interventions for studies investigating disease management. This systematic review aimed to 
document reported physical impairments in adults with ankle OA by comparing affected and 
unaffected sides in adults with unilateral ankle OA and healthy controls.  
3.2 Methods 
3.2.1 Design 
The protocol for this review was registered with the International Prospective Register 
of Systematic Reviews (PROSPERO; registration number CRD42016036720). The following 
variations from the protocol were implemented: (a) gait-related outcomes were excluded 
from this review as they were deemed of sufficient quantum to warrant a separate review; 
and (b) the I² statistic was used as the indicator of statistical homogeneity instead of chi-
square statistic. Reporting was conducted in accordance with the Meta-analysis of 
Observational Studies in Epidemiology (MOOSE) criteria 230 and the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) statement 231,232. 
3.2.2 Search Strategy  
A comprehensive search strategy was devised in collaboration with a medical librarian. 
Three sets of entry strings were combined with AND. The first set of terms included synonyms 
for ankle OA and the second set specified anatomical location. The terms in each set were 
combined using OR. Those two sets of search strings were combined using AND to a third 
search string consisting of physical outcomes and synonyms (range of motion, muscle 
strength, balance, and proprioception). Finally, a set of NOT terms (searched in titles and 
abstracts) was used to exclude animal, cadaveric and pediatric studies, and papers 
investigating unrelated health conditions, such as anterior cruciate ligament injury, 
patellofemoral pain or hallux valgus. PubMed, EMBASE, CINAHL, Web of Science, and 
SPORTDiscus databases were searched with no language or date restriction. The detailed 
search algorithm for different databases is presented in Appendix 1. 
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3.2.3 Eligibility Criteria  
Retrieved titles and abstracts were screened for eligibility using the following criteria: 
1) the study investigated physical impairments associated with ankle OA, and 2) the study 
compared physical impairments between individuals with and without ankle OA or compared 
the affected and unaffected side in individuals with ankle OA. Intervention studies were 
eligible for inclusion if pre-intervention measures were compared to individuals without ankle 
OA or to the unaffected side. Studies of different types of arthritis (e.g. rheumatoid arthritis, 
septic arthritis) were only included if data for ankle OA were reported separately. Abstracts 
from scientific meetings, case reports, and descriptions of surgical techniques were excluded.  
3.2.4 Study Selection  
One author (MM) screened all articles identified in the literature search using the pre-
defined inclusion and exclusion criteria. A second author (MDS) screened a randomly selected 
5% of the total studies. Full articles were retrieved and screened when inclusion could not be 
determined by reading the title and abstract. Translations were sought to determine the 
eligibility of five non-English publications (three French, one German and one Korean), one of 
which was eligible. Reference lists of all eligible studies were manually screened for potential 
studies not found by the electronic database search. The final eligibility of selected 
publications was determined by consensus with all authors.  
3.2.5 Assessment of Study Quality and Risk of Bias 
Quality assessment of all eligible studies was completed using the Epidemiological 
Appraisal Instrument (EAI) 233. The EAI has demonstrated good/excellent validity, and (intra 
and inter-rater) reliability 233. Ten of the original EAI items (related to intervention, 
randomisation, and follow-up) were not used, because they did not apply to cross-sectional 
and case-control study designs. Two reviewers (MM) and (DM) independently rated each 
article after de-identification by removal of author, journal, and title. Scores were compared 
for consensus and disagreements were resolved by a third investigator (although this was not 
necessary). The overall score was recorded as an average of the scores from all applicable 
items (range 0-1). 
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3.2.6 Data Extraction 
Data from eligible studies were extracted into a pre-designed evidence table by one 
reviewer (MM) and verified by a second (DAM). The following data were extracted from 
eligible studies: authors, publication year, country, study objectives as stated by the authors, 
study design, OA definition/diagnosis, population characteristics, comparisons made, 
outcome measures, measurement tools used and study findings (values expressed as mean 
and SD). 
3.2.7 Data Analysis 
Kappa statistics were used to report the inter-rater reliability between the two 
assessors for study selection and quality assessment. Inter-rater reliability was categorized as 
poor (<0.00), slight (0.00–0.2), fair (0.21–0.4), moderate (0.41–0.6), substantial (0.61–0.8) or 
almost perfect (0.81– 1.0) 234. Data were analysed using SPSS V.25 software (SPSS Inc., 
Chicago, USA). 
Studies with similar outcome measures and methods were considered for meta-
analyses using RevMan 5 (Copenhagen, Denmark, The Nordic Cochrane Centre, 2006). 
Heterogeneity was assessed by inspecting the I² statistic and was considered unacceptably 
high for values greater than 75% 235. When homogeneity was less than or equal to 75%, data 
were pooled in a statistical meta-analysis with random effects. 
Data representing point estimates of effect are presented as standardized mean 
differences (SMDs) and their confidence intervals (CI) in tabular format and in forest plots 
where appropriate. The SMD was calculated as the difference between ankle OA and control 
group means divided by the pooled standard deviation (SD) for all outcomes. For studies in 
which the SD was not available, it was calculated as the product of the standard error of the 
mean and the square root of the sample size 236. Differences in outcomes between the 
affected side in individuals with ankle OA and controls were calculated such that negative 
differences indicated that the measure for ankle OA was lower relative to controls, and 
positive differences indicated the opposite. Between-group differences were considered 
significant if the 95% CI did not contain zero. Effect sizes were interpreted as small (SMD>0.2), 
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medium (>0.5) and large (>0.8) 237. SMD [CI] is reported throughout the text to provide a 
point estimate of effect for comparisons between measures with different units.  
3.3 RESULTS 
3.3.1 Study Selection 
The search identified 4565 results, with 3439 unique studies remaining after removal 
of duplicates. After screening titles and abstracts, it was decided to exclude gait-related 
measures from this review due to the quantum of papers, which warrants a separate review. 
This left 28 full-text articles that were then assessed for eligibility. Corresponding authors 
were contacted when information unavailable in the paper was needed to determine 
eligibility 145,147. Eight studies met the eligibility criteria (Figure 3.1). There were no 
disagreements between the two reviewers in the eligibility assessment (undertaken on a 
random 5% (172) of the studies identified). A subsequent manual reference list search of 
included studies did not reveal any additional studies.  
 
FIGURE 3. 1: PRISMA 2009 flow chart for the selection process 
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3.3.2 Assessment of Study Quality and Risk of Bias  
There were no disagreements between the two raters among the 264 quality 
assessment items rated (κ=1.000 (p<0.01)). The EAI quality assessment demonstrated a 
median score of 0.36 out of 1 (range: 0.30-0.56; Appendix 2). Descriptions of the research 
objectives 145-147,155,238-241, study design 145-147,155,238-241, main outcomes 145,146,155,238,239,241, 
standardized assessment of outcomes 145,146,155,238,239,241,and key findings 145-147,155,238-241 were 
addressed in most studies. The items which were not well addressed were a priori sample size 
calculation 239, missing data and dropouts 238, and assessor blinding 146. Three studies 145,146,239 
collected prior history of ankle injuries as a contributing factor to OA development, but only 
one study 145 included this information in the analysis. No study reported the results by age or 
sex. Only two studies reported the validity of their main measures 155,239, and two provided 
information about the psychometric properties of the physical impairment measures 145,240. 
3.3.3 Study Characteristics 
All studies were published between 2006 and 2013 and conducted in the following 
geographical locations: Switzerland (n=2) 155,239, Korea (n=2) 240,241, Japan (n=1) 238, USA (n=2) 
147,146, and Canada (n=1) 145, There were a total of 343 ankle OA and 220 control participants 
across studies. Individual study sample sizes ranged from 10 (5 ankle OA and 5 controls) 147 
participants to 154 (104 ankle OA and 50 controls) 240. Seven studies compared data between 
individuals with ankle OA and controls 145-147,155,238,240,241, and 4 studies compared the affected 
and unaffected ankles in individuals with ankle OA 145,146,155,239 (with 3 studies reporting both 
comparisons 146,145,155). Characteristics of studies included in the review are presented in 
Table 3.1.
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Table 3.1: Characteristics of studies included in the review 
Author Year Country EAI score OA cases Control cases Outcomes investigated Results 
Wiewiorski et al. (2012) Switzerland 0.41 21 (10 M, 11 F) 
Age (35–76 y) 
Unaffected side 
▪ Total DF/PF ROM 
▪ Calf circumference 
▪ Muscle CSA 
▪ Muscle fatty infiltration 
▪ Less total DF/PF ROM and lower calf circumference on 
the affected side compared to the unaffected side 
▪ Greater Fatty infiltration and smaller overall anatomical 
CSA in all compartments and muscles on the affected 
compared to unaffected side in individuals with ankle 
OA. 
▪ Smaller CSA for Soleus and the deep posterior muscles 
on the affected compared to the unaffected side. 
Valderrabano et al. 
(2006) 
 
Canada 0.36 15 (6M, 9F) 
Age 53.3(33- 74 y) 
 
15 (6M, 9F) 
Age 52.9 (27-65y) 
▪ Total DF/PF ROM 
▪ Calf circumference  
▪ DF-PF torque 
▪ Surface EMG amplitude 
and frequency during 
muscle MVC 
 
 
▪ Less total DF/PF ROM on the affected side compared to 
the unaffected side.  
▪ No difference in calf circumference on the affected side 
compared to the unaffected side and controls. 
▪ Significant DF/PF weakness on the affected side 
compared to unaffected and control. 
▪ No difference in calcaneal alignment between moderate-
advanced OA and controls or between sides in 
individuals with OA. 
▪ Mean EMG frequency was lower for all tested muscles 
on the affected compared to unaffected side in ankle OA 
▪ Lower Anterior tibial and medial gastrocnemius EMG 
frequencies in ankle OA compared to controls 
▪ Lower Medial gastrocnemius but not anterior tibial, 
peroneus longus or soleus EMG amplitude in ankle OA 
compared to controls 
Nüesch et al. (2012) Switzerland 0.35 12 (6M+ 6F) 
Age 56.60 y 
12 (7M, 5F) 
Age 48.41 
▪ Calf circumference  
▪ DF-PF torque  
▪ No difference in calf circumference on the affected side 
compared to the unaffected side and controls. 
▪ Significant DF/PF weakness on the affected side 
compared to control. 
Hayashi et al. (2008) 
 
Japan 0.56 80 (15M, 65F)  
Age 64 (32 -85 y)  
50 (10 M, 40F) 
Age 39 (13- 86 y) 
 
▪ Radiographic bony 
alignment 
▪ Progressive increase TPC angle from mild OA to 
moderate OA, then decreased in advanced OA compared 
to controls 
▪ Less TTS and TAS angles in all stages of ankle OA 
compared to controls 
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▪ Smaller TAS and TLS angles in ankle OA compared to 
controls 
▪ Greater TMM angle in advanced OA and less TTS angle 
for moderate and advanced ankle OA compared to 
controls 
Hubbard et al. (2009) 
 
USA 0.33 (4M, 4F) 
Age (51.8±11.41y) 
(4M, 4F) 
Age (51.5±11.2y) 
▪ Mechanical stability  
▪ DF-PF and INV-EV torque 
▪ Static balance 
▪ Less anterior displacement on the affected ankle 
compared to the unaffected ankle in ankle OA and 
controls. 
▪ Less inversion and eversion on the affected compared to 
the unaffected ankle in individuals with ankle OA and 
controls. 
▪ No difference in posterior displacement between sides or 
groups.  
▪ Greater total COP displacement and total velocity. 
▪ Greater ML velocity and AP sway in OA compared to 
controls. 
▪ Weaker DF, PF, INV, and EV on the affected ankle 
compared to the unaf-fected ankle in individuals with 
ankle OA and controls.  
Lee et al. (2011) 
 
Korea 0.39 98 (47M, 51F)  
Age 58.2 (43 -78y)  
 
80 (57M, 23F)  
Age 23.4 (18 – 25y)  
 
▪ Radiographic bony 
alignment 
▪ Greater talar tilt angle on the affected ankle than 
controls. 
▪ Smaller TAS and TLS angles and an increase in TMM 
angle as the stage of OA progressed compared to 
controls. 
Lee et al. (2013) 
 
Korea 0.36 104 (72M,32 F) 
Age 62 (22-77 y) 
50 
▪ Radiographic bony 
alignment 
▪ Smaller tibio-talar ratio in individuals with ankle OA than 
controls. 
Wikstrom & Anderson. 
(2013) 
USA 0.30 5  
Age (63.4±11.3y) 
5 
Age (60.0±3.0y) 
▪ Standing balance ▪ Greater anteroposterior sway in OA compared to 
controls. 
Abbreviations: F, female; M, male; Y, years; PF, plantar flexion; DF, dorsiflexion; INV, inversion; EV, eversion; MVC, maximum voluntary contraction; COP, centre of pressure; AP, Anteroposterior; ML, Medial-lateral; 
TMM (◦), The angle between the distal third of the tibial shaft and the medial malleolar joint surface; TTS (◦), The angles between the tibial shaft the articular surface of the talar dome; TPC (◦), The angle between 
the tibial shaft axis and the articular surface of the posterior facet of the calcaneus; TAS (◦), The angle between the tibial shaft and tibial articular surface in the frontal plane on weight-bearing x-ray; TLS (◦), The 
angle between the tibial shaft axis and the articular surface of the tibial shaft in the sagittal plane on weight-bearing x-ray; SIA, angle between the articular surface of the talar dome and the posterior facet of the 
calcaneus; Tibiotalar ratio, ratio into which the mid-longitudinal axis of the tibial shaft divides the longitudinal talar length; CSA, cross sectional area; EMG, electromyography; ±, standard deviation. 
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3.3.4 OA Diagnosis 
The majority of studies used radiographic imaging to establish the presence of OA 
(n=7) 147,238,239,146,240,145,241. One study did not specify the method of establishing OA diagnosis  
155. Four studies 238,145,239,241 reported radiographic classification criteria used to establish a 
diagnosis of ankle OA; whereas, three studies did not specify how the radiographs were 
evaluated 147,146,240. No study provided information on the reliability of the radiographic 
classification system.  
The radiographic classifications used were the three-stage Morrey and Wiedeman 
classification 54 (n=2) 145,239 and the modified five-stage Takakura classification 55 (n=2) 238,241. 
The Morrey and Wiedeman and the modified Takakura classification systems have similar 
early stage (1and 2) OA definitions (e.g., early sclerosis, minimum narrowing, and osteophyte 
formation). The modified Takakura classification includes an intermediate stage 3 OA 
classification that further differentiates the extent of joint space narrowing and subchondral 
bone contact. The advanced stage OA is similar in both classifications (e.g., gross deformity, 
ankyloses, no joint space and bone contact). For this systematic review, ankle OA radiographic 
severity was collapsed to three categories incorporating both classifications: mild (stage 1), 
moderate (stage 2) and advanced OA (stages 3-4; Appendix 3). 
3.3.5 Meta-analyses   
Three studies contributed data to the meta-analyses of total sagittal plane ROM, calf 
circumference, and maximal voluntary isometric dorsiflexion (DF) and plantar flexion (PF) 
strength. Data (SMD and CI) are presented in forest plots (Figures 3.2 and 3.3). Large effects 
were identified for sagittal plane ROM (two studies 145,239) and maximal voluntary isometric 
strength (two studies 145,155). Pooled data indicate less sagittal plane ROM on the affected 
compared to unaffected side in individuals with ankle OA, and lower maximum ankle DF and 
PF torque on the affected side in individuals with ankle OA compared to controls. 
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FIGURE 3. 2: Range of movement and calf circumference differences between sides in ankle OA 
 
FIGURE 3. 3: Calf circumference and muscle strength differences between groups 
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3.3.6 Outcomes from Single Studies 
Single studies assessed ROM, torque, calf circumference, ankle arthrometry, bony 
alignment, muscle electromyography (EMG), calf cross-sectional area (CSA) and fatty 
infiltration in calf muscles in individuals with ankle OA compared to controls or the 
individual’s unaffected side. Pooling of data was not possible due to differences in reported 
outcomes or methods of measurement, or high heterogeneity. All data pertaining to effect 
sizes for outcomes are presented in (APPENDIX 4) and outcomes with large effect sizes are 
reported below. 
3.3.6.1 Range of Movement (ROM) 
One study compared total ankle DF and PF (sagittal) ROM and inversion and eversion 
(frontal) ROM between individuals with ankle OA and controls, with frontal plane ROM also 
compared between sides in individuals with ankle OA 145 (sagittal plane ROM reported in the 
meta-analysis, Figure 3. 2). Large effects were found for less frontal and sagittal plane ROM in 
individuals with ankle OA compared to controls, and less frontal plane ROM in individuals with 
ankle OA compared to the contralateral side 145.  
3.3.6.2 Ankle Arthrometry 
One study 146 used a portable ankle arthrometer (Blue Bay Research, Navarre FL) to 
measure anterior-posterior displacement and inversion-eversion rotation. Large SMDs 
indicated less anterior displacement and inversion and eversion rotation on the affected ankle 
in individuals with OA compared to the unaffected ankle and controls. Eversion rotation was 
also less on the unaffected side in ankle OA than in controls.  
3.3.6.3 Calf cross Sectional Area (CSA) and Fatty Infiltration 
One MRI study 239 quantified CSA and fatty infiltration in the medial and lateral 
gastrocnemius and soleus muscles, and the anterior, lateral and deep posterior 
compartments of the calf in individuals with ankle OA. Large effects indicated smaller soleus 
CSA, smaller overall anatomical calf CSA, and greater fatty infiltration in all 
muscles/compartments in the affected compared to the unaffected side in individuals with 
ankle OA.  
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3.3.6.4 Joint Torque 
Comparison of DF and PF torque between sides in individuals with ankle OA indicated 
lower torque on the affected than on the unaffected side 145. Ankle DF, PF, inversion and 
eversion torque normalised to body weight was less on the affected and unaffected ankles in 
individuals with OA compared to controls 146. There were also large deficit effects for 
normalised eversion and inversion torque on the affected compared to the unaffected side in 
individuals with ankle OA.  
3.3.6.5 Muscle Electromyography (EMG) 
Large SMDs from one study indicated lower medial gastrocnemius EMG amplitude 
and lower anterior tibial and medial gastrocnemius muscle EMG frequencies on the affected 
side in individuals with ankle OA compared to controls 145. EMG frequency on the affected 
side was also lower for the medial gastrocnemius, soleus and peroneus longus compared to 
the unaffected side. 
3.3.6.6 Standing Balance 
Balance during double leg stance was assessed in two studies using different testing 
methodology and outcomes 147,146. Data indicated a greater total centre of pressure (COP) 
displacement and velocity 146, mediolateral velocity 146 and anteroposterior sway 147 in 
individuals with ankle OA compared to controls.  
3.3.6.7 Bony Alignment  
Alignment data were identified in four studies using radiographic 238,240,241, or 
goniometric measures 145. The angle between the distal third of the tibial shaft and the joint 
surface of the medial malleolus (TMM) was greater in those with advanced OA 238,241, and the 
angle between the tibial shaft and the articular surface of the talar dome (TTS) was less for 
those with moderate and advanced ankle OA compared to controls, both measures indicating 
greater varus in those with ankle OA. Individuals with moderate and advanced ankle OA also 
had a greater angle between the articular surface of the talar dome and the posterior facet of 
the calcaneus (SIA) than did controls 238. The angles between the tibial shaft and tibial 
articular surface in the frontal (TAS) and sagittal (TLS) planes were assessed in two studies 
238,241, which could not be pooled due to high heterogeneity (I2 values>75%). Large effects 
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indicated that TAS (two studies 238,241) and TLS (one study 241) was smaller for individuals with 
moderate and advanced ankle OA compared to controls. The tibio-talar ratio (the mid-
longitudinal axis of the tibial shaft divided into that of the talus) 240 was smaller in individuals 
with advanced ankle OA than controls. SMDs for talar tilt angle (the angle between talo-crural 
joint surfaces with the ankle in supination 242) could not be calculated due to a standard 
deviation of zero in the control group 241. 
3.4 Discussion 
This systematic review synthesised data from eight studies investigating physical 
impairments in individuals with ankle OA compared to controls or the unaffected side. The 
quality appraisal highlighted a general lack of reporting missing data, assessor blinding and 
measurement validity. Meta-analyses of three studies provided evidence of less sagittal plane 
ROM and smaller calf circumference on the affected compared to unaffected side in 
individuals with ankle OA and lower ankle torque production in individuals with ankle OA 
compared to controls. Evidence from single studies reported less total frontal plane ROM, 
lower frontal plane torque production, and less talar translation and rotation on arthrometry 
on the affected compared to the unaffected side in individuals with ankle OA and controls. 
Single studies also reported more fatty infiltration, smaller muscle CSA and a shift towards 
lower EMG frequencies for some muscles that influence ankle movements on the affected 
compared to the unaffected side with differences in bony alignment on the affected ankle 
compared to controls.  
Ankle OA impairments are likely to present as elements of a complex patho-etiologic 
paradigm. Limited joint mobility is one of the clinical signs of OA 243,151,244,245 and is commonly 
present after an ankle sprain 246,247. Large ROM differences are present between affected and 
unaffected ankles in individuals with ankle OA 145,239 and between the affected ankle in 
individuals with ankle OA and controls 145. The limited joint mobility may be due to factors 
such as shortened musculotendinous structures (i.e. shortened gastrocnemius-soleus 
complex) 248,249, limited accessory or physiological joint motions (i.e. limited talar glide) 250-252 
due to degeneration or capsular restriction 253, or chronic inflammation or pain 254. Consistent 
with restricted ankle ROM, individuals with ankle OA have less anterior talar translation and 
inversion and eversion rotation on arthrometry compared to controls. These findings suggest 
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that ROM deficits in individuals with ankle OA are related to joint restriction, in addition to 
potentially shortened musculotendinous structures. Because only total ankle ROM is 
reported, it is unclear whether ROM deficits at the ankle are due to PF restriction, DF 
restriction, or both. This is important because reduced ankle DF has been associated with 
impaired gait, and compromised balance and function 169,165-167,168. An improved 
understanding of the underlying mechanisms of movement restriction could lead to improved 
patient management. 
Large differences in isometric PF, DF, inversion, and eversion torque production were 
found between the affected side in individuals with ankle OA and controls. Lower PF torque 
production is consistent with findings of lower medial gastrocnemius EMG amplitude and 
frequency in individuals with ankle OA (affected side) compared to controls. The relationship 
between lower torque production in other directions of ankle movement and EMG 
amplitude/frequency of relevant muscles was not readily apparent, and the interpretation of 
altered EMG findings is unclear. Lower EMG amplitude and muscle strength may be due to an 
inability of the central nervous system to fully activate the muscle 255 (arthrogenous muscle 
inhibition) which has been shown in knee OA 256,257, post-knee trauma 258, acute ankle sprains 
259 and functional ankle instability 260. OA-related muscle inhibition is thought to occur due to 
pain 167, 257,261, joint immobilization 145 and altered sensory output accompanying articular 
cartilage structural changes 262,263.  
Weaker muscles and lower muscle activation may contribute to, or be a consequence 
of, muscle atrophy. Calf circumference was smaller on the affected compared to the 
unaffected side in individuals with ankle OA, but not between individuals with ankle OA and 
controls. The difference in calf circumference between the affected and unaffected sides in 
individuals with ankle OA 145,239,155 was driven by the findings of Wiewiorski et al 239. Greater 
fatty infiltration and smaller posterior muscle size 239 may contribute to smaller calf 
circumference and muscle weakness on the affected side in individuals with ankle OA. The 
hypertrophy/increased muscle CSA on the unaffected side in ankle OA may be an adaptation 
related to increased use of the unaffected side in individuals with unilateral ankle OA. 
Although only investigated in studies with small sample sizes 147,146, the standing 
balance was impaired in individuals with ankle OA compared to controls. Standing balance 
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264,265 and proprioception 266-268 deficits are also observed in ankle sprains. Reduced joint 
motion 168,189, weak muscles 187 and pain 269 could contribute to compromised balance in 
ankle OA. As impaired balance is linked with falls 187;191,270, this may suggest an increased risk 
of falls in this population. Further research to understand specific elements of balance 
impairment and evaluate the incidence of falls in people with ankle OA is needed.  
Individuals with ankle OA commonly present with concomitant varus hindfoot 55,116. 
This shift in alignment alters the normal load bearing across the ankle joint resulting in 
asymmetrical load distribution. A direct correlation between the extent of malalignment and 
amount of degenerative changes at the ankle has been reported 120. Key findings from data 
on tibio-calcaneal and tibio-talar angles suggest that the progressive subtalar joint valgus 
inclination is an attempt to compensate for tibial varus. It is unclear whether the 
malalignment was pre-existing and possibly contributed to ankle OA or was a consequence of 
ankle OA. In individuals with knee joint OA, malalignment predicts a decline in physical 
function 271, but the effect of alignment on physical function in individuals with ankle OA is yet 
to be explored.  
A number of factors must be considered when interpreting the findings from this 
systematic review. First, many studies used a convenience sample of individuals with end-
stage OA awaiting surgical intervention 238,239,240. These participants likely have the most 
severe symptoms and impairments related to ankle OA, which may not represent the broader 
ankle OA population and limits the generalizability of data. Further research investigating 
impairments present in the earlier stages of ankle OA is warranted. Second, pooling data and 
comparison between studies was limited by the populations, comparisons made, and single 
studies that assessed many measures (e.g., weighted muscle torque 146, calf CSA 239, balance 
146, muscle EMG 145,239 and mechanical instability 146). Third, some studies compared 
individuals with ankle OA to controls whereas others compared data between affected and 
unaffected sides in individuals with ankle OA. Evidence from other musculoskeletal conditions 
of bilateral impairments in individuals with unilateral problems 272, 273-275 suggests that 
comparison to the unaffected side may not be the most appropriate approach to study 
impairments in individuals with ankle OA.  
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Fourth, while there were methodological limitations in the research of physical 
impairments in individuals with ankle OA, the included studies offered insight into OA related 
impairments that should be explored by further research. The assessment of study quality 
highlights the need for future studies to specify validity of outcome measures, include a 
control (unaffected) group, recruit individuals with ankle OA from the general population, and 
consider demographics and stage of OA in analyses; to optimize generalizability of findings. 
Investigation of direction-specific ROM deficits and performance of functional tasks (such as 
walking and stairs) is needed. Further, longitudinal study designs are necessary to understand 
the development and progression of physical impairments in individuals with different stages 
of ankle OA. Finally, to our knowledge this review is the first to study impairments in ankle 
OA, it has employed a comprehensive strategy with terms that cast a broad net over the 
literature. However, it may have missed relevant articles with different keywords, an unclear 
or covert title or abstract, or studies not indexed in the specified databases.  
3.5 CONCLUSION 
This systematic review assessed the literature and identified issues with the 
methodological quality of studies investigating physical impairments in individuals with ankle 
OA. Meta-analyses indicated large impairments in ankle sagittal ROM and torque in ankle OA 
compared to controls. Single studies suggest that altered joint alignment, impaired standing 
balance and EMG activity, and limited arthrokinematic movements may be characteristic of 
ankle OA. Considerations of these impairments may lead to improved outcomes in the 
management of individuals with ankle OA. Further high-quality research is needed to better 
understand impairments in the different stages of ankle OA, particularly early OA which has 
received little attention in the literature, and the relation between specific impairments, 
function/disability and quality of life. 
3.6 KEY POINTS 
FINDINGS: Physical impairments are evident in the affected and unaffected sides in 
individuals with ankle OA compared to controls. In terms of mobility, ankle joints affected by 
OA are stiffer with less range of motion and translation. Leg muscle weakness and fatty 
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infiltrate along with altered neuromuscular function are characteristic of individuals with 
ankle OA. Balance deficits are also present in this population. 
IMPLICATIONS: Identified physical impairments associated with ankle OA would likely 
compromise physical capacity. Targeted interventions to address those specific impairments 
in torque production, ROM, mechanical and sensorimotor outcomes may lead to improved 
outcomes. 
CAUTION: Data pooling was not always possible due to single studies assessing the 
measure or different variables collected between studies. Thus, meta-analyses only included a 
small number of studies which had small sample sizes. This review has not identified different 
outcomes between stages of OA. Further research is required to assess the impact of ankle 
OA on individuals with the early-stage disease.
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Chapter 4 Cross-sectional studies methodology 
As reported in chapter 3, a systematic review of studies investigating physical 
impairments in ankle OA identified methodological limitations and limited generalisability of 
findings, which reinforces the need for further research into impairments characterising ankle 
OA, particularly in those not in end-stage of the condition. To address this gap in the literature, 
cross-sectional laboratory and survey studies were undertaken to improve our understanding 
of how ankle symptoms and OA affect physical measures and function, psychosocial health 
and QoL. This chapter describes the research methodology employed in the cross-sectional 
studies. Part 1 deals with physical laboratory examination and part 2 deals with self-reported 
outcomes collected via 2 independent online surveys. 
4.1 Cross-sectional laboratory study 
4.1.1 Study participants 
4.1.1.1 Recruitment methods 
Study participants were recruited via community advertising between February 2016 
and November 2017. Advertisements targeting individuals aged between 18 and 75 years 
with and without ankle joint symptoms were placed in a university staff electronic newsletter, 
and on websites and communications from Arthritis Australia, Arthritis Queensland, Arthritis 
NSW, and The University of Queensland Ageing Mind Initiative 50+ Registry. Participants were 
also recruited through social media platforms such as Facebook, Twitter, Nabo, and 
WeekendNotes (targeting volunteers from different Australian states). The advertisements 
contained a link to an online screening survey which contained preliminary information about 
the study and questions to check eligibility. Responders to the online screening survey who 
met the study eligibility requirements were contacted by phone to confirm eligibility and 
were invited to participate. Ethical approval was gained from The University of Queensland’s 
Medical Research Ethics Committee (Appendix 5), and all participants provided informed 
consent prior to participation (Appendix 6). 
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4.1.1.2 Eligibility criteria 
To be eligible to participate in the laboratory study, participants were required to be 
between 18 and 75 years of age. Similar to criteria in other studies, eligibility for the ankle 
symptom group was based on an affirmative response to the following question: “Have you 
experienced any of the following ankle symptoms: 1) Pain or ache in/or around the ankle, 2) 
Ankle joint stiffness or reduced movement when you wake up in the morning for more than 3 
months on most days over the past months?”. Individuals in the asymptomatic group were 
required to have no injury or pain to either ankle or foot within last 12months and no 
previous ankle surgery. Exclusion criteria for both groups were: pain or injury to other areas 
of the lower limb or low back in the last 3 months that interfered with participation in daily 
activities, recreation or sport, or required consultation with a healthcare professional; 
previous surgery to the lower limb (aside from the ankle in the symptomatic OA group); ankle 
or foot joint fusion or replacement; any of the following conditions: neurological or vestibular 
disorders (i.e. stroke, epilepsy or Parkinson disease), peripheral vascular disease, diabetes, 
rheumatoid or inflammatory arthritis; and unable to be exposed to radiological investigations 
(e.g. pregnancy).  
4.1.1.3 Matching of symptomatic and asymptomatic groups 
Participants in the symptomatic and asymptomatic groups were required to be of 
similar sex and age (±10 years) and were matched for leg dominance (i.e. the leg tested in 
individuals in the asymptomatic group was matched for dominance to the symptomatic ankle 
of an individual of similar age and sex in the symptomatic group).The dominant foot was 
identified using the lateral preference inventory 276. The inventory measures lateral 
preference on the four dimensions of handedness, footedness, eyedness, and earedness. 
Participants were asked four questions concerning foot preference: 1) ‘Which foot would you 
use to kick a ball or hit a target?’, 2) ‘If you wanted to pick up a pebble stone with your toes, 
which foot would you use?’, 3) ‘Which foot would you use to step on a bug?’, 4) ‘When 
stepping up onto a chair, which foot would you use first?’. In participants with bilateral 
symptoms, the ankle with the greater pain or stiffness within the last 3 months was 
nominated as the symptomatic limb.  
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4.1.2 The definition of symptomatic ankle OA 
Similar to definitions used in hip OA research 277, symptomatic ankle OA was defined 
as radiographic evidence of OA and symptoms of ankle pain and/or stiffness. Asymptomatic 
radiographic OA was defined as radiographic evidence of OA with no reported ankle 
symptoms (pain or stiffness). Evidence of radiographic OA was defined as KL grades of ≥ 2 
277,278,44,279,63 which is a minimum presentation of osteophytes with mild joint space narrowing 
280. Individuals with KL grades of 0–1 (no or doubtful OA) were categorized as no signs of 
radiographic OA. 
4.1.3 Radiographic evidence of ankle OA  
A mortise radiographic view of the ankle (an AP-view with the foot/ankle positioned in 
10° internal rotation) with the beam centered on the ankle was taken for grading of OA 
features of the medial and lateral aspects of the tibiotalar and talofibular joints. A lateral 
ankle view (with the foot/ankle positioned in 15° external rotation) with the beam centered 
on the medial aspect of the ankle joint was taken for grading of OA features of the anterior 
and posterior aspects of the tibiotalar and subtalar joints) 280,281. Assessment of radiographs 
to determine the presence and grade of OA in the tibiotalar, talofibular and subtalar joints 
was undertaken using the atlas of radiographic features of OA of the ankle and hindfoot and 
modified KL scale 280 (Table 4.1). The scale has been validated for defining ankle OA 60. 
Radiographs were de-identified by a researcher uninvolved in the study or grading process. 
Grading of de-identified x-rays was undertaken by two independent assessors (MM and MS). 
Table 4.1: Radiographic grades of severity of ankle OA 
KL Grade Description 
0 No radiographic findings of OA 
1 Minute osteophytes of doubtful clinical significance 
2 Definite osteophytes with mild joint space narrowing 
3 Definite osteophytes with moderate joint space narrowing  
4 Definite osteophytes with severe joint space narrowing 
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4.1.4 Data collection sessions 
4.1.4.1 Laboratory testing sessions 
Participants attended a laboratory testing session for assessment of outcomes. Prior 
to testing, participants rated their current pain level on an 11-point numerical rating scale 
(NRS) from 0 to 10 (with 0 anchored with the words “no pain” and 10 anchored with “the 
worst pain imaginable”). The same scale was used to rate pain before and after each outcome 
tested (functional task, strength, ROM, ankle joint laxity, and plantarflexion endurance). 
Participants also rated their confidence in their ability to perform the task using an 11-point 
NRS (´0´ = Not at all confident and ´10´= Completely confident). If a participant reported 
severe pain or requested to discontinue, then the outcome measure was stopped. All 
measurements were taken by a single examiner. Participants either attended testing on one 
occasion (n=98) or on two different days (n=7) depending on participant preference and 
equipment availability. Participants also attended a local radiography clinic for ankle 
radiographs as described above.  
4.1.4.2 Patient-reported outcomes data collection 
Upon completion of the laboratory testing, participants with ankle symptoms, OA and 
asymptomatic controls were invited to complete an online survey to obtain information on 
the history of ankle injury, QoL, perceived function, pain, disability, kinesiophobia, ankle 
instability and physical activity. The survey took approximately 20-30 minutes to complete.  
4.1.5 Outcome measures 
4.1.5.1 Performance of functional tasks 
Performance of tasks involved in daily function were measured using a timed 10-
meter walk test and timed stair ascent and decent. The 10-meter walk test has excellent 
inter-rater reliability for use in healthy participants 282 and has been used with good reliability 
in adults with foot pain 283. Participants walked along a 10-meter walkway as quickly as 
possible without running. Participants started 0.5 m behind a starting line in a stride stance 
with feet hip-width apart and even weight distribution. Participants were not allowed to 
transfer weight to their back leg to build momentum to start the test. The participant started 
walking when signalled by the investigator. The stopwatch was started when the participant 
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reached the starting line and stopped when the participant crossed the end line. For 
consistent encouragement of participants to maintain the effort to the end of the test, the 
phrase “Keep going” was repeated twice as they approach the finish line. The 10-m walk was 
repeated 3 times with no rest between trials. Time to complete each walking trail was 
recorded in seconds using a stopwatch, and the fastest of the 3 trials was used for analysis. 
Stair ambulatory function was assessed using timed ascent and descent tests. This 
outcome measure has been used to assess function in other OA populations 284 and has been 
shown to have good inter-rater reliability in individuals with knee OA 285. Study participants 
were instructed to descend a set of 20 stairs (17.5 cm high, 26 cm deep) as quickly as 
possible. Participants started at the top of the stairs in stride stance and with the feet hip-
width apart. Time to complete the stair descent was recorded with a stopwatch which was 
started when the participant’s first foot was lifted from the floor. The stopwatch was stopped 
when one of the participant’s feet touched the floor below the bottom step. The same 
process was repeated to measure the time taken to ascend the set of stairs with the 
stopwatch stopped when the participant’s foot reached the floor above the top step. Time to 
complete each test was recorded in seconds. Each test was repeated 3 times with a 1-minute 
rest between trials. The fastest of 3 trials was used for analysis.  
4.1.5.2 Muscle strength and joint torque 
Maximum isometric ankle dorsiflexor, plantar flexor, invertor, and evertor muscle 
strength was measured using a custom-build device and a portable hand-held dynamometer 
(HHD; 01165 manual muscle tester, Lafayette Instrument Company, USA). This HHD has been 
reported to be reliable and valid for measuring hip, knee 286 and ankle strength 287 in research 
and clinical practice 288. The device consisted of a square wooden bench on which the 
participant’s leg rested (secured to the bed with G clamps) and a vertical piece of wood at the 
distal end which was positioned against the plantar aspect of the participant’s forefoot. A 
wooden wedge placed between the vertical piece of wood and the participant’s heel to 
position the foot in slight plantarflexion. Two Velcro straps secured the lower leg to the 
testing device to minimize movement. Torque testing was undertaken in a set order. When 
testing symptomatic participants, the asymptomatic/less symptomatic side was assessed first. 
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For testing ankle dorsiflexion, plantarflexion, eversion and inversion participants were 
positioned supine with the knee and hip flexed to 90° (Figure 3-1.A). A rigid belt around the 
distal thigh (just above the knee) and vertical piece of wood were used to secure the thigh to 
the device and minimise the effect of knee movement on testing (Figure 3-1.B). 
Ankle plantarflexion muscle strength testing was also performed with knee and hip 
extended (Figure 3-1.B). For this testing position, the wooden bench was removed and a rigid 
belt passed around the vertical piece of wood and over the shoulder to secure the participant 
to the device and minimize the effect of body movement on testing. The positioning of the 
HHD for each muscle group testing is shown in Figure 3-1 B-D. For dorsiflexion and 
plantarflexion strength, the HHD was placed against the metatarsal heads at the dorsum or 
plantar surface of the foot respectively (Figure 3-1.B and C). The HHD was placed against the 
first metatarsal head medially to test inversion strength, and against the head of the fifth 
metatarsal laterally to test eversion (Figure 3-1.D and E).  
 
FIGURE 4. 1: Starting position and HHD placement for torque testing. 
 
Participants were instructed to minimize hip and knee movement during testing and 
cross their arms over the chest. The movement to be performed was demonstrated, followed 
by a submaximal contraction (~50% of perceived maximal contraction) for familiarisation, and 
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then a practice contraction at 100% maximum voluntary contraction (MVC). Each participant 
was encouraged to perform MVC lasting for 5 seconds, with consistent verbal encouragement 
throughout testing. Each measurement was repeated 3 times with a 1-minute recovery time 
between measures. The mean force generated across trials was assessed. Torque was 
calculated by multiplying the force (measured in Newtons (N)) by the lever arm length 
(measured in meters (m). The lever arm was measured from the center of first metatarsal 
head medially to the center of the medial malleolus 289. Torque data was normalized to body 
weight in kilograms (kg) and presented as Nm/kg. 
4.1.5.3 Bent knee dorsiflexion range of motion (ROM) 
Ankle dorsiflexion ROM was measured using a custom-built lunge ankle dorsiflexion 
measurement device (Figure 3- 2) and established testing procedures with excellent inter- 
and intra-rater reliability 290-292. The participant stood on the measurement device with their 
longest toe just touching a front vertical upright. The mid-calcaneum of the test foot and web 
space between the second and third toe was placed on a line on the base of the device and 
the mid patella was placed on a line on the upright of the device. This foot and knee position 
was maintained throughout testing to avoid compensatory subtalar pronation 293. The non-
test leg was positioned with the heel in line with the longest toe of the test foot, and two 
fingers rested on a wall for balance.  
The participant slowly lunged forward (the knee moving the vertical upright forward), 
with the heel maintaining contact with the floor, until they were unable to go any further. The 
assessor ensured maintenance of heel contact with the ground via verbal instructions, visual 
examination, and palpation. This was repeated five times per limb for familiarization, followed 
by four test trials per ankle. Participants were blinded to the outcome of previous trials to 
prevent motivational effects 294. Maximal dorsiflexion ROM was defined as the maximum 
displacement of the anterior knee (resting on the device upright) measured in millimeters. 
The average of four DF measures was used for analysis 
If a participant was unable to touch the upright with their knee when it was positioned 
at the end of the longest toe, the upright was moved to touch the knee (Figure 4. 4). The 
participant was then asked lunge forward as far as possible as described above. The measure 
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was recorded as the negative distance of the anterior knee/device upright and the longest toe 
(negative measure) 295. 
 
FIGURE 4. 2: Measure of ankle dorsiflexion ROM (A: starting position, B: end position) 
 
 
Figure 4. 3: Bent knee dorsiflexion ROM measurement for a severely compromised range 
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4.1.5.4 Ankle-subtalar joint laxity 
A portable Hollis instrumented ankle arthrometer (Blue Bay Research Inc., Navarre, L) 
was used to quantify joint laxity at the ankle using a previously described procedure 296. The 
reliability of ankle arthrometer has been established 296,297,298. The participant was positioned 
in supine with the foot extended over the edge of the plinth. The lower leg was secured to the 
plinth with a strap placed above the malleoli. The foot was fixed to the arthrometer using 
clamps placed around the heel, at the dorsum of the foot and on the lower tibial. To begin all 
tests, the ankle was placed in a position of neutral dorsiflexion-plantarflexion and inversion-
eversion 299. An anterior load of 125 N was applied to the ankle joint to measure anterior 
displacement, with a similar posterior load applied to measure posterior displacement. For 
inversion-eversion rotation, a 4 Nm load was applied to the ankle, rotating it clockwise and 
then counter-clockwise. For all directions, the load was applied in a slow, controlled manner 
by the same examiner and stopped when the maximal load was reached (represented on a 
graphical interface as 125 N for anterior and posterior displacement and 4 Nm for inversion 
and eversion rotation). Each outcome was repeated 3 times and the mean value for each 
direction (Anterior and posterior displacements recorded in millimetres and inversion and 
eversion rotations in degrees) was calculated from exported raw files and was used for 
analysis. 
4.1.5.5 Foot posture 
The static foot posture was assessed using The Foot Posture Index (FPI). This is a valid 
and reliable 300 method of classifying foot postures as either pronated, supinated or normal, 
based on observations of six visual foot posture criteria. As per published protocol 301, 
participants were asked to march on the spot prior to settling into a relaxed double limb 
support stance, looking straight ahead with arms by the side. Observations of talar head 
palpation, curves above and below lateral malleolus, inversion /eversion of the calcaneus, 
talonavicular congruence, medial arch height and forefoot abduction /adduction were rated 
on a scale from -2 to +2. Total scores ranged from -12 to +12. Scores 0 to 5 denotes a normal 
foot posture, 6 to 9 a pronated posture, >10 a highly pronated posture, -1 to -4 a supinated 
posture, and -5 to -12 a highly supinated foot posture. 
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4.1.5.6 Foot mobility 
Three different variables pertaining to foot mobility were assessed: difference in 
dorsal arch height (DAHDIFF), the difference in midfoot width (MFWDIFF) and the foot 
mobility magnitude (FMM) using the Foot Assessment Platform (Figure 4.4). Dorsal arch 
height (DAH) and midfoot width (MFW) was measured in both weight-bearing and non–
weight-bearing, using a previously described protocol 302.  
For weight-bearing measures, participants stood with equal weight on both feet on a 
foot measurement platform. Heels were positioned in heel cups 15.24 cm apart. To ensure 
consistent forefoot placement on the platform, a sliding first metatarsophalangeal joint 
indicator was positioned over the medial prominence of the first metatarsal head. Weight-
bearing measurements included 1) foot length measured as the distance from the posterior 
tip of the heel to the tip of the longest toe; 2) 50% of the total foot length determined by 
dividing the measured total foot length in half; 3) dorsal arch height (DAH) measured as the 
vertical distance from the dorsal to plantar surface of the foot at 50% of total foot length and 
4) midfoot width (MFW) measured as the distance from the medial to the lateral aspect of 
the foot at 50% of total foot length. 
For the non-weight-bearing measurements, participants sat at the edge of a bed with 
thighs fully supported and knees in 90o flexion. Measurements of DAH and MFW were taken 
using a portable platform lightly positioned under the plantar surface of the test foot. Foot 
mobility was calculated as the difference between weight-bearing and non-weight-bearing 
DAH and MFW. Foot mobility magnitude (FMM), a composite measure representing a change 
in both DAH and MFW, was determined using the following formula: FMM= square root of 
(Difference DAH) 2 + (Difference MFW) 2. 
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Figure 4. 4: Measure of mid-foot width (A: weight-bearing, B: non-weight-bearing) and dorsal arch 
height (C: weight-bearing, D: non-weight-bearing) 
 
4.1.5.7 Plantarflexion endurance  
Plantarflexion endurance was assessed using a custom built device based on that 
reported in previous research 303. Participants stood on one leg facing a wall and placed 
fingertips against the wall for support. The knee of the non-test limb flexed to clear the foot 
from the floor. Heel raise height was standardized as 80% of the maximal height achieved 
when the participant lifted the heel as high as possible off the ground. A horizontal rod placed 
at the anterior ankle joint crease was used to measure maximal heel raise height, from which 
80% height was calculated. The rod was then adjusted to 80% maximal height. The participant 
raised the heel up and down to the height of the horizontal rod at a pace cued with a 
metronome set at 46 beats/min (23 lifts/min) 304,305. Participant continued to raise and lower 
the heel at the metronome pace until: vertical displacement fell below 80% of maximum for 
two consecutive repetitions, the participant leaned on the wall with more than fingertip 
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support or had decreased wall-to-body distance that was not corrected after one verbal 
warning, the non-tested leg touched the floor a second time after one verbal warning, the 
participant was unable to maintain pace with the metronome for two consecutive heel raises. 
This test was performed twice with a 1-minute rest between trails. The total time in seconds 
was recorded for each trial and the average time was used for analysis. 
 
 
Figure 4. 5: Plantarflexion endurance testing (A: starting position, B: end position) 
4.1.6 Assessment of measurement reliability 
Inter-rater reliability of radiographic assessment completed by two independent 
assessors was performed using SPSS V.25 software (SPSS Inc, Chicago, Illinois, USA). Data from 
both left and right ankles in symptomatic individuals and the single matched ankle in 
asymptomatic individuals were used, with each ankle considered a separate unit in the 
analysis. This approach is considered appropriate to compare two sets of measurements and 
not to draw conclusions regarding individual subjects 306. Kappa (κ) Statistics were used to 
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report the total inter-rater reliability which was interpreted as poor (<0.00), slight (0.00–0.2), 
fair (0.21–0.4), moderate (0.41–0.6), substantial (0.61–0.8) or almost perfect (0.81–1.0) 234. 
The intra-rater reliability of physical measures was evaluated in a small sample of 
healthy adults, who were tested twice a minimum of seven days apart. Reliability was 
interpreted as: very good for intraclass correlation coefficients (ICCs) >0.9, good for ICCs 0.75-
0.89, and moderate for ICCs 0.5 and 0.74 307. The reliability coefficients (one-way (ICCs)) were 
used to generate a measure of absolute reliability (standard error of measurement (SEM)), 
using the formula: (SEM = SD X √(1 – ICC)) 308. The following formula(MDC = 1.96 X SEM X √2) 
was used to calculate minimal detectable change (MDC) at the 95% confidence limit 309. 
Results of reliability testing for the different outcomes are reported in Appendix 7. 
4.2 Patient-reported outcomes 
The cross-sectional surveys comprised of two independent online surveys designed to 
capture measures of pain, disability, function, QoL, falls related measures, work limitation, 
psychosocial variables as well as generic health data. These outcomes were measured to 
provide information on the body function and structure (pain, stiffness, instability), activities 
(ADL activities, balance confidence), participation (FAAM-Sport, physical activities, work) and 
contextual factors (comorbidities, multiple pain sites, pain self-efficacy,) domains of the ICF 
and QoL. An enhanced version of the online survey software (SurveyMonkey) was utilised to 
assemble and create the surveys and for data collection. This section provides detail 
information about the survey participants and a description of participant recruitment 
procedures employed in the cross-sectional surveys. Each survey took 20-30 minutes to 
complete. 
4.2.1 Study participants 
4.2.1.1 Recruitment method  
The sample for each survey was recruited at a different time with independent 
community and social media advertisements via UQ Update, Twitter, Nabo, WeekendNotes 
and paid online advertising via Facebook. Advertisements were also placed on websites of 
Arthritis Australia, Arthritis Queensland, Arthritis NSW, and The University of Queensland 
Ageing Mind Initiative 50+ Registry. A variety of advertisement pictures were chosen to cater 
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to the target demographics. Pictures such as ankle joint, swollen ankles, sprain, and sports 
participation were used. Flyers were distributed to community sports-venues such as soccer, 
football and bowling clubs in Queensland and masters sporting groups e.g. Queensland 
Volleyball Association and Queensland Rugby League. All participants were asked to indicate 
the state they reside. At the completion of physical testing, participants were invited to 
complete an online survey. 
4.2.1.2 Eligibility criteria 
For the surveys, the participants were adult volunteer aged 18 to 82 years. To ensure 
that the survey retains an adequate sample size to offer valid results, the sample was drawn 
from Australian states and included symptomatic people who suffer ankle pain or stiffness 
lasting >3 months and asymptomatic controls.  
4.2.2 Data and outcome measures  
The severity of pain and stiffness was measured using separate 11-point NRS. The NRS 
has been reported as a valid and reliable measure of knee OA pain with an excellent test-
retest reliability (ICC= 0.95) 310. Participants rated their ankle pain at rest, average ankle pain 
over the past 24-hours, and worst pain over the past 7 days using NRS anchored at 0 with “no 
pain” and at 10 with “worst pain imaginable”. Similarly, participants rated their usual level of 
ankle stiffness felt over the past week on 11-point NRS anchored at 0 with “no stiffness” and 
at 10 with “worst stiffness imaginable”. 
Number of musculoskeletal pain sites was assessed using a labeled body diagram as a 
reference. Participants rated the pain felt during the past 7 days in 13 musculoskeletal sites 
(including the ankle) using NRS where 0 is 'no pain' and 10 is 'the worst pain imaginable'. 
Participants were advised to select 0 if no pain was experienced in the body site. The number 
of bodily pain sites is the sum of the affirmed sites with a pain score of ≥2including the ankle. 
A modified version of the 13 item-Self-Administered Comorbidity Questionnaire (SCQ) 
was used to collect data on comorbid health conditions 311. The test‐retest reliability for the 
original SCQ validated in patients with surgical and medical conditions was (ICC= 0.94) 311. For 
the current study, the SCQ was adapted by adding auto-immune disease and gouty arthritis to 
the list of comorbid conditions and by rephrasing the question related to OA to specifically 
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indicate OA other than the ankle. Testing of psychometric properties of this modified SCQ was 
not undertaken. Participants indicated if they experienced any of the following 15 medical 
problems: heart disease, high blood pressure, lung disease, diabetes, ulcer or stomach 
disease, kidney disease, liver disease, anaemia or other blood disease, cancer, depression, 
auto-immune disease, back pain, rheumatoid arthritis, gouty arthritis and OA other than 
ankle). They were also asked if they received treatment for any of the defined health problem 
and whether it limited their activities. The number of comorbidities that participants reported 
they were receiving treatment for were summed (scores ranging from 0-15). This was 
calculated as an indication of multi-morbidity 312.  
Quality of life was assessed using the Assessment of Quality of Life questionnaire 
(AQoL-6D), which is an Australian instrument with age- and gender-based population norms 
313. It comprises 20 questions in 6 dimensions (independent living, mental health, coping, 
relationships, pain, and senses). The unweighted responses of all questions were added to 
create an overall profile score (0-100) and individual scores for each of the six dimensions. 
Higher scores indicate better QoL. This instrument has been shown to have strong construct 
validity 314 and discriminative validity for use in OA populations 315. Test-retest reliability 
(ICC=0.85-0.88) for this measure has been reported 316. 
Function was measured using the Foot and Ankle Ability Measure (FAAM) 317. This 
questionnaire consists of 21-item activities of daily living subscale (FAAM-ADL) and an 8-item 
sports subscale (FAAM-sport). Each item is scored on a 5-point Likert scale ranging from ‘no 
difficulty’ (4) to ‘unable to do’ (0). A “not applicable” option is available to indicate activities 
limited by factors other than foot or ankle problems, with these items removed from scoring. 
The total score (sum of responses) is converted to a percentage, with a higher percentage 
indicating a higher level of function. Test-retest reliability (ADL subscale; ICC= 0.87 and Sports 
subscale; ICC= 0.89) and internal consistency of the FAAM have been reported 317.  
The Ankle Osteoarthritis Scale (AOS) is a disease-specific instrument used to assess 
pain and disability related to ankle OA. It contains pain and disability subscales, each of which 
has nine questions. Participants indicated how much pain and difficulty they experienced 
when performing certain activities over the past week, such as walking barefoot, standing 
barefoot or standing on tiptoes. The original scoring of the two subscales is measured along a 
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100-mm visual analogue scale (VAS) anchored with “No pain/difficulty” (0 mm) and “Worst 
pain imaginable/So difficult, unable” (100 mm). To enable this questionnaire to be used in an 
online format, an 11-point (0-10) NRS was used rather than a 100 mm VAS, with the same 
anchors as the original scale. The original AOS has been reported to be reliable (ICC= 0.94 to 
0.97) and valid for individuals with ankle OA 318. 
Perceived ankle instability was measured using The Cumberland Ankle Instability Tool 
(CAIT) 319. This tool contains 9-items with scores assigned based on the rank of the chosen 
response 319. Responses are summed separately for each limb. The maximum score is 30 with 
a higher score indicating less instability. The CAIT has been shown to be a reliable (ICC=0.96) 
and valid measure of instability in individuals with a history of recurrent ankle sprain 319. 
Kinesiophobia was measured using The Tampa Scale of Kinesiophobia (TSK-11) 320. It 
comprises 11 statements about the perception of movement that are scored on a 4-point 
Likert scale ranging from 1= strongly disagree to 4= strongly agree. Examples of statements 
include “My body is telling me I have something dangerously wrong’, and “I can't do all the 
things normal people do because it's too easy for me to get injured”. The answer to each 
question is summed to produce a total score from 0 to 44, with higher scores indicate a high 
degree of kinesiophobia. This scale has good internal consistency (Cronbach’s =0.79) and 
test-retest reliability (ICC=0.81) 321. 
The short form of the International Physical Activity Questionnaire (IPAQ-SF) was used 
to measure physical activity 322. The total amount of time spent performing moderate, 
vigorous activities, walking or sitting in bouts of 10 minutes or greater over the last 7 days was 
recorded 322. The IPAQ categorizes physical activity as “low”, “moderate” or “high". Published 
guidelines for data processing and analysis of IPAQ-SF were used (available from: 
http://www.ipaq.ki.se). Validity and test-retest reliability (ICC = 0.51) in hip and knee OA 
population has been reported 323. 
Falls history in the last 12 months was determined by the question: “In the last 12 
months, have you had any falls?”. A fall was defined as “an event which results in a person 
coming to rest inadvertently on the ground or floor or other lower level” 324. Participants 
were categorised as fallers (an individual who fell at least once over the last 12 months 325) or 
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non-fallers. Participants indicated the number of falls they experienced in the past 12 months, 
if they sustained an injury from falling, the type of injury experienced (i.e. bruises, 
cuts/grazes, sprain/strain, broken bones, dislocation), and if any fall resulted in 
hospitalization. 
The Falls Efficacy Scale-International (FES-I) is a short falls efficacy survey with an 
excellent internal and test-retest reliability (Cronbach's alpha=0.96, ICC=0.96) 326. The FES-I 
was used to determine how concerned a person is about the possibility of falling when doing 
16 different basic and more challenging physical (inside and outside the home) and social 
activities. The level of concern was rated using a four-point Likert scale (1=not at all 
concerned to 4=very concerned) 326. The total score is a sum of scores that range from 16 to 
64. A higher score indicates a greater fear of falling. Cut off –points are defined as to 
differentiate between low, moderate and high concern (16-item FES-I: 16–19, 20–27 and 28–
64) 327. 
To measure balance confidence when performing activities of daily living, The 
Activities-Specific Balance Confidence Scale (ABC) was used. It estimates the percent self-
confidence that one would not lose balance during 16 separate theoretical activities; ranging 
from walking around the house to walking on icy sidewalks 328. Participants rated confidence 
in performing each activity, with a score from (0%=not confident at all to 100%=completely 
confident) in increments of 10%. ABC score is the total ratings (possible range = 0 – 1600) 
divided by 16 which is an indication of balance confidence. Scores below 68 correlate with 
high fall risk 329. Reliability of ABC in symptomatic knee OA was ICC= 0.95 330. 
The Hospital Anxiety and Depression Scale (HADS) 331 was used to rate anxiety and 
depression in the participants’ sample. Participants were required to select the most 
appropriate response about how they have felt over the past 7 days to 14 statements where 
seven statements relate to anxiety and seven relate to depression. Each item is scored from 
0-3, HADS responses are summed to obtain an anxiety score and a depression score. Scores 
range from 0 to 21 for either anxiety or depression. A score of 8/21 is identified as a cut-off 
point for anxiety or depression 332. The total score can be used as a measure of global 
negative affect. Scores 8 to 10 indicate mild, 11 to 15 indicate moderate and scores ≥ 16 
indicate severe anxiety or depression. The HADS is a valid scale for assessment of the 
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symptom severity, anxiety disorders and depression in different health conditions and in the 
general population 332. The reliability for HADS (Cronbach’s alpha 0.68 -0.93 for HADS-A) and 
(Cronbach’s alpha 0.67 -0.90 for HADS-D) has been reported 332. The HADs was reported as a 
good predictor of interview-diagnosed anxiety in a population with lower limb OA 211. 
The Workplace Ability Limitation Scale (WALS) used to measure the extent to which 
health conditions interfere with the performance of workplace activities. It is comprised of 12 
items, each item is rated on a four-point Likert scale (0=No difficulty to 3=not able to do). Not 
applicable to my job and difficulty unrelated to ankle response options are also available 
(both scored 0). Examples of statements are: “How much difficulty do you have getting to and 
from work (e.g., subway, bus, car, walking) and getting to and from work on time?”, “How 
much difficulty do you have getting around the workplace (e.g., stairs, hallways, furniture)?” 
and “How much difficulty do you have standing for long periods of time at your job (e.g., 
more than 20 minutes)?”. Higher scores indicate greater workplace activity limitations. WALS 
is identified as a preferred instrument for measuring productivity in workers with arthritis, it 
has high internal consistency and construct validity and was found to be the most responsive 
questionnaire to a perceived change in workplace ability in people with arthritis 333. Reported 
reliability for WALS was Cronbach's alpha =0.87 in working populations with arthritis 333. 
Scores of 0-4 indicate little work difficulty; scores of 5-8 reflect moderate disability related to 
workplace adaptations, and scores >9 indicate considerable workplace disability 334. 
A 2-Item Short Pain Self-Efficacy Questionnaire(PSEQ-2) 335 which is an abbreviated 2 
item pain self-efficacy tool was used to assess pain self-efficacy. The tool consists of two 
questions stating: “I can do some form of work, despite the pain (‘‘work’’ includes housework 
and paid and unpaid work)” and “I can live a normal lifestyle, despite the pain”. The tool 
highly correlated with that of the original PSEQ. The test-retest reliability for PSEQ-2 was 
ICC=0.87, 95% CI =0.80- 0.91 in a heterogeneous population with chronic pain 335. The total 
score is the sum of responses on the 2 items; range from 0 to 12 with a score of ≥8 indicating 
high self-efficacy and scores ≤ 5 indicating the need for assistance with confidence in 
functioning 335. 
Pain Catastrophizing Scale (PCS), a 13-item reliable and valid self-report scale for 
catastrophizing 336. The test-retest in a population with chronic pain is ICC= 0.67 337. The PCS 
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items are rated on a scale from 0= not at all and 4= all the time. A total score (range from 0- 
52) is a sum of all 13 item responses. Pain Catastrophizing Scale yields three different 
categories: Rumination (Sum of items 8, 9, 10, 11), Magnification (Sum of items 6, 7, 13) and 
Helplessness (Sum of items 1, 2, 3, 4, 5, 12). A total score of ≥30 is indicative of clinically 
relevant levels of catastrophizing 336. 
4.7 Data management and statistical analyses 
Detailed statistical procedures and analyses specific to each study within the thesis are 
outlined in the respective chapters. Extracted data variables were entered into Excel 
spreadsheets (Microsoft® Office Excel version16.13.1) for data management and analysis. All 
statistical analyses were completed using IBM®SPSS Statistics for Windows V.25.0 software 
(SPSS, Chicago, Illinois, USA).  
4.8 Conclusion 
This chapter has outlined the participant recruitment methods, measurement 
procedures and statistical methods underpinning the cross-sectional studies described in 
chapters (5- 9) of the thesis. The study findings, discussion, and conclusions from the cross-
sectional studies are reported in respective chapters and in Chapter 10. 
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Chapter 5 Physical impairments and quality of life in individuals with 
ankle osteoarthritis: A cross-sectional laboratory study 
5.1 Introduction 
Ankle OA affects over 75 million adults worldwide 43,45. Unlike hip and knee OA, ankle 
OA is typically post-traumatic in origin and occurs earlier in life 14,15,17,18,129 (possibly due to 
the majority of traumatic events occurring earlier in life and the reduced ankle OA onset 
latency following severe ankle sprains 13). Although the investigation of the physical 
impairments associated with ankle OA is limited, evidence from a recent systematic review 338 
reported that individuals with ankle OA have less ankle joint range of motion (ROM), strength, 
and altered ankle joint alignment compared to healthy controls. A single study has shown 
limited arthrokinematic joint mobility and poorer standing balance in this population 146. 
Ankle OA is associated with poor QoL compared to the general population 173,214. A limitation 
of previous research is that it focussed on individuals with end-stage ankle OA which limits 
the generalizability of those findings to the broader ankle OA population who are not 
candidates for ankle joint surgery. To optimise the management of ankle OA across the 
spectrum of disease severity, it is important to understand the physical impairments that 
characterise the condition and the relationship between impairments, function, and QoL. 
Such understanding could assist with the management of individuals with ankle OA and the 
selection of outcome measures used to determine treatment effectiveness in clinical and 
research settings.  
It is becoming apparent that radiographic evidence of OA does not correlate well with 
symptoms in a range of musculoskeletal disorders 339,340. For example, there is evidence that 
radiographic findings of knee OA may not closely relate to either symptoms or impairments 
341,342. However, the relation between radiographic evidence of ankle OA and ankle symptoms 
remains to be investigated. An improved understanding of that relationship could influence 
the assessment and management of individuals with ankle pain and disability.  
The primary aim of this study was to compare physical measures (ambulatory 
function, ankle muscle strength, endurance, ROM, ankle -subtalar joint laxity, foot mobility 
and posture) and patient-reported outcomes (QoL, function, pain, disability, ankle instability, 
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kinesiophobia and physical activity) between the following groups: 1) symptomatic (pain or 
stiffness) individuals with radiographic evidence of ankle OA and individuals without any ankle 
symptoms (asymptomatic), and 2) asymptomatic individuals with radiographic evidence of 
ankle OA and asymptomatic individuals without radiographic evidence of ankle OA. A 
secondary aim was to explore the relationship between QoL, self-reported function and 
physical measures.  
5.2 Methods 
In order to identify the physical impairments that characterise individuals with ankle 
OA, this cross-sectional clinical laboratory study compared physical measures and patient-
reported outcomes between individuals with and without ankle symptoms to ascertain the 
influence of ankle symptoms on the assessed outcomes, and between asymptomatic 
individuals with and without radiographic evidence of OA to ascertain the influence of 
radiographic OA on the assessed outcomes.  
5.2.1 Participants 
Symptomatic and asymptomatic individuals were recruited via community 
newsletters, social media and flyers between February 2016 and November 2017. 
Respondents were screened for eligibility using an online survey and via the telephone. 
Individuals were defined as symptomatic or asymptomatic based on the presence of ankle 
pain and stiffness. Individuals who reported pain or aching in or around the ankle and 
stiffness or reduced movement in the morning on most days for greater than 3 months and 
no lower limb injury within the last 12 months were defined as symptomatic. Individuals who 
reported no ankle pain/ache, stiffness or injury to the ankle or foot in the last 12 months and 
no previous ankle surgery were defined as asymptomatic. There was no specific definition of 
‘ankle’ shared with participants. However, all participants underwent screening and physical 
exam prior to laboratory testing to discern the presence or absence of symptoms as well as 
locality of the symptoms. Asymptomatic participants were required to be of similar sex, and 
age (±10 years) to the symptomatic participants.  
Individuals were excluded from participation in this study if they had pain or an injury 
in the lower limb (other than the ankle in the symptomatic group) or low back in the last 3 
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months that interfered with participation in daily activities, recreation or sport, or required 
consultation with a healthcare professional. Individuals were also excluded if they reported a 
history of previous lower limb surgery (other than surgery related to a previous ankle injury in 
symptomatic individuals), neurological or vestibular disorders, peripheral vascular disease, 
diabetes, rheumatoid or inflammatory arthritis, or if they were unable to undertake 
radiological investigations. Ethical approval was received from the institutional Human 
Research Ethics Committee and all participants provided informed written consent prior to 
participation. 
5.2.2 Ankle OA definition 
Mortise and lateral radiographic views of the ankle were captured and used to 
determine the presence and grade of ankle OA. Bilateral ankle x-ray images were captured for 
symptomatic individuals but due to the absence of clinical indication and associated radiation 
risks, only the matched ankle was imaged in the asymptomatic group. The test leg of 
asymptomatic participants was matched for dominance to that of the symptomatic 
participants prior to grouping based on radiographic findings. The dominant foot was 
determined according to the lateral preference inventory 276. The modified Kellgren and 
Lawrence scale 280 was used to assess radiographs and identify radiographic features of OA at 
the talo-crural and subtalar joints. This scale has been validated for defining ankle OA 60. 
Similar to definitions used in other studies 277,44,63,278,279, radiographic ankle OA was defined as 
a Kellgren and Lawrence (KL) grade of ≥ 2 (definite osteophytes with mild-severe joint space 
narrowing 280). Participants with KL grades 0–1 (no radiographic findings of OA and minute 
osteophytes of doubtful clinical significance were categorized as non-OA. Radiographic 
assessment on de-identified x-rays was undertaken by two independent assessors (MM and 
MS).  
5.2.3 Physical outcomes 
For the assessment of unilateral physical outcomes (muscle strength, heel raise 
endurance, ROM, ankle-subtalar joint laxity, foot mobility, and posture), data from both sides 
in the symptomatic group and from the matched ankle in the asymptomatic group were 
analysed. Before and after each physical test, participants rated their current pain intensity on 
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an 11-point NRS anchored with “No pain” at 0 and “Worst pain imaginable” at 10. All physical 
outcomes were administered by a single examiner (MM) in a standardised order. When 
testing symptomatic participants, the asymptomatic/less symptomatic side was measured 
first. To determine intra-rater reliability, physical measures were evaluated in a small sample 
of healthy adults, with test-retest measures obtained a minimum of seven days apart. 
5.2.3.1 Ambulatory function  
Walking speed was assessed over a 10-meter distance. Participants started 0.5 m 
behind the “start line” and walked as quickly as possible for 10 metres across the ‘finish line’. 
Stair performance was assessed using timed ascent and descent tests. Participants were 
instructed to ascend/descend a set of 20 stairs (17.5 cm high, 26 cm deep) as quickly as 
possible. Time to complete each task was recorded in seconds using a stopwatch. Each test 
was repeated three times and the fastest time was used for analysis. 
5.2.3.2 Ankle muscle torque 
 Maximum isometric ankle dorsiflexion, plantar flexion, inversion, and eversion muscle 
strength was measured with a handheld dynamometer (HHD) (01165 manual muscle tester, 
Lafayette Instrument Company, USA). Handheld dynamometry is a reliable and valid method 
for measuring muscle strength 287. Torque measurement was undertaken in a set order. 
Participants were positioned in supine with the knee and hip flexed to 90° (Figure 5.1). 
Plantarflexion torque was also measured with the knee and hip extended (Figure 5.1). The 
HHD was secured to foot at the level of centre of the first metatarsal head using an external 
device (Figure 5.1). Participants were instructed to push as hard as they could into the device, 
building up to MVC over 5 seconds. For familiarization, two practice contraction were 
performed first: one at approximately 50% MVC, and a second at 100% MVC. Following this, 
three MVCs for each strength measure was performed with a 1-minute rest between 
repetitions. Consistent verbal encouragement was used throughout testing. Ankle joint 
torque was calculated by multiplying the muscle force (measured in Newton’s (N)) with the 
lever arm length (measured in meters (m)). The lever arm for all movement directions was 
the distance between the centre of the first metatarsal head (HHD position) and the centre of 
the medial malleolus (used to represent the axis of rotation of the ankle joint). Torque was 
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normalized to body weight (measured in kilograms (kg)) and presented as Nm/kg. The 
average of three torque measures was used for analysis. 
 
 
FIGURE 5. 1: Starting position and HHD placement for torque testing 
 
5.2.3.3 Plantar flexion (Heel raise) endurance 
Plantar flexion endurance was assessed by having participants perform single leg heel 
raises until fatigue. Participants stood on one leg (knee extended) on a custom-built device 
with the non-weight-bearing knee bent to 90° 303. Heel raise height was standardised as 80% 
of the maximal height achieved when participants lifted their heel as high off the ground as 
possible. A horizontal rod at this height was set at the anterior ankle crease at this point. 
Participants performed heel raises to this pre-determined height at a pace of 23 lifts/minute 
controlled by a metronome 304,305 downloaded from App store. The test was stopped when 
the participant was unable to reach the rod or keep pace with the metronome for two 
consecutive heel raises, leaned on the wall or used the wall for assistance after one verbal 
warning, the non-weight-bearing leg touched the floor, or the participant was unable to 
continue due to pain or fatigue. This test was performed twice with a 1-minute rest between 
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trails. The total time in seconds was recorded for each trial and an average time was used for 
analysis. 
5.2.3.4 Ankle dorsiflexion ROM 
Dorsiflexion (DF) ROM was measured with a custom-built device during the weight-
bearing lunge test using a previously described protocol 291. This test has excellent inter- and 
intra-rater reliability 290,291. Participants stood with their mid-calcaneum and web space 
between the second and third toe on a line on a platform and their longest toe just touching 
an upright 293. With the knee resting on a vertical upright (and the patella aligned with the 
web space between the second and third toe), participants lunged their knee forward into DF 
ROM to move the vertical upright 292. Participants were required to maintain heel contact 
with the floor at all times, and the knee remained aligned between the second and third toe. 
For familiarisation, five practice trials were completed before the test then the test was 
repeated four times on each side for data collection. Maximal DF ROM was defined as the 
distance between the end of the longest toe and the maximal horizontal projection of the 
knee measured in millimetres. Positive values indicate movement of the knee beyond the 
longest toe, and negative values indicate movement short of the longest toe 295. The average 
of four measures was used for analysis. 
5.2.3.5 Ankle -subtalar joint laxity 
Anterior-posterior and inversion-eversion ankle joint arthrokinematics were assessed 
using a portable ankle arthrometer (Hollis instruments, Blue Bay Research Inc., Navarre, FL). 
Testing was based on a previously reported protocol with demonstrated reliability 296-298,343. 
Participants were positioned supine with the foot extended over the edge of a plinth and the 
leg secured using a strap placed superior to the malleoli. The foot was fixed to the 
arthrometer using clamps around the heel and the dorsal side of the foot and tibia. To begin 
all tests, the ankle was placed in a neutral position (0° dorsiflexion/plantar flexion). To 
measure anterior displacement, an anterior load of 125 N was applied to the ankle joint. The 
same load was applied posteriorly to measure posterior displacement. For inversion-eversion 
rotation, a 4000N/mm load was applied to the ankle, rotating it into inversion and then 
eversion. For all directions the load was applied in a slow, controlled manner and was 
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stopped when the maximal load was reached (125 N for anterior and posterior displacement 
and 4000 N for inversion and eversion rotation). Joint laxity testing was stopped if the 
participant experienced pain during the assessment. Testing in each direction was repeated 
three times. The mean value for each direction was calculated from exported raw files and 
was used for analysis. Anterior and posterior displacements were recorded in millimetres and 
inversion and eversion rotations in degrees. 
5.2.3.6 Dorsal arch height, mid-foot width and foot mobility 
Dorsal arch height (DAH) and midfoot width (MFW) were assessed in weight-bearing 
and non-weight-bearing using the Foot Assessment Platform as previously described in the 
literature 302. DAH was measured as the vertical distance from the dorsum of the foot at 50% 
of total foot length to the platform. MFW was measured from the medial to the lateral aspect 
of the foot at 50% of total foot length. Foot mobility was calculated as the difference between 
weight-bearing and non-weight-bearing DAH and MFW measures. Foot mobility magnitude 
(FMM), a composite measure representing a change in both DAH and MFW, was calculated 
using the following formula = √𝐷𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝐷𝐴𝐻2 + 𝐷𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑀𝐹𝑊2. DAH, MFW and 
FMM were recorded in millimetres 344, 345. 
5.2.3.7 Static foot posture  
The Foot Posture Index (FPI) was used to classify foot posture based upon the 
following six criteria: talar head palpation, curves above and below the lateral malleoli, 
inversion/eversion of the calcaneus, bulge in the region of the talonavicular joint, congruence 
of the medial longitudinal arch, and abduction/adduction of the forefoot on the rearfoot 346. 
Each criterion was rated on a scale from -2 to +2, with total scores ranging from -12 to +12. 
Scores ranging from 0 to 5 denotes normal, 6 to 9 pronated, 10+ highly pronated, -1to -4 
supinated and -5 to -12 highly supinated foot posture. High intra-rater reliability for the FPI 
has been reported 300.  
5.2.4 Patient-reported outcomes 
At the completion of physical testing, participants were invited to complete an online 
survey that provided information on QoL, perceived function, pain, disability, ankle instability, 
kinesiophobia and physical activity. The 20-questions Assessment of Quality of Life 
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questionnaire (AQoL-6D) 313 was used to assess QoL. It comprises 6 dimensions (independent 
living, mental health, coping, relationships, pain, and senses). The unweighted responses of all 
questions were added to create an overall profile score (0-100) and individual scores for each 
of the six dimensions. Higher scores indicate better QoL. Construct 314 and discriminative 
validity for use of AQoL-6D in OA populations 315 and test-retest reliability (ICC= 0.85- 0.88) 
have been reported 316. 
The Foot and Ankle Ability Measure (FAAM) was used to assess perceived function 317. 
It consists of a 21-item activities of daily living subscale (FAAM-ADL) and an 8-item sports 
subscale (FAAM-sport). Each item was scored on a 5-point Likert scale ranging from ‘no 
difficulty’ (4) to ‘unable to do’ (0). A “not applicable” option is available to indicate activities 
limited by factors other than foot or ankle problems, and those items were removed from 
scoring. The total sum of responses was converted to a percentage, with a higher percentage 
indicating a higher level of function. This questionnaire has excellent test-retest reliability 
(ADL subscale; ICC= 0.87 and Sports subscale; ICC= 0.89) and internal consistency 317.  
The Ankle Osteoarthritis Scale (AOS) was used to measure ankle-related pain and 
disability when performing nine activities over the past week. Participants indicated how 
much difficulty or pain they experienced using an online version of the AOS with an 11-point 
NRS anchored with “No pain/difficulty” and “Worst pain imaginable/So difficult, unable”. The 
original paper-based AOS has been shown to be reliable (ICC= 0.94 to 0.97) and valid patient-
reported outcome for ankle arthritis 318. The online version utilised in this study was only 
tested for intra-rater reliability, not for validity. 
The Cumberland Ankle Instability Tool (CAIT) measured perceived ankle instability 319. 
This valid and reliable tool (ICC=0.96) contains 9 items with scores assigned based on the rank 
of the chosen response 319. Responses are summed separately for each limb. The maximum 
score is 30 with a higher score indicating less instability.  
Kinesiophobia was measured using The Tampa Scale of Kinesiophobia (TSK-11) 320. 
This scale has good internal consistency (Cronbach’s =0.79) and test-retest reliability 
(ICC=0.81) 321. It comprises 11 statements about the perception of movement that are scored 
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on a 4-point Likert scale to produce a total score from 0 to 44. Higher scores indicate a high 
degree of kinesiophobia.  
The short form of the International Physical Activity Questionnaire (IPAQ-SF) 
measured the total amount of time spent performing moderate, vigorous activities, walking 
or sitting in bouts of 10 minutes or greater over the last 7 days 322. The IPAQ categorizes 
physical activity as “low”, “moderate” or “high". Published guidelines for data processing and 
analysis of IPAQ-SF were used (available from: http://www.ipaq.ki.se). The IPAQ-SF has been 
shown to have a moderate test retest reliability (ICC = 0.51) in hip and knee OA populations 
323.  
5.2.5 Statistical analysis 
Inter-rater reliability of radiographic assessment was performed using data from both 
left and right ankles in symptomatic participants and the matched (for dominance) ankle in 
asymptomatic participants, with each ankle considered a separate unit in analysis 306 (n =134 
ankles). The Kappa (κ) statistic was calculated and inter-rater reliability was interpreted as 
almost perfect (0.81–1.0), substantial (0.61–0.8), moderate (0.41–0.6), fair (0.21–0.4), slight 
(0.00–0.2) or poor (<0.00) 234. Kappa statistic was also used to assess the reliability between 
the online and paper version of AOS. One-way model ICCs were calculated to determine the 
intra-rater reliability of physical outcomes taken one week apart. ICCs were interpreted as 
very good (ICC> 0.9), good (ICC 0.76-0.9) or moderate (ICC 0.5-0.75) 307.  
Age and BMI were compared between groups using a one-way analysis of variance 
(ANOVA). Chi-square tests were conducted to compare categorical variables (sex, categories 
of physical activity, and KL grades of OA) between groups. Differences in physical measures 
and patient-reported outcomes between the symptomatic OA and the asymptomatic group 
(including both asymptomatic OA and asymptomatic non-OA), and between the 
asymptomatic OA and asymptomatic non-OA groups were examined using an analysis of 
covariance (ANCOVA) with age, sex and BMI entered as covariates. BMI was not entered as a 
covariate for torque measures as torque was normalized to body weight. To reduce chances 
of obtaining false-positive results (type I errors) with multiple comparisons, a Bonferroni 
adjustment method was used. 
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In participants with bilateral symptoms, the ankle with the greater pain or stiffness 
within the last 3 months was nominated as the symptomatic limb. For ankle strength, 
endurance, ROM, ankle joint laxity, foot mobility and foot posture, only data from the 
symptomatic limb were compared to the matched limb in asymptomatic participants. Cases 
with missing data were excluded on an analysis by analysis basis (pairwise deletion). Results 
are reported in the tables as mean values and their standard deviation (SD), mean differences 
(MD) between groups and their 95% confidence intervals [CI], and point estimate of effect 
expressed as SMDs and 95% CI for continuous variables. Frequencies and percentages with 
risk difference [95% CI] are reported for categorical and binary data. Effect sizes are reported 
in the results section and are interpreted as trivial: 0.0-0.2, small: 0.2-0.6, medium: 0.6-1.2, 
large: 1.2-2.0, very large: 2.0-4.0 and distinct:>4.0 347.  
Because not all variables were normally distributed, the bivariate relation between 
group, physical outcomes (10-m walk time, timed stair ascent, timed stair decent, plantar 
flexion, dorsiflexion, inversion, eversion muscle torque, heel raise endurance, DF ROM, total 
arthrokinematic displacement and rotation, FPI, differences in DAH and MFW, and FMM), 
QoL (AQoL-6D) and function (FAAM-ADL) was investigated using Spearman's Rank-Order 
Correlation. The correlation was interpreted as low (rho = 0.1-0.29), moderate (rho = 0.3-
0.49), large (rho= 0.5-0.69) and very large (rho= 0.7-0.9) 347.  
Separate univariate multiple regressions using backward elimination was conducted to 
investigate associations between physical outcomes (independent variables) with each of the 
dependent variables of QoL and FAAM-ADL. Independent variables were eligible for inclusion 
in the multiple regression model if they were significantly associated with QoL and FAAM 
(p≤0.05). Group was also entered into the model through a dummy coded variable (i.e., 
reference group = asymptomatic). The multiple regression model was tested for 
multicollinearity. Variables were systematically eliminated leaving only those with p<0.1. 
Statistical analysis was conducted using SPSS V.25 software (SPSS Inc., Chicago, Illinois, USA) 
and significance was set at p≤0.05.  
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5.3 Results 
5.3.1 Participants 
A total of 450 individuals (260 symptomatic and 190 asymptomatic) expressed interest 
in participating in this study, from which 105 individuals consented and attended the 
laboratory testing session (Figure 5.2). Of the 105 participants, four were excluded due to late 
disclosure of comorbidities (three knee OA and one hip OA) and three participants did not 
obtain ankle x-rays of their symptomatic ankles. Two symptomatic participants did not have 
evidence of ankle OA on imaging and were excluded as the group would be too small for 
meaningful comparison. Laboratory data for most outcomes were available from 96 
participants (37 males and 59 females; mean age 52.4 years (SD=13.5, range=24 to 76 years) 
which formed the following study groups: 31 symptomatic OA and 65 asymptomatic 
(comprised of 41 asymptomatic OA and 24 asymptomatic non-OA) (Figure 5.2). Three 
symptomatic and one asymptomatic participants were unable to attend some sessions 
(ambulatory function, Plantar flexion endurance, foot mobility, and plantar flexion torque) of 
the full laboratory testing due to other personal commitments and time limitations. 
Seventeen participants (8 symptomatic and 9 asymptomatic) provided incomplete set of 
survey data. The sums of available data for each outcome are reflected in table 5.1.  
Nineteen participants in the symptomatic group had bilateral x-rays while 12 did not 
obtain x-ray for the asymptomatic side. Of the 19 x-rays of the asymptomatic side in the 
symptomatic group, 13 asymptomatic ankles had radiographic evidence of joint degeneration 
defined as a KL grade of ≥ 2.The symptomatic group presented with bilateral ankle symptoms 
in 4 (12.9 %) cases. Six individuals in the symptomatic group had previous surgery to the ankle 
(2 reported arthroscopy, 1 talocalcaneal incision, 1 post fracture pins and screws and 2 
provided no details of the type of surgery). Details of past fracture, ankle sprain history and 
Kellgren–Lawrence grades for the symptomatic OA, asymptomatic OA and asymptomatic non-
OA are reported in Appendix 8. No participant had to discontinue physical testing due to 
ankle pain. 
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FIGURE 5. 2: Participant recruitment and grouping for cross-sectional laboratory study 
 5.3.2 Reliability of measures 
Inter-rater reliability of radiographic assessment of 134 ankles (2 examiners) was 
substantial (Kappa = 0.69 (p <.0.001), 95% CI (0.59, 0.79)). Intra-rater reliability of physical 
measures taken on 10 subjects (one week apart) by a single examiner was good to very good 
(ICCs=0.84-1.00), see Appendix 7. Reliability between online NRS and paper VAS version of 
AOS was 0.898, with 95% CI (0.86, 0.92). 
5.3.3 Comparison between symptomatic and asymptomatic groups 
Participant characteristics and comparison of outcomes between symptomatic and 
asymptomatic participants are reported in Table 5.1. There were no differences in age or sex 
between the groups. BMI of the symptomatic group was significantly higher than that of the 
asymptomatic (SMD=0.93). There were significant large differences between groups in KL 
grades (SMD=1.07). Among the symptomatic group, 13 reported a history of 1 to 3 ankle 
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fractures and history of an ankle sprain on the symptomatic side while the asymptomatic 
groups reported no ankle fractures but 12 reported history of ankle sprain.  
Symptomatic participants reported moderately lower scores for total AQol-6D 
(SMD=0.98), independent living (SMD=1.55) and higher pain (SMD=1.56) domains compared 
to asymptomatic participants. No differences were identified for coping, senses, relationships 
and mental health. Symptomatic participants had moderately higher levels of kinesiophobia 
(SMD=1.16), pain (SMD=1.70) and disability (SMD=1.44) on AOS and very large deficits in ADL 
(SMD=2.10) and Sports function (SMD=2.85) on FAAM. Greater perceived instability 
(SMD=3.92) was identified in symptomatic compared to asymptomatic participants. There 
were no differences in the self-report weekly total physical activity participation between 
groups. 
Symptomatic participants were moderately slower in the 10-m walk (SMD=0.65), stair 
ascent (SMD=0.57) and descent (SMD=0.58) than asymptomatic participants. Symptomatic 
participants had moderate to very large deficits in muscle torque for all assessed muscle 
groups (SMDs from 0.73 to 1.71) in knee flexion. Plantar flexion in knee extension was 
markedly weaker (SMD= 8.9) in the symptomatic group. Moderate shorter time to fatigue 
during single leg heel raises (SMD=0.71) and large deficits in DF ROM (SMD=1.54) were also 
evident in symptomatic compared to asymptomatic participants. Results of the ankle 
arthrometer testing revealed small differences (SMDs from 0.48 to 0.56) where symptomatic 
participants had significantly less inversion, eversion, and total inversion-eversion rotation 
than asymptomatic participants. There were no differences in the other arthrometer 
measures, any of the foot mobility measures, or the total FPI score.  
5.3.4 Comparison between asymptomatic OA and asymptomatic non-OA  
There were no differences between asymptomatic participants with or without OA on 
imaging for most of the assessed measures (Table 5.2). There were medium effects for lower 
scores on the Senses domain of the AQoL-6D and for anterior displacement on the 
arthrometer.  
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Table 5.1: Characteristics of the symptomatic and asymptomatic groups  
Mean (Standard deviation, n) of between-group mean differences and point estimate of effect expressed as standardised mean difference and its 95% 
confidence interval (95% CI)  
Characteristic Symptomatic 
 
Asymptomatic 
 
MD (95%CI) Point estimate of effect 
(95%CI) 
p value 
Age years 51.19 (14.24,31) 53.00 (13.26, 65) 1.81[-4.08,7.69] -0.13 [-0.56, 0.30] 0.544 
Sex, Female n (%)  16 (51.6%)  43 (66.2%)  0.55 [0.23, 1.31]~ 0.17 
BMI kg/m2 28.45 (5.37,31)  24.37 (3.8, 65) -4.08[-5.70,-2.20] 0.93 [0.48, 1.38] <0.001 
Kellgren–Lawrence grade 2.72 (0.89, 31) 1.78 (0.86, 65) 0.94 [0.56, 1.32] 1.07 [0.62, 1.53] <0.001 
Patient-reported outcomes      
AQoL-6D Total range 0-100 77.48 (9.93, 26) 87.02 (9.47, 60) -9.54 [-14.33, -4.75] -0.98 [-1.47, -0.50] <0.001 
Independent Living range 0-100 80.24 (11.06, 26) 96.99 (10.55, 60) -16.75 [-22.09, -11.41] -1.55 [-2.07, -1.03] <0.001 
Relationships range 0-100 88.47 (12.39, 26) 94.0 (11.82, 60) -5.53 [-11.51, 0.46] -0.46 [-0.92, 0.01] 0.070 
Mental Health range 0-100 76.05 (15.95, 26) 79.75 (15.23, 60) -3.70 [-11.41, 4.00] -0.21 [-0.67, 0.25] 0.342 
Coping s range 0-100 74.96 (16.18, 26) 79.04 (15.45, 60) -4.08 [-11.90, 3.74] -0.26 [-0.72, 0.20] 0.302 
Pain range 0-100 63.22 (17.03, 26) 89.11 (16.25, 60) -25.89 [-34.11, -17.66] -1.56 [-2.07, -1.04] <0.001 
Senses range 0-100 80.25 (11.01, 26) 82.53 (10.50, 60) -2.29 [-7.60, 3.03] -0.21 [-0.67, 0.25] 0.395 
FAAM- ADL% 77.04 (10.48, 26) 98.98 (10.28, 60) -21.94 [-27.011, -16.86] -2.10 [-2.66, -1.54] <0.001 
FAAM- Sport % 55.27 (15.13, 26) 97.46 (14.44, 60) -42.19 [-49.50, -34.88] -2.85 [-3.49, -2.22] <0.001 
AOS- Overall % 27.86 (15.83, 26) 2.68 (15.10, 60) 25.18 [17.53, 32.82] 1.63 [1.11, 2.15] <0.001 
AOS- Pain % 28.50 (15.44, 26) 2.80 (14.73, 60) 25.69 [18.24, 33.15] 1.70 [1.18, 2.23] <0.001 
AOS- Disability % 27.34 (17.55, 26) 2.66 (16.75, 60) 24.69 [16.21, 33.16] 1.44 [0.93, 1.95] <0.001 
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CAIT score range 0-30 10.57 (4.67, 26) 28.45 (4.45, 61) -17.88 [-20.13, -15.63] -3.92 [-4.68, -3.17] <0.001 
Tampa scale score range 0-44 23.965 (5.79, 23) 17.336 (5.63, 56) 6.63 [3.71, 9.54] 1.16 [0.64, 1.68] <0.001 
IPAQ-Total activity MET-min/week 3220.85 (3504.69, 26) 3982.63 (3344.14, 60) -761.78 [-2454.17, 930.60] -0.22 [-0.68, 0.24] 0.373 
High physical activity n (%) 11 (35.5%) 33 (50.8%)  -13% [-35, 10]^  
Moderate physical activity n (%) 8 (25.8%) 10 (15.4%)  14% [-6, 34]^  
Low physical activity n (%) 7 (22.6%) 17 (26.2%)  -1% [-22, 19]^  
Ambulatory function      
10-m walk sec. 5.08 (0.72, 30) 4.62 (0.70, 65) 0.46 [0.14, 0.79] 0.65 [0.20, 1.09] 0.006 
Stair ascent sec. 7.46 (1.49, 29) 6.62 (1.44, 64) 0.85 [0.16, 1.53] 0.57 [0.13, 1.02] 0.016 
Stair descent sec. 7.94 (1.99, 29) 6.81 (1.91, 64) 1.13 [0.22, 2.040] 0.58 [0.13, 1.03] 0.016 
Mobility and joint range      
WB lunge test mm 60.08 (42.33, 31) 124.4 (40.93, 65) -64.36 [-83.25, -45.47] -1.54 [-2.02, -1.06] <0.001 
DAHDIFF mm 12.88 (5.25, 30) 14.24 (5.09, 65) -1.36 [-3.72, 1.01] -0.26 [-0.70, 0.17] 0.26 
MFWDIFF mm 9.40 (3.71, 30) 10.13 (3.59, 65) -0.73 [-2.40, 0.94] -0.20 [-0.63, 0.23] 0.39 
FMM mm 16.38 (5.37, 30) 17.78 (5.18, 65) -1.40 [-3.81, 1.00] -0.27 [-0.70, 0.17] 0.25 
FPI score range -12 to 12  0.86 (2.43, 31) 1.14 (2.36, 65) -0.28[-1.37, 0.81] -0.12 [-0.54, 0.31] 0.609 
Normal FPI n (%)  21 (67.7%) 57 (87.7%)  -20% [-38, -2]^ 0.019 
Pronated FPI n (%) 2 (6.5%) 0 (0%)  6% [-3, 16]^  
Supinated FPI n (%) 8 (25.8%) 7 (10.8%)  15% [-2, 32]^  
Arthrometer measurements      
Anterior displacement mm 10.15 (3.57, 31) 10.86 (3.46, 65) -0.71 [-2.31, 0.88] -0.20 [-0.63, 0.23] 0.376 
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Posterior displacement mm 9.83 (3.17, 31) 9.63 (3.07, 65) 0.20 [-1.21, 1.62] 0.06 [-0.36, 0.49] 0.777 
Total displacement mm 19.961 (6.17, 31) 20.70 (5.97, 65) -0.74 [-3.49, 2.01] -0.12 [-0.55, 0.31] 0.60 
Inversion Rotation ° 23.49 (9.28, 31) 28.55 (8.97, 65) -5.06 [-9.19, -0.92] -0.55 [-0.99, -0.12] 0.02 
Eversion Rotation ° 22.83 (7.78, 31) 26.55 (7.53, 65) -3.72 [-7.20, -0.25] -0.48 [-0.92, -0.05] 0.04 
Total Rotation ° 46.31 (15.72, 31) 55.05 (15.20, 65) -8.74 [-15.75, -1.72] -0.56 [-1.00, -0.13] 0.015 
Torque and endurance      
PF in knee Flex. N.m/kg 0.30 (0.17, 31) 0.42 (0.16, 65) -0.13 [-0.20, -0.05] -0.73 [-1.17, -0.29] 0.001 
DF in knee Flex. N.m/kg 0.24 (0.08, 31) 0.32 (0.07, 65) -0.08 [-0.12, -0.05] -1.08 [-1.54, -0.63] <0.001 
Inversion in knee Flex. N.m/kg 0.15 (0.06, 31) 0.21 (0.01, 65) -0.06 [-0.09, -0.03] -1.71 [-2.20, -1.21] <0.001 
Eversion in knee Flex. N.m/kg 0.18 (0.08, 31) 0.25 (0.07, 65) -0.08 [-0.11, -0.04] -0.95 [-1.40, -0.50] <0.001 
PF in knee Ext. N.m/kg 0.61 (0.04, 30) 0.91 (0.03, 65) -0.30 [-0.43, -0.18] -8.90 [-10.26, -7.54] <0.001 
Endurance heel raises sec. 63.15 (43.55, 28) 93.48 (41.92, 65) -30.33 [-50.44, -10.23] -0.71 [-1.16, -0.25] 0.004 
~ Odds Ratio; ^ Risk Difference; *based on data from 61 asymptomatic and 26 symptomatic 
Continuous data are reported as mean (SD), and dichotomised/binary data presented as frequency (%), point estimates of effect are reported as SMD for interval data, OR 
odds ratio or RD risk difference for binary data 
Abbreviations and definitions: n=number; BMI= body mass index; SD=standard deviation; SMD= standardised mean difference; CI=confidence interval; P=P 
value/significance level; AOS=ankle osteoarthritis scale; FAAM=Foot and Ankle Ability Measure; AQoL-6D= The Assessment of Quality of Life questionnaire-6D; CAIT= The 
Cumberland Ankle Instability Tool; IPAQ=The International Physical Activity Questionnaire; sec.=seconds; FMM=Foot mobility magnitude; DAHDIFF=dorsal arch height 
difference; MFWDIFF= mid-foot width difference; FPI= foot posture index ;PF=Plantarflexion; DF=dorsiflexion; ROM=range of movement; Ext=extension; Flex=flexion 
All outcomes adjusted for age, sex and body mass index except for torque measures,  
Significance level based on ANCOVA post-hoc comparisons with Bonferroni correction or Pearson’s Chi-squared 
Higher scores in AQoL, FAAM, CAIT, IPAQ, Lunge test, muscle torque, ROM and endurance heel raises are better than lower scores. Higher AOS and timed ambulatory scores 
are worse than lower scores.  
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Table 5.2: Characteristics of asymptomatic OA and asymptomatic non-OA 
Mean (Standard deviation, n) of between-group mean differences and point estimate of effect expressed as standardised mean difference and its 95% 
confidence interval (95% CI) 
Characteristics Asymptomatic OA Asymptomatic non-OA  MD (95%CI) Point estimate of effect 
(95%CI) 
p-value 
Age years 55.6 (12.75, 41) 48.6 (13.2, 24) 7.002 [-1.37, 15.37] 0.54 [0.02, 1.05] 0.133 
Sex, Female n (%)  29 (70.7%)  14 (58.3%)   0.58 [0.20, 1.66] ~ 0.308 
BMI kg/m2 24.27(3.82, 41)  24.53 (3.76, 24) -0.26 [-3.00, 2.47] -0.07 [-0.57, 0.44] 1.00 
Kellgren–Lawrence grade 2.36 (0.49) 0.89(0.49) 1.47 [1.22, 1.73] 2.96 [2.24, 3.69] <0.001 
Patient-reported outcomes      
AQoL-6D Total score range 0-100 85.55 (9.33, 38) 89.54 (9.24, 22) -3.99 [-10.01, 2.03] -0.42 [-0.95, 0.11] 0.33 
Independent Living score range 0-100 96.43 (10.53, 38) 97.95 (10.45, 22) -1.53 [-8.33, 5.28] -0.15 [-0.67, 0.38] 1.00 
Relationships score range 0-100 93.07 (11.78, 38) 95.59 (11.67,22) -2.52 [-10.12, 5.09] -0.22 [-0.75, 0.31] 1.00 
Mental Health score range 0-100 77.82 (15.07, 38) 83.08 (14.93, 22) -5.26 [-14.99, 4.47] -0.35 [-0.87, 0.18] 0.57 
Coping score range 0-100 77.96 (15.40, 38) 80.90 (15.26, 22) - 2.94 [-12.88, 7.00] -0.19 [-0.72, 0.34] 1.00 
Pain score range 0-100 87.25 (16.12, 38) 92.28 (15.98, 22) - 5.03 [-15.43, 5.38] -0.31 [-0.84, 0.22] 0.72 
Senses score range 0-100 79.90 (10.07, 38) 87.04 (9.98, 22) -7.14 [-13.64, -0.64] -0.70 [-1.24, -0.16] 0.026 
FAAM- ADL% 98.94 (10.49, 40) 99.04 (10.35, 22) -0.10 [-6.80, 6.60] -0.01 [-0.53, 0.51] 1.00 
FAAM- Sport % 97.72 (14.44, 40) 97.01 (14.32, 22) 0.71 [-8.61, 10.03] 0.05 [-0.47, 0.57] 1.00 
AOS- Overall % 3.62 (15.07, 38) 1.07 (14.94, 22)  2.55 [-7.18, 12.28] 0.17 [-0.36, 0.69] 1.00 
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AOS- Pain % 3.59 (14.71, 38) 1.46 (14.58, 22) 2.13 [-7.36, 11.63] 0.14 [-0.38, 0.67] 1.00 
AOS- Disability % 3.71 (16.71, 38) 0.85 (16.56, 22) 2.86 [-7.93, 13.64] 0.17 [-0.36, 0.70] 1.00 
CAIT score range 0-30 28.23 (4.45) 28.84 (4.39) -0.62 [-3.46, 2.23] -0.62 [-3.46, 2.23] 1.00 
Tampa scale score range 0-44 17.43 (5.72, 36) 17.17 (5.66, 20) 0.26 [-3.65, 4.17] 0.04 [-0.50, 0.59] 1.00 
IPAQ-Total activity MET-min/week 4021.77 (3345.37, 38) 3915.54 (3315.74, 22) 106.22 [-2053.11, 2265.55] 0.03 [-0.49, 0.56] 1.00 
High physical activity n (%) 23 (60.5.1%) 10 (45.5.7%)  15% [-11, 41]^  
Moderate physical activity n (%) 6 (15.8%) 4 (18.2%)  -2% [-22, 17]^  
Low physical activity n (%) 9 (23.7%) 8 (36.4%)  -13% [-37, 12]^  
Ambulatory function      
10-m walk sec. 4.68 (0.70, 41) 4.51 (0.69, 24) 0.18[-0.26,0.62] 0.24 [-0.26, 0.75] 0.98 
Stair ascent sec. 6.73 (1.46, 40) 6.43 (1.42, 24) 0.30[-0.60,1.21] 0.21 [-0.30, 0.71] 1.000 
Stair descent sec. 7.01 (1.94, 40) 6.49 (1.88, 24) 0.52[-0.69,1.72] 0.27 [-0.24, 0.78] 0.892 
Mobility and joint range       
WB lunge test mm 123.57 (41.44, 41) 125.86 (40.57, 24) - 2.29[-27.91,23.33] -0.06 [-0.56, 0.45] 1.00 
DAHDIFF mm 14.40 (5.15, 41) 13.97 (5.06, 24) 0.43 [-2.77, 3.62] 0.08 [-0.42, 0.59] 1.00 
MFWDIFF mm 10.43 (3.63, 41) 9.65 (3.56, 24) 0.78 [-1.47, 3.03] 0.21 [-0.29, 0.72] 1.00 
FMM mm 18.07 (5.24, 41) 17.30 (5.14, 24) 0.77 [-2.48, 4.02]  0.15 [-0.36, 0.65] 1.00 
FPI score range -12 to 12 1.31 (2.41, 41) 0.87 (2.33, 24) 0.44 [-1.04, 1.92] 0.18 [-0.32, 0.69] 1.00 
Normal FPI n (%) 36 (87.8%) 21 (87.5%)  0% [-16, 17]^ 0.971 
Pronated FPI n (%) 0 (0%) 0 (0%)  0% [-6, 6]^  
Supinated FPI n (%) 4 (9.8%) 3 (12.5%)  -3% [-19, 13]^  
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Arthrometer measurements      
Anterior displacement mm 9.99 (3.28, 41) 12.24 (3.26, 24) -2.25 [-4.33, -0.18] -0.68 [-1.20, -0.16] 0.03 
Posterior displacement mm 9.19 (3.00, 41) 10.21 (2.98, 24) -1.02 [-2.92, 0.87] -0.34 [-0.84, 0.17] 0.575 
Total displacement mm 19.48 (5.76, 41) 22.53 (5.71, 24) -3.05 [-6.68, 0.59] -0.52 [-1.04, -0.01] 0.132 
Inversion Rotation ° 27.65 (8.79, 41) 29.97 (8.73, 24) -2.32 [-7.87, 3.23] -0.26 [-0.77, 0.24] 0.931 
Eversion Rotation ° 26.20 (7.45, 41) 27.91 (7.40, 24) -1.71 [-6.42, 3.00] -0.23 [-0.73, 0.28] 1.00 
Total Rotation ° 53.77 (14.92, 41) 57.88 (14.80, 24) -4.11 [-13.52, 5.31] -0.27 [-0.78, 0.23] 0.872 
Torque and endurance      
PF in knee Flex. N.m/kg 0.44 (0.17, 41) 0.44 (0.16, 24) -0.01[-0.11,0.10] 0.00 [-0.50, 0.50] 1.00 
DF in knee Flex. N.m/kg 0.30 (0.07, 41) 0.34 (0.07, 24) -0.03[-0.08,0.02] -0.56 [-1.08, -0.05] 0.56 
Inversion in knee Flex. N.m/kg 0.22 (0.05, 41) 0.21 (0.06, 24) 0.01[-0.03,0.05] 0.18 [-0.32, 0.69] 1.00 
Eversion in knee Flex. N.m/kg 0.24 (0.07, 41) 0.26 (0.07, 24) -0.02[-0.07,0.03] -0.28 [-0.79, 0.22] 1.00 
PF in knee Ext. N.m/kg 0.91 (0.27, 41) 0.90 (0.26, 24) 0.01[-0.18,0.20] 0.04 [-0.47, 0.54] 1.00 
Endurance heel raises sec. 97.06 (42.49, 41) 87.71 (41.33, 24) 9.35 [-16.90, 35.60] 0.22 [-0.29, 0.72] 1.00 
~ Odds Ratio; ^ Risk Difference; *Based on data from 22 asymptomatic non-OA and 39 asymptomatic OA 
Continuous data reported as mean (SD), and dichotomised/binary data presented as frequency (%), point estimates of effect are reported as SMD for interval data, OR 
odds ratio or RD risk difference for binary data 
Abbreviations and definitions: ROA =radiographic osteoarthritis; n=number; BMI= body mass index; SD=standard deviation; SMD= standardised mean difference; 
MD=mean difference; CI=confidence interval; P=P value/significance level; AOS=ankle osteoarthritis scale; FAAM=Foot and Ankle Ability Measure; AQoL-6D= The 
Assessment of Quality of Life questionnaire-6D; CAIT= The Cumberland Ankle Instability Tool; IPAQ=The International Physical Activity Questionnaire; sec.=seconds; 
FMM=Foot mobility magnitude; DAHDIFF=dorsal arch height difference; MFWDIFF= mid-foot width difference; PF=Plantarflexion; DF=dorsiflexion; ROM=range of 
movement; Ext=extension; Flex=flexion= foot posture index. 
All outcomes adjusted for age, sex and body mass index except for torque measures. 
Significant difference at (p < 0.05) based on ANCOVA post-hoc comparisons with Bonferroni correction or Pearson’s Chi-squared 
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5.3.5 The association between physical outcomes, QoL and function 
Spearman's Correlations between physical outcomes, QoL (total AQoL-6D), function 
(FAAM-ADL), and between independent variables are presented in Appendix 9. Spearman’s 
correlation revealed no significant association between total displacement, total rotation, FPI, 
difference in DAH, difference in MFW, and FMM and QoL or FAAM. These variables were 
therefore not included in the multiple regression model. Tests for multicollinearity revealed a 
variance inflation factor of less than 10 for all included variables in the models. The initial full 
model including group (Ref. – asymptomatic), 10-m walk time, timed stair ascent and 
descent, muscle torque (plantar flexion, dorsiflexion, inversion, and eversion), heel raise 
endurance, and DF ROM explained 66% of the variance in FAAM-ADL and 51% of the variance 
in QoL. Independent variables with p>0.1 were systematically excluded. In the final regression 
model (Table 5.3), stair descent (=-0.82, p<.001), stair ascent (=-0.44, p=0.047) and group 
(Ref. – asymptomatic) (=-0.26, p=0.008) explained 48% of the total variance in AQoL-6D. For 
self-reported function, group (Ref. – asymptomatic) (=-0.64, p<.001) and stair descent (=-
0.59, p=0.001) explained 64% of the total variance in FAAM-ADL (Table 5.4). 
Table 5.3: Multiple linear regression model total AQoL-6D as the dependent variable 
Significant predictor variables Standardized β weight p-value R2 
Stair descent time -0.818 0.000 0.48 
Group (Ref. – asymptomatic)  -0.260  0.008 
Stair ascent time 0.443 0.047 
Eversion strength in knee 90◦ Flexi. 0.184 0.077 
Variables not retained in the model    Change in R2 
Inversion strength in knee 90◦ Flex. 0.024 0.870 0.000 
Heel raises total time -0.027 0.785 -0.001 
WB lunge test -DF ROM 0.060 0.617 -0.002 
Plantar flexion strength in knee 90◦ Flex. 0.057 0.605 -0.002 
10-m. walk time 0.134 0.281 -0.008 
Dorsi flexion strength in knee 90◦ Flex. 0.130 0.294 -0.007 
Plantar flexion strength in knee Ext. -0.138 0.301 -0.007 
Analysis based on sample of 86 participants, DF=dorsiflexion, ROM=range of movement, Ext=extension; 
Flex=flexion 
Independent variables with p>0.1 were systematically excluded. 
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Table 5.4: Multiple linear regression model with self-reported function (FAAM-ADL) as the dependent 
variable 
Significant predictor variables Standardized β weight p-value R2 
Group (Ref. – asymptomatic) -0.642 0.000 0.64 
Stair descent time -0.593 0.001 
Stair ascent time 0.308 0.085 
Variables not retained in the model    Change in R2 
Heel raises total time -0.005 0.955 0.000 
10-m. walk time 0.018 0.866 0.000 
Plantar flexion strength in knee Ext. 0.023 0.842 0.000 
WB lunge test -DF ROM 0.047 0.604 -0.001 
Plantar flexion strength in knee 90◦ Flex. -0.047 0.599 -0.001 
Eversion strength in knee 90◦ Flex. 0.115 0.279 -0.005 
Inversion strength in knee 90◦ Flex. -0.078 0.402 -0.003 
Dorsi flexion strength in knee 90◦ Flex. 0.122 0.160 -0.008 
Analysis based on sample of 90 participants, DF=dorsiflexion, ROM=range of movement, Ext=extension; 
Flex=flexion 
Independent variables with p>0.1 were systematically excluded. 
 
5.4 Discussion 
This study aimed to identify impairments that characterize individuals with ankle OA 
by comparing physical measures and patient-reported outcomes between the symptomatic 
OA group and the pooled asymptomatic group (asymptomatic OA + asymptomatic non-OA) 
and between the asymptomatic OA group and asymptomatic non-OA group. Analysis of 
physical outcome measures revealed significant deficits in ambulatory function, muscle 
strength, and DF ROM in individuals with symptomatic OA compared to individuals without 
ankle symptoms. Symptomatic ankle OA was associated with greater pain, patient-reported 
disability, instability and kinesiophobia, and lower self-reported function and QoL. These 
findings highlight the impairments characterising individuals with symptomatic ankle OA.  
Interestingly, 41 of the 65 individuals with no clinical signs of ankle OA (i.e. no pain or 
stiffness) and 13 asymptomatic ankles in the symptomatic group had radiographic evidence of 
joint degeneration based on evaluation using the KL scale. This is consistent with evidence 
from a systematic review reporting that radiographic OA of the knee is an imprecise guide to 
the likelihood that knee pain will be present 340. Further, most physical and patient-reported 
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outcomes were similar between individuals with asymptomatic OA and asymptomatic non-
OA. It is unlikely that degenerative joint changes are the only cause of limited ROM and 
strength deficits. It seems likely that pain is a contributing factor because 41 asymptomatic 
individuals with evidence of ankle OA presented with comparable ROM to that of 
asymptomatic non-OA. In the knee, the inhibitory effect of joint pain on range of motion has 
been established 348. This also applies to the ankle strength deficits identified in the 
symptomatic but not the asymptomatic OA group which is consistent with findings of deficits 
in isometric knee extensor and flexor strength related to knee pain and not to the structural 
status of the knee on radiographs 67. Our findings suggest that the presence of ankle 
symptoms may present a greater impact on an individual’s overall function and QoL than the 
presence of radiographic evidence of joint degeneration. Further, our findings highlight the 
need to assess symptoms when interpreting the impact of radiographic joint degeneration 
and raise questions regarding the relevance of radiographs alone when determining the 
management of individuals with ankle OA.  
Clinical tests of physical function such as timed level walking and stairs ascent/descent 
have not previously been investigated in individuals with ankle OA. Stair ascent/descent has 
been related to independence and community participation 349,350,351 and stair descent time is 
a significant marker of functional decline among older adults 350. Our results reveal slower 
timed walking and stair ascent/descent in symptomatic individuals with ankle OA than 
individuals without ankle symptoms. Additionally, these physical measures associated with 
QoL and function indicate that addressing deficits in the ability to ascend and descend stairs 
may be important in the management of individuals with ankle OA. While the correlation was 
large for function (r 0.64), it is clear that the strength of that correlation is moderate for QoL 
(r 0.48) and much of the variance in the total AQoL-6D remain unexplained or unaccounted 
for. Stair descent is a complex functional task that relies on strength but also on visual 
processing, motor planning and coordination. Association of stair descent time with pain, 
strength of knee extensors and flexors, proprioception, balance and fear of falling has been 
reported 352 and it is possible that these factors may also influence QoL and function.  
There is evidence to indicate that ankle strength may influence the performance of 
functional tests. Ankle dorsiflexor and plantar flexor muscles strength have been shown to be 
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correlated with walking speed 353 stair tests 354 and stair ascent 355. Taking into account that 
muscle strength improvements have shown to improve function 356, there may be a role for 
strengthening exercises to increase strength in individuals with ankle symptoms and thereby 
improve function and QoL. 
Limited ROM is a common impairment in OA. It has been suggested that osteophytes 
in OA create bone blocks that can contribute to capsular contracture and subsequently limit 
physiological ROM 146,357. Previous research identified less total sagittal plane (dorsiflexion 
and plantar flexion) ROM on the affected ankle compared to the unaffected ankle in 
individuals with ankle OA and to healthy controls 338. Our data indicate that decreased DF 
ROM contributes to the loss of sagittal plane ankle ROM. This is important because reduced 
ankle DF has been associated with impaired gait, compromised balance and function 
168,169,165,166,167, greater perceived ankle instability 358,359, falls 360 and to the development of 
lower limb musculoskeletal pain and injuries (such as patellar tendon injury 361). Addressing 
deficits in ankle DF ROM should be included in the management of individuals with 
symptomatic ankle OA.  
Even though ankle ligament sprains are thought to contribute to ankle OA 
development 13,14,15 and are associated with increased joint displacement 362,363, the one 
study 146 that investigated arthrokinematics in ankle OA reported less anterior displacement 
and inversion-eversion rotation in the osteoarthritic ankle compared to the unaffected ankle 
and healthy controls. Although the anterior displacement, inversion and eversion rotation 
observed in asymptomatic individuals who participated in our study were not different from 
the healthy controls in that single study. Our investigation revealed deficits in rotational 
arthrokinematics in the symptomatic compared to the asymptomatic group, but no 
differences in displacement were identified between groups. It is possible that differences in 
arthrokinematics findings between this study and that reported by Hubbard 146 are due to 
heterogeneity in the ankle OA population or may be due to small sample size in Hubbard’s 
study (8 ankle OA and 8 controls). However, the control group variability in that single study 
was extremely small. It is likely more complex than just sample size. 
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FIGURE 5. 3: Comparison between laboratory study asymptomatic group and data for healthy control 
from Hubbard 2009 study 
Despite physical and patient-reported impairments identified in symptomatic 
individuals with OA, and while expected that these impairments may affect the ability to 
exercise, self-reported physical activity did not differ between groups in our study. It is 
possible that individuals with symptomatic OA adapt activity choices in line with their pain 
and physical capabilities as previous research reported 364. Evidence suggests that pain relief 
can make it tolerable for people with OA to maintain a certain level of physical activity 365,366. 
Alternatively, the absence of significant differences in physical activity may be due to the 
limitations of using the IPAQ-SF to determine self-reported physical activity. IPAQ responses 
depend on the perception of the different levels of activity (what activities fit in the vigorous 
or moderate categories 367) and recall of activity pattern over the last 7 days. It is also likely 
that individuals will report the highest or desired physical activity participation rather than the 
actual activity performed 368. Further, evidence of weak specificity of IPAQ-SF to accurately 
estimate physical activity compared with objective measures of activity and fitness has been 
reported 369.  
Findings from this study should be considered in light of the following limitations. This 
study provided information on the association of physical outcomes, QoL and self-reported 
function but no causal relationship between any of the assessed variables can be derived due 
80 
 
to the cross-sectional design of this study. Data related to the history of injury including the 
number of ankle sprains and fractures were collected retrospectively. This method can be a 
potential source of error as the ability to reliably and accurately recall this information vary 
among individuals of different age. Conclusions reached in this study were limited by the 
small number of individuals who presented with symptoms but no radiographic evidence of 
ankle OA. This small sample limited our ability to report findings related to the presence of 
symptoms without OA and whether the combination of symptoms and radiographic OA or 
symptoms alone contributed to ankle joint impairments. We were also unable to determine 
the relationship between radiographic evidence of ankle OA and physical asymmetry in 
symptomatic individuals with evidence of unilateral ankle OA due to the number of missing 
images of the asymptomatic ankles. Further, it is known that OA coincides with other 
comorbid disease 214,370-372. Since individuals with comorbid conditions were excluded from 
the laboratory examination in this study, this limits the ability to generalise these findings to 
the wider ankle OA population who typically present with other comorbidities. Volunteers 
with a wide age range and high physical activity levels participated in this study with all 
participants able to complete the functional tasks. Our findings may not be generalizable to 
populations with higher levels of physical disability. Due to a lower representation of severe 
OA (grade 4 KL), findings from this study may not be reflective of end-stage ankle OA. 
Asymptomatic participants may have had degenerative joint changes on the opposing 
unexrayed ankle. However, based on the results of comparison between asymptomatic with 
and without OA, we, therefore, assume that the presence of OA on the opposing unexrayed 
ankle may not change the results of comparison between symptomatic and asymptomatic 
groups. Finally, while muscle torque was lower in the symptomatic group than the 
asymptomatic, our data is not able to ascertain whether this is related to atrophy, weakness, 
or inhibition.  
This study was not designed to determine the association between grades of OA and 
function/symptoms. Further research to determine if higher grades of OA have greater 
deficits (and whether this is related to pain and stiffness symptoms) is warranted. We have 
only assessed association of physical measures with QoL and perceived function, however, 
QoL and function can be influenced by non-physical factors which were not within the scope 
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of this study. Hence the inclusion of other physiological and psychological factors will likely 
yield different findings. Self-reported physical activity using IPAQ-SF may have yielded an 
overestimation. Hence future studies may utilise objective measures such as activity monitors 
to substantiate the level of physical activity in populations with ankle OA. Since presence of 
chronic joint pain, limited ankle DF and muscles weakness have been associated with risk of 
fall 373,168,198, 360, coexistence of these impairments may suggest an increased risk of falls in 
individuals with symptomatic ankle OA. Future research assessing the incidence of falls and 
the contribution of the identified impairments to the occurrence of falls in individuals with 
ankle OA seem warranted. 
In summary, individuals with symptomatic (but not asymptomatic) ankle OA present 
with higher pain, patient-reported disability, instability, kinesiophobia, lower self-reported 
function and QoL, impaired calf muscle strength, lower calf muscle endurance, less ankle 
ROM and slower ambulatory function compared to asymptomatic individuals without ankle 
OA. The asymptomatic individuals with radiographic OA did not have physical deficits or 
impairments in patient-reported outcomes compared to the control group. Our findings 
suggest that stair function is related to impaired QoL and self-reported function. Until further 
research provides a better understanding of the mediators of the observed physical 
impairments and self-reported outcomes in a symptomatic ankle OA population, 
management should be guided by the clinical presentation and functional status of those 
individuals rather than radiological findings. 
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Chapter 6 Health-related quality of life, pain, function, and disability in 
individuals with symptomatic ankle problems: a cross-sectional online 
survey 
In the previous chapter, evidence from the cross-sectional laboratory study revealed 
that the presence of radiographic OA with no ankle symptoms was not associated with 
impairments in physical and patient-reported outcomes. In this chapter, we opted to focus on 
the presence of ankle symptoms rather than radiographic evidence of ankle OA. The sample 
was drawn from Australia wide to retain adequate sample size and access to individuals in 
distant locations. This study aimed to compare self-reported ankle symptoms (pain, stiffness 
and instability), function, disability, physical activity and QoL between individuals with ankle 
symptoms and asymptomatic controls. A secondary aim was to explore factors associated 
with QoL. 
6.1 Introduction 
Musculoskeletal conditions represent the second leading cause of disability affecting 
20-33% of individuals world-wide 1. Pain associated with musculoskeletal conditions is 
reported as the main reason for seeking medical care 5,374. Chronic musculoskeletal ankle 
conditions (mostly due to an ankle injury) affect nearly 20% of Australian adults 2. Other 
population estimates for ankle pain range from 9-15% of adults from different studies 3-5.  
Pain and physical impairments related to musculoskeletal conditions negatively impact 
function, mental health and QoL 7,375. However, the relation between ankle pain and physical 
function, social interaction, and QoL remains unclear. After the 3rd decade of life, ankle pain 
and stiffness may be related to OA, particularly in individuals who have had previous ankle 
injuries 128. There is some evidence to suggest poor QoL in late-stage ankle OA 173,214 but this 
only represents a small proportion of the ankle pain population.  
Symptoms from lower limb joints (other than the ankle) were significantly associated 
with lower physical QoL but not asymptomatic radiographic evidence of OA 376. Several 
studies 64,377,378,379 reported that the severity of lower limb joint pain had a greater impact on 
disability than the structural changes observed on radiographs. Hence, it seems reasonable to 
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focus on symptoms rather than radiographic evidence of joint changes when studying 
populations with joint symptoms in relation to QoL and disability. 
In accordance with the biopsychosocial approach for chronic pain management 380, 
addressing all aspects of chronic pain presentations (physical, psychological, and social 
components) seems warranted in the management of individuals with chronic ankle 
conditions. As a first step, the relation between the clinical presentation and self-reported 
pain, disability, function, and QoL in individuals with chronic ankle symptoms requires 
investigation. The aim of this study was to compare self-reported pain, function, ankle 
instability, physical activity, and QoL outcome measures between individuals with ankle 
symptoms and asymptomatic controls. A secondary aim was to identify which of those 
outcome measures are most associated with QoL. 
6.2 Methods 
An online survey of individuals with and without ankle pain and/or stiffness was 
implemented to address the following questions: (i) what are the differences in function, 
ankle instability, physical activity and QoL between those who report ankle symptoms and 
asymptomatic controls and (ii) what outcome measures are associated with QoL. 
6.2.1 Recruitment 
Between July 2015 and February 2017, 1948 volunteers aged 30 to 75 years with and 
without a history of ankle pain and/or stiffness present on most days for >3 months duration 
sought to participate in this cross-sectional survey. Of those 270 symptomatic, and 124 
asymptomatic controls participated in the study. Participants were recruited via community 
advertisements placed in a local university staff and community newsletters, communications 
from National and State arthritis organisations, and social media. Participants were asked to 
indicate if they “experienced any of the following ankle symptoms for more than 3 months on 
most days”: 1) Pain or ache in/or around the ankle, 2) Ankle joint stiffness or reduced 
movement in the morning. Participants who indicated they did not experience any ankle pain 
or stiffness in the last 3 months were included in the asymptomatic control group. The study 
was approved by the institutional human research ethics committee and all participants 
provided informed consent.  
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6.2.2 Outcome measures 
Participants provided information about their age, sex, body weight, height and 
history of ankle injuries and health-care consultations. They also completed the following 
questionnaires and scales. 
6.2.2.1 Severity of Pain and Stiffness 
Participants rated their ankle pain at rest, average ankle pain over the past 24-hours, 
and worst pain over the past 7 days using an 11-point NRS anchored at 0 with “no pain” and 
at 10 with “worst pain imaginable”.  
Similarly, participants rated their usual level of ankle stiffness over the past week on 
11-point NRS anchored at 0 with “no stiffness” and at 10 with “worst stiffness imaginable”. 
Validity and reliability of The NRS (ICC= 0.95) as a measure of knee OA pain has been reported 
310. 
6.2.2.2 Quality of Life 
The Assessment of Quality of Life questionnaire (AQoL-6D) was used to evaluate QoL. 
The AQoL-6D is an Australian multi-attribute utility instrument 313. It comprises 20 questions 
in 6 separate dimensions (independent living, mental health, coping, relationships, pain, and 
senses). The unweighted responses of all questions were added to create an overall profile 
score (0-100) and individual scores for each of the six dimensions. Higher scores indicate 
better QoL. Strong construct 314 and discriminative validity for use in OA population have 
been reported 315. Test-retest reliability (ICC=0.85-0.88) for this measure has been reported 
316. 
6.2.2.3 Function 
Foot and Ankle Ability Measure (FAAM) was used to assess function 317. It consists of a 
21-item Activities of Daily Living subscale (FAAM-ADL) and an 8-item sports subscale (FAAM-
sport). Each item is scored on a 5-point Likert scale (0-4) ranging from no difficulty (4) to 
unable to do (0). A “NA” option is available to indicate activities limited by factors other than 
foot or ankle problems. The total score is a sum of responses that range from 0 to 84 for the 
FAAM-ADL and from 0 to 32 for the FAAM-Sport. Items selected as “NA” are excluded from 
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scoring, resulting in a lower total number of possible points (denominator). The total score is 
divided by the denominator and multiplied by 100 to create a percentage, with a higher 
percentage indicating a higher level of function. In a separate question, participants also rated 
their current level of function as “normal”, “nearly normal”, “abnormal”, or “severely 
abnormal”. Test-retest reliability (ADL subscale; ICC= 0.87 and Sports subscale; ICC= 0.89) and 
internal consistency of the FAAM have been reported 317. 
6.2.2.4 Pain and Disability 
Ankle Osteoarthritis Scale (AOS) was used to evaluate disability and pain. The AOS is a 
disease-specific instrument used to measure pain and disability related to ankle OA. The AOS 
has been reported to be a reliable and valid self-reported outcome for ankle arthritis 318. It 
consists of two subscales: pain and disability, with nine questions each. Participants indicate 
how much pain and difficulty they experience when performing certain activities over the 
past week. The original scoring of the two subscales was measured along a 100-mm visual 
analogue scale (VAS) anchored with “No pain” (0mm) and “Worst pain imaginable” (100mm), 
and “No difficulty” (0mm) and “So difficult, unable” (100mm), respectively. The original AOS 
was modified to an online format with an 11-point (0-10) NRS and same anchors as the 
original scale (paper version). 
6.2.2.5 Ankle Instability 
The Cumberland Ankle Instability Tool (CAIT) was used to evaluate ankle instability. 
The CAIT is a valid, and reliable (ICC=0.96) tool used to measure perceived ankle instability 319. 
The tool contains 9-items with scores assigned based on the rank of the chosen response. 
Responses were summed separately for each limb. The maximum score is 30 with a higher 
score indicating less instability. 
6.2.2.6 Physical Activity 
The International Physical Activity Questionnaire- short form (IPAQ-SF) was used to 
capture data on self-reported physical activity. The IPAQ (short-form) measures the total 
amount of time spent performing a moderate activity, vigorous activity, walking or sitting in 
bouts of 10 minutes or greater over the last 7 days 322. The time (in minutes) spent on each 
activity is multiplied by the defined metabolic equivalent of each task category and scores are 
86 
 
presented as MET-minutes per week. The IPAQ categorises physical activity into “low”, 
“moderate” or “high". Data processing, scoring and analysis were done according to the 
published guidelines for IPAQ-SF (available from: http://www.ipaq.ki.se). Validity and test-
retest reliability (ICC = 0.51) in hip and knee OA population have been reported 323. 
6.2.3 Statistical analysis  
Body mass index (BMI) was calculated from self-reported height and body weight. 
Statistical analysis was performed using IBM SPSS Statistics for Windows (Version 25.0. 
Armonk, NY: IBM Corp). To assess the reliability of the online version of AOS, both versions 
were administered to 10 volunteers with ankle pain with an average time of 3 days between 
administrations. After completing one randomly selected version, individuals were sent the 
other version to complete. Kappa statistics were used to assess the reliability between the 
online and paper version of AOS. Reliability was categorized as poor (<0.00), slight (0.00–0.2), 
fair (0.21–0.4), moderate (0.41–0.6), substantial (0.61–0.8) or almost perfect (0.81– 1.0) 234. 
Reliability between online NRS and paper VAS version of AOS was 0.898, with 95% CI (0.86, 
0.92).  
A univariate analysis of covariance (ANCOVA) with age, sex and BMI entered as 
covariates and group as a fixed factor was used to compare differences between groups for 
all outcomes. AQoL-6D data was compared between controls and published norms for AQoL-
6D. Data representing point estimates of effect are presented as mean differences (MDs) and 
their confidence intervals (CI) in tabular format and as standardized mean differences (SMDs) 
and (CI) in forest plots. The SMD was calculated as the difference between the two groups 
means divided by the pooled SDs. Differences in outcomes were calculated such that negative 
differences indicated a deficit in the measure for the symptomatic group compared to that 
for the asymptomatic controls, and positive differences indicated the opposite. Effect sizes 
were interpreted as trivial: 0.0-0.2, small: 0.2-0.6, medium: 0.6-1.2, large: 1.2-2.0, very large: 
2.0-4.0 and distinct:>4.0 347. 
Chi-square test was conducted to compare categorical variables (sex and categories of 
physical activity) between groups. Odds ratio (OR) and risk difference (RD) were reported for 
categorical and binary data.  
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As bivariate normality was not assumed, the relationship between variables (AQoL-6D, 
group, sex, BMI, Age, ankle stiffness, CAIT, AOS-Pain, FAAM-Sport, FAAM-ADL and AOS-
Disability) was investigated using nonparametric Spearman's Rank-Order Correlation. The 
correlation was interpreted as low (0.1 to 0.3), moderate (0.3 to 0.5), high (0.5-0.7) and very 
high(0.7-0.9) 347. A stepwise backward elimination regression was conducted to establish the 
most influential independent variables associated with the dependent variable of AQoL-6D. 
The independent variables were group, sex, BMI, age, ankle stiffness, CAIT, AOS (pain and 
disability), and FAAM (ADL and sport). Those with a higher correlation to AQoL-6D were 
entered first. The multiple regression model was tested for multicollinearity. Statistical 
significance was set at p<0.05.  
6.3 Results 
There were 1948 volunteers who responded to advertisements seeking to participate 
for the study, of which 1388 were excluded, largely due to not providing any data for the AOS, 
FAAM, AQoL-6D, IPAQ and CAIT questionnaires (1055), not meeting selection criteria (298) 
and not providing consent (20). Fifteen records were removed as they were duplicates (Figure 
6.1). Participants with missing item responses in questionnaires were followed up by email 
and invited to complete the missing data. Survey data were available for analysis from 394 
participants (263 female) with a mean age 48.83 years (SD=12.05, range=30 to 75 years) and 
mean BMI 28.7(7.68), range=17.4 to 74.3). The cohort consisted of 270 symptomatic, and 124 
asymptomatic controls reporting no ankle symptoms or history of ankle injury (Figure 6.1).  
The majority of the symptomatic group reported both ankle pain and stiffness (93%), 
while a few reported either ankle pain/ache (5.9 %) or stiffness (1.1%) in the previous 3 
months. The majority of symptomatic individuals 92.6 % had sought help from a health care 
practitioner for their symptoms (Table 6.1). 
 
88 
 
 
FIGURE 6. 1: Flow chart of recruitment and group allocation 
 
Table 6.1: Characteristics (symptoms, injury history and health care consultation) of the symptomatic 
group. 
Characteristic Symptomatic 
Pain intensity at rest, mean (SD) 2.91 (2.27) 
Pain intensity at worst, mean (SD) 6.52 (2.42) 
Average pain intensity mean (SD) 4.62 (2.36) 
Usual level of stiffness mean (SD) 4.41 (2.68) 
Unilateral ankle pain n (%) 167 (61.9%) 
Bilateral ankle pain n (%) 100 (37%) 
Unilateral ankle stiffness n (%) 164 (60.7%) 
Bilateral ankle stiffness n (%) 90 (33.3%) 
Previous injury n (%) 
No ankle sprain  73 (27%) 
Single ankle sprain  35 (13%) 
Multiple ankle sprains  162 (60%) 
No fracture  186 (68.9%) 
Single fracture  53 (19.6%) 
Multiple fractures  31 (11.5%) 
Healthcare practitioner consultation for ankle n (%) 
General practitioner GP  182(33.2%) 
Orthopaedic surgeon  114 (20.8%) 
Rheumatologist  26 (4.7%) 
Sports physician  35 (6.4%) 
Physiotherapist  136 (24.8%) 
Osteopath  15 (2.7%) 
Not visited a healthcare practitioner  40 (7.3 %) 
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6.3.1 Individuals with symptomatic ankle problems compared to asymptomatic controls 
The symptomatic ankle group had a higher BMI (SMD = 1) and had 22% fewer 
females than the control group but were similar in age (Table 6.2 and Figure 6.2). There were 
significant differences between symptomatic ankle and control groups for all measures 
(AQoL-6D, AOS, FAAM, CAIT; SMD ranging from 1.1 to 3.2), with the exception of self-report 
physical activity (IPAQ short) (p<0.001).  
In the separate FAAM question, where responders rate the level of functional 
normality, control participants were more likely to rate their function as “normal” RD 90% 
[85, 95]. More than half of symptomatic individuals rated their level of function as abnormal 
(47%), or severely abnormal(10.7%) while no controls rated their function as abnormal or 
severely abnormal. 
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Figure 6. 2: Forest plot representing the differences between symptomatic and control
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Table 6.2: Comparison of participant characteristics and outcomes between symptomatic (n=270) and asymptomatic control (n=124) groups. 
Characteristic Symptomatic Asymptomatic controls Point estimate of effect* (95%CI) p value 
Age years 48.4 (11.9, 270) 49.9 (12.3, 124) 1.5 [-1.1, 4.1] 0.249 
Sex, Female n (%) 162 (60%) 101 (81.5%) 0.34 [020, 0.57] # < 0.001 
BMI kg/m2 30.9 (8.1, 266)  24.1 (3.9, 124) -6.8 [-8.0, -5.6] < 0.001 
AQoL-6D /100 
Total  72.3 (11.8, 263) 84.9 (12.4, 124) -12.6 [-15.4, -9.9] < 0.001 
Independent Living  76.9 (15.8, 263) 93.8 (16.5, 124) -16.9 [-20.6, -13.3] < 0.001 
Relationships  81.3 (16.1, 263) 92.4 (16.8, 124) -11.1 [-14.8, -7.3] < 0.001 
Mental Health  69.5 (17.0, 263) 77.3 (17.8, 124) -7.7 [-11.7, -3.8] < 0.001 
Coping  67.1 (16.4, 263) 74.3 (17.1, 124) -7.2 [-11.0, -3.4] < 0.001 
Pain 54.1 (20.5, 263) 85.8 (21.4, 124) -31.8 [-36.5, -27.0] < 0.001 
Senses 81.0 (10.9, 263) 85.3 (11.4, 124) -4.3 [-6.8, -1.8] 0.001 
FAAM- ADL % 67.7 (16.9, 266) 95.9 (17.7, 113) -28.2 [-32.2, -24.1] < 0.001 
FAAM- Sport % 48.5 (21.0, 266) 95.9 (22.0, 111) -47.4 [-52.4, -42.3] < 0.001 
FAAM-level of function n (%) 
Severely abnormal  29 (10.7%) 0 (0%) 11% [7, 15] ^  
Abnormal  127 (47.0%) 0 (0%) 47% [41, 53] ^  
Nearly normal  106 (39.3%) 9 (7.3%) 32% [25, 39] ^  
Normal  8 (3.0%) 115 (92.7%) -90% [-95, -85] ^  
AOS- Overall % 37.4 (19.4, 266) 3.9 (20.4, 108) 33.5 [28.8, 38.2] < 0.001 
AOS- Pain % 38.0 (18.7, 266) 3.0 (19.6, 99) 35.0 [30.3, 39.6] < 0.001 
AOS- Disability % 37.1 (22.1, 266) 4.6 (23.2, 108) 32.5 [27.2, 37.9] < 0.001 
CAIT /30 10.4 (5.7, 229) 28.9 (5.9, 124) -18.5 [-19.8, -17.1] < 0.001 
IPAQ (MET-min/week) 
Total activity 3417.4 (3339.5, 265) 3259.3 (3492.7, 124) 158.0 [-616.8, 932.9] 0.689 
Vigorous activity 1251.1 (1843.7, 265) 1279.4 (1928.3, 124) -28.3 [-456.1, 399.5] 0.897 
Moderate activity 822.8 (1179.9, 265) 719.2 (1234.0, 124) 103.7 [-170.1, 377.4] 0.457 
Walk  1343.4 (83.9, 265) 1260.8 (128.4, 124) 82.7 [-234.4, 399.7] 0.609 
IPAQ, level of activity %(n) 
High  131 (48.5%)  61 (49.2%)  0 % [-10, 11] ^  
Moderate  79 (29.3%) 48 (38.7%) -9 % [-19, 1] ^  
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Low  59 (21.9%) 15 (12.1%) 10 % [3, 18] ^  
# Odds ratio, ^ risk difference  
Abbreviations: n=number; BMI= body mass index; SD=standard deviation; MD= mean difference; CI=confidence interval; p=p value/significance level; AOS=ankle 
osteoarthritis scale; FAAM=Foot and Ankle Ability Measure; AQoL-6D= The Assessment of Quality of Life questionnaire-6D; CAIT= The Cumberland Ankle Instability Tool; 
IPAQ=The International Physical Activity Questionnaire;  
All outcomes adjusted for age, sex and BMI  
Significant difference at (p < 0.05) based on ANCOVA post-hoc comparisons with Bonferroni correction or Pearson’s Chi-squared 
Data presented as group mean (SD, n) and MD (CI), unless otherwise stated 
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Comparison between AQoL-6D results of controls with published age and sex-matched 
population norms 313 revealed that they were similar to published norms except for female 
controls between 55-64 years old who had higher AQoL-6D than published norms (Figure 
6.3).  
 
FIGURE 6. 3: Comparing AQoL results between survey asymptomatic respondents and published norms 
6.3.2 Outcomes associated with QoL 
The bivariate correlations between the different survey variables are presented in 
appendix 9. Higher BMI was associated with poorer patient-reported outcomes. The most 
important single factor independently associated with QoL was the FAAM-ADL as it accounted 
for the largest amount of variance in the regression model, which explained 65.7% of the total 
variance (Table 6.3). 
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Table 6.3: Multiple linear regression model with the quality of life (AQoL-6D) as the dependent 
variable 
*Significant predictor variables Standardized β weight P value R2 
FAAM-ADL 0.819 0.000 0.657 
Age 0.067 0.087 
Variables not retained in the model    Change in R2 
Ankle stiffness  0.021 0.732 0.00 
FAAM Sport -0.055 0.583 0.00 
AOS-Pain -0.085 0.301 -0.002 
Sex -0.044 0.265 -0.002 
BMI -0.062 0.159 -0.003 
Group 0.089 0.138 -0.003 
CAIT 0.060 0.372 -0.001 
Abbreviations: p-value/significance level; AOS=ankle osteoarthritis scale; FAAM=Foot and Ankle Ability 
Measure; ADL=Actvitiesof daily living; AQoL-6D= The Assessment of Quality of Life; BMI= body mass 
index; CAIT= The Cumberland Ankle Instability Tool. 
*Initial multiple regression revealed that FAAM-ADL had the greatest contribution to AQoL-6D (=-
0.520, p<0.001) then the AOS-Disability (=-0.314, p=0.001) both explaining 66.9% of the total variance. 
Multicollinearity test revealed a 10.35 variance inflation factor for FAAM and 9.36 for AOS-Disability. A 
Hierarchical multiple Linear regression was re-run after removing AOS-Disability based on  and p 
values. 
 
6.4 Discussion 
This survey compared ankle symptoms (pain, stiffness, and instability), self-reported 
function, disability, physical activity and QoL between individuals with and without ankle 
symptoms and investigated the factors associated with QoL. The relation between the three 
ankle specific measures (CAIT, FAAM and AOS) and QoL in a large population of individuals 
with and without ankle symptoms was also evaluated. Our data indicate that individuals with 
ankle symptoms reported higher BMI, ankle related pain and disability, and lower ankle 
stability, function and QoL than asymptomatic controls. FAAM-ADL scores were shown to be a 
good representation of QoL in this population. This suggests that FAAM-ADL scores could be 
used as an outcome measure to determine the effectiveness of ankle management on ADL 
ability and QoL in both clinic and research.  
Although the symptomatic sample in this study does not have confirmed ankle OA, we 
propose that the prevalence of ankle OA in this sample is likely to be high. This proposition is 
based on the presence of classical OA symptoms for more than 3 months on most days 52. 
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There is evidence from a cross-sectional laboratory study 381, which revealed that 94% (n=31) 
of participants who presented with ankle symptoms also had evidence of radiographic ankle 
OA defined as a Kellgren and Lawrence grade of ≥ 2 (definite osteophytes with mild-severe 
joint space narrowing 280). This is also consistent with findings in knee OA where radiographic 
changes on imaging is common in those who have had >3 months of knee pain in the past 12 
months and >90 days of pain in the past 6 months 52.  
Understanding the association between the different variables and QoL has important 
implications. Our data indicate that functional disability at the ankle contributes to a lower 
QoL. In people with knee difficulties 5 to 20 years post anterior cruciate ligament 
reconstruction, improved function (in the form of return to sport at the same or higher level) 
was related to better QoL as measured by AQoL-8D 382. This highlights the interplay between 
function and QoL and the importance of using function as an outcome measure in the 
management of individuals with ankle symptoms. The outcomes of this study may guide the 
selection of patient-reported outcome measures for clinicians managing patients with ankle 
symptoms and researchers investigating the effectiveness of interventions. 
High BMI in our study population was associated with higher pain and disability, lower 
functional capacity and lower QoL. These findings are comparable to a large body of evidence 
reporting negative consequences for QoL in individuals with higher BMI 383,384,385-387. The BMI 
of more than 65% of participants in the symptomatic group exceeded values for normal 
weight (>24.99 kg/m2) 388. There are possible mechanical and inflammatory mechanisms by 
which increased BMI is associated with OA. Obesity is characterized by excessive adipokine 
expression on the surface of chondrocytes 389,390, synoviocytes and subchondral osteoblasts 
391 which increases degradative enzymes and pro-inflammatory cytokines production 392-394. 
Obesity also modifies the joint mechanical environment due to increased joint load, inducing 
cartilage damage through activation of the mechanoreceptors (the stretch-activated 
channels, the a-5b1 integrin, and CD44) on chondrocytes 389,390. Following mechanoreceptor 
activation, proinflammatory mediators such as prostaglandins and nitric oxide may be 
generated which fuel cartilage degradation 395,396. Research has shown that weight 
management through exercise 397 and diet 398 improves self-reported function 397,399,400, 
pain397,400 and QoL397,398 in over-weight individuals with knee OA. In light of the relation 
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between obesity and pain, disability and QoL and the effect of weight loss intervention on 
these outcomes, providing weight loss interventions may be important in the management of 
this population. 
Individuals reporting ankle symptoms demonstrated significantly poorer FAAM- ADL 
and AOS-Disability outcomes than asymptomatic controls. This is consistent with findings that 
65% of people with musculoskeletal ankle conditions limit or modify their physical activity 
(predominantly sports) because of the ankle problem, with more significant limitation in 
individuals with OA (80%) than those with ankle sprains (55%) 2.  
Individuals in the symptomatic group reported severe ankle instability defined as a 
CAIT score less than or equal to 23 401 that is similar to the instability experienced by 
individuals with chronic ankle instability 100. Further research is needed to understand the 
implications of instability in individuals with ankle pain and stiffness, and to determine if other 
symptoms common in a chronic ankle instability population, such as giving way, are also a 
problem in this population. It is important to ascertain the extent to which differences in 
outcomes between groups are clinically relevant. For most of these measures, information 
related to the minimal clinically important difference (MCID) or minimal detectable change 
(MDC) have not been specifically explored in a population with ankle symptoms. To supply 
clinical context, effect sizes can be used to measure the magnitude of difference between 
groups in the absence of MCID or MDC. In terms of effect size, group comparisons for ankle 
specific outcomes (AOS, FAAM, and CAIT) was large to very large and medium for total QoL, 
with most QoL related subscales indicating that individuals in the symptomatic group 
experienced significantly compromised QoL compared to asymptomatic controls. 
Despite reports of lower ADL function and higher disability in the symptomatic group, 
the level of self-reported physical activity did not differ between groups in our study. 
Although unexpected, a limitation of self-reported outcomes compared to objective 
measures is the reduced sensitivity to low or moderate activity 368,402. Nonetheless, the 
physical activity findings from the symptomatic group is similar to that reported for other 
joint pain populations. Previous studies have not identified any difference in self-reported 
physical activity between individuals with rheumatoid arthritis and controls 403, or in physical 
activity assessed using an activity monitor in individuals with knee and hip OA compared with 
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controls, despite lower scores on a physical function questionnaire 365. There are possible 
reasons why activity may not be limited in the symptomatic group despite the reported 
increased disability and impaired function. It is possible that symptomatic individuals may 
alter the type of physical activity performed, such as participating in non-weight-bearing 
activities, to enable pain-free or low pain physical activity participation. Alternatively, as 
suggested by previous authors, use of analgesics may enable symptomatic individuals to 
maintain a certain level of physical activity 365.  
Although this study provides important information on the relationship between ankle 
symptoms, function and QoL and the factors that influence QoL in this population, there are 
limitations that must be considered. First, data for this survey was collected using an online 
survey, which limited participation to internet users. Second, all data collected was self-
reported and required long-term recall which may affect the ability to reliably self-report and 
may contribute to reporting bias. Third, responses related to the assessment of physical 
activity using the IPAQ depend on the perception of the different levels of activity (what 
activities fit in the vigorous or moderate categories 367), and increase the likelihood of 
reporting the highest or desired level of physical activity participation rather than the actual 
activity performed 368. These factors can lead to inaccuracies and over-reporting 404,405. Future 
studies may verify levels of  physical activity in individuals with ankle symptoms using 
objective measures. Although participants were specifically asked to indicate their level of 
function, ability and pain based on ankle symptoms, other comorbid factors may have also 
influenced our findings. Therefore, studies to identify the presence of comorbid conditions, 
psychologic status and balance confidence in individuals with ankle symptoms, and to explore 
the influence of those factors on pain and function, are warranted. 
In summary, this study highlighted the significant burden of ankle symptoms. 
Individuals with ankle symptoms are characterized by lower QoL, lower function and high 
disability. Quality of life in symptomatic ankle population was positively associated with 
FAAM-ADL. Based on these findings, the management of ankle symptoms should target 
improvements in function and the FAAM-ADL is an appropriate tool to evaluate the change in 
function associated with management. 
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Chapter 7 The psychological features of symptomatic ankle problems: 
a cross-sectional survey 
7.1 Introduction 
Musculoskeletal conditions are a major cause of chronic pain and disability 7. The 
World Health Organisation estimates that approximately 20-33% of people live with a painful 
musculoskeletal condition 1. Chronic ankle conditions affect up to 20% of the Australian adult 
population 2, with ankle pain being the most common symptom affecting 73.5% of this 
population. Psychological morbidities such as pain-related fear of movement, anxiety, 
depression, catastrophizing and poor self-efficacy have been associated with pain 201. Further, 
psychological morbidities can have a stronger influence on function than pain itself. For 
example, research on individuals with chronic low back pain identified kinesiophobia as a 
more disabling factor than the presence of back pain 202. In another study involving individuals 
with chronic pain conditions, pain self-efficacy explained 30% of the variance of patient-
reported disability, while pain intensity only explained 9% of the variance 406. This highlights 
the interplay between psychological factors and disability, and the importance of addressing 
these factors when assessing and managing individuals with chronic pain.  
While there is evidence to suggest that individuals with ankle pain present with higher 
levels of disability and lower levels of function than the asymptomatic population 407, the 
contribution of possible psychological factors has not been assessed. There is recent evidence 
that 29% and 33% of individuals with symptomatic ankle OA experience anxiety and 
depression respectively; however, this incidence was not compared to a control group 408. 
Thus, it remains unclear whether individuals with ankle symptoms present with psychological 
features that are different than the asymptomatic population. In light of the relationship 
between depression, anxiety and pain-related fear of movement and higher levels of pain 
severity, greater disability, poorer health-related QoL and poorer treatment outcomes in 
individuals with chronic pain,409,410-412,213, it is important to understand possible associations 
between these variables in individuals with ankle symptoms.  
This cross-sectional survey aimed to (1) identify whether the psychological 
characteristics of individuals with symptomatic ankle problems differ from that of controls 
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and (2) investigate whether an association is present between psychological characteristics, 
ankle pain and self-reported function in this population.  
7.2 Methods 
A cross-sectional online survey of individuals with and without ankle symptoms was 
implemented to address the study aims. 
7.2.1 Recruitment 
Volunteers aged 18 to 82 years participated in this cross-sectional online survey 
between March 2017 and February 2018. Participants were recruited via community 
advertisements placed in university and community newsletters, communications from 
national and state arthritis organizations, and social media. Participants were asked if they 
experienced pain/aching in or around the ankle and/or stiffness or reduced movement of the 
ankle in the morning on most days for more than three months. Presence of pain was defined 
as pain ≥2 out of 10 on an 11-point NRS anchored with ‘no pain’ at 0 and ‘worst pain 
imaginable’ at 10. Symptomatic individuals were those with stiffness and/or pain. Participants 
were excluded from the symptomatic group if they reported pain in other body sites which is 
more or equal to that reported at the ankle. Participants who indicated not having ankle pain 
and/or stiffness on most days for more than three months or ankle pain less than 2 out of 10 
on the NRS was were included in the control group. The institutional human research ethics 
committee approved this study. All participants provided informed consent.  
7.2.2 Outcome measures 
Participants completed an online survey to obtain information on general 
demographics (age, and sex), pain severity, pain self-efficacy, pain catastrophizing, 
kinesiophobia, anxiety, depression, and daily activities function. 
Pain severity was rated on an 11-point NRS anchored with 'no pain' at 0 and 'worst 
pain imaginable’ at 10. The NRS has been reported as a valid and reliable measure of knee OA 
pain with an excellent test-retest reliability (ICC= 0.95) 310. Participants rated the worst pain 
they experienced at the ankle/s and 12 other musculoskeletal body sites during the past 7 
days.  
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A 2-Item Abbreviated Pain Self-Efficacy Questionnaire (PSEQ-2) 335 was used to assess 
pain self-efficacy. Participants indicated their level of confidence to perform ‘some type of 
work’ and’ live a normal life style’, despite experiencing pain. The tool is highly correlated 
with the original PSEQ 335. The test-retest reliability for PSEQ-2 was ICC=0.87, 95% CI =0.80- 
0.91 in a heterogeneous population with chronic pain 335. Each item was scored on a 7-point 
scale with 0=not at all confident and 6=completely confident. Responses for the 2 items were 
summed to form a total score (0-12) with scores of ≥8 indicating high pain self-efficacy. 
The Pain Catastrophizing Scale (PCS), a 13-item reliable and valid self-report scale, was 
used to assess pain catastrophizing 336. The test-retest reliability in a population with chronic 
pain is ICC= 0.67 337. PCS items are rated on a scale from 0 (not at all) to 4 (all the time). PCS 
yields three different categories: Rumination (Sum of items 8, 9, 10, 11), Magnification (Sum 
of items 6, 7, 13) and Helplessness (Sum of items 1, 2, 3, 4, 5, 12). A total score (sum of all 13 
item responses) was used as the outcome measure. Total scores range from 0 – 52, with a 
score of ≥30 indicative of clinically relevant levels of catastrophizing 336. 
The Tampa Scale of Kinesiophobia -11 (TSK-11) 320 is a scale that consists of 11 
statements about the perception of movement. It has good internal consistency (Cronbach’s 
=0.79) and test-retest reliability (ICC=0.81) 320. Participants selected the most appropriate 
response on a 4-point Likert scale (1=strongly disagree to 4=strongly agree) to each 
statement. The total score was the sum of responses to the 11 items. Scores ranged from 0 to 
44, with higher scores indicative of a greater degree of kinesiophobia. The specific cut-off 
score for high or low kinesiophobia for TSK-11 has not been established. 
The Hospital Anxiety and Depression Scale (HADS) 331 was used to assess psychological 
distress (HADS total), anxiety and depression. The HADS is a valid scale to assess the severity 
of anxiety and depression symptoms in the general population and in somatic, psychiatric and 
primary care patients 332. The reliability for HADS (Cronbach’s alpha 0.68 -0.93 for HADS-A) 
and (Cronbach’s alpha 0.67 -0.90 for HADS-D) has been reported 332. Participants selected the 
most appropriate response to seven statements related to feelings of anxiety and seven 
statements related to the feeling of depression over the past 7 to 14 days. Each item was 
scored from 0-3. Responses were summed to obtain separate anxiety and depression scores. 
Scores ranged from 0 to 21 for both anxiety and depression. The HADS subscale scores were 
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classified as mild=8 to 10, moderate=11-15 and severe=≥16. A score of 8/21 was used as the 
cut-off point to indicate the presence of anxiety or depression 332. 
Foot and Ankle Ability Measure Activities of Daily Living subscale (FAAM-ADL) is a 21-
item scale that is used to assess ADL function 317. Each item is scored on a 5-point Likert scale 
ranging from no difficulty (4) to unable to do (0). An ”NA” option is available to indicate 
activities limited by factors other than foot or ankle problems. The total score is the sum of 
responses (range from 0 to 84) divided by the denominator (number of possible points based 
on questions answered) and multiplied by 100 to create a percentage. A higher percentage 
indicates a higher level of function. Items selected as “NA” are excluded from scoring, 
resulting a lower total number of possible points (denominator). Test-retest reliability (ADL 
subscale; ICC= 0.87 and Sports subscale; ICC= 0.89) and internal consistency of the FAAM 
have been reported 317. 
7.2.3 Statistical analysis  
Chi-squared tests were conducted to compare the binary variable (sex) and 
dichotomised scores for the anxiety, depression, pain catastrophising and pain self-efficacy 
between groups. Depression and anxiety scores were dichotomised using 8 as a cut-off 
(>8=presence of anxiety/depression or ≤8=absence of anxiety/depression) 332. For the PSEQ, 
scores of ≥8/12 indicated high pain self-efficacy 335. Pain catastrophising scores were 
dichotomised to ≥30 (clinically relevant levels of catastrophizing) or <30 (no clinically relevant 
levels of catastrophizing) 336. 
A univariate analysis of covariance (ANCOVA) was used to compare differences in 
continuous variables (anxiety, depression, pain catastrophizing, and function) between 
individuals with ankle symptoms and controls, with age, sex and pain severity in areas other 
than the ankle included as covariates. Wilcoxon rank-sum (Mann-Whitney) tests were used 
for skewed continuous variables and effect size (r) was calculated by dividing the Z statistic by 
the square root of sample size 413. Missing data were excluded pairwise on analysis. Results 
for continuous variables are reported in the table as means and standard deviation (SD), as 
well as the between-group mean differences (MD), standardized mean differences (SMDs) 
and 95% confidence intervals (CI). Frequencies and percentages with risk differences (95% CI) 
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are reported for categorical and binary data. Effect sizes were interpreted as trivial: 0.0-0.2, 
small: 0.2-0.6, medium: 0.6-1.2, large: 1.2-2.0, very large: 2.0-4.0 and distinct: > 4.0 347. 
Using data from the symptomatic group only, the bivariate (nonlinear) relationship 
between age, sex, FAAM-ADL, PCS, HADS-A, TSK, HADS-D, and worst ankle pain was 
investigated using Spearman’s correlation coefficient. Correlations were interpreted as per 
Hopkins recommendations as trivial (0.0-0.1), minor (0.1 to 0.3), moderate (0.3 to 0.5), major 
(0.5-0.7), huge (0.7-0.9) and distinct (0.9-1.0) 347. For all analyses, the alpha level was set at p 
≤ 0.05.  
Associations between ankle pain and psychological factors were determined using a 
multiple regression (backward elimination) model with PCS, HADS-A, TSK, HADS-D, included as 
independent variables (entered concurrently). A second multiple regression was run to 
investigate factors associated with a self-reported function (FAAM-ADL). The independent 
variables included were PCS, HADS-A, TSK, HADS-D, and worst ankle pain. Independent 
variables were eligible for inclusion in the multiple regression (backward elimination) model if 
results of Spearman’s correlation coefficient showed they were associated significantly with 
FAAM and ankle pain (p≤0.05). The regression models were tested for multicollinearity. 
Variables were sequentially eliminated leaving only those with p<0.1. Statistical analysis was 
performed using IBM SPSS Statistics for Windows (Version 25.0. Armonk, NY: IBM Corp). 
7.3 Results 
Two hundred seventy-four volunteers responded to study advertisements seeking 
participants with ankle symptoms and controls. After removing entries with incomplete data 
for HADS, PCS, TSK and PSEQ (n=20), data from symptomatic participants with pain from 
other body sites that was more or equal to that at the ankle pain (n=17), duplicate entries 
(n=5), and age ineligibility (n=1), survey data was available for analyses from 231 individuals 
(Figure 7- 1). Survey participants were 67% female (154 Females) with an overall mean (SD, 
range) age of 54.24 (12.96, 18 to 82) years. The cohort was comprised of 137 symptomatic 
participants (reporting ankle pain or/and stiffness on most days for more than three months), 
and 94 control participants (reporting no ankle stiffness or pain ≥2 out of 10). Two 
participants in the control group reported ankle pain of 1 out of 10 during the past week. 
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Data were available for analysis from all participants except for FAAM-ADL which was only 
completed by the final 121 participants.  
7.3.1 Comparison between individuals with symptomatic ankle problems and controls 
Participant characteristics and comparison of outcomes between symptomatic and 
controls are reported in Table 7.1. There were no age (p=0.97) or sex (p=0.85) differences 
between symptomatic and control groups. The symptomatic group reported worse pain at 
the ankle (medium effect; p <0.001, r =0.85) and worse pain at sites excluding the ankle (small 
effect; p<0.001, r =0.54) during the past week compared to the controls. There was a large 
difference between groups in function, with symptomatic participants reporting lower ADL 
function than controls (SMD=1.67). The symptomatic group reported moderately higher 
depression compared to controls (SMD=0.60). 
Small but significant differences were identified for higher total psychological distress 
(HADS-Total; SMD=0.38), and greater risk of depression (28% higher risk) and anxiety (21% 
higher risk) in the symptomatic group compared to the asymptomatic control group. While 
the groups were comparable in pain catastrophizing, total and sub-scores (p>0.05), the 
symptomatic group presented with 12% higher risk of clinically relevant levels of 
catastrophizing than controls.
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Table 7.1: Function and psychological characteristics of the symptomatic and control participants 
Mean (standard deviation (SD)), mean difference (MD; 95% confidence intervals (CI)) and effect size #, unless otherwise indicated^ 
Outcome Symptomatic 
(n=137) 
Control 
(n=94) 
Mean Difference 
(95%CI) 
Effect size # 
 
p-value 
Age years # 54.2 (12.5) 54.3 (13.7) 0.06 [-3.4, 3.5] -0.01 [-0.27, 0.25]  0.97 
Sex, Female n (%) ^ 92 (67.2%)  62 (66%)   1% [-11, 14] ^ 0.85 
Worst ankle pain /10 † 7 (5-8.5) 0 (0- 0)  0.85†  <0.001 
Worst pain excluding ankle /10 † 6 (3- 8) 2 (0- 3.3)  0.54†  <0.001 
PCS /52# & 12.5 (10.4) 11.1 (10.7) 1.5 [-1.5, 4.5] 0.13 [-0.13, 0.40]  0.337 
PCS Magnification# & 2.7 (2.5) 2.2 (2.5) 0.5 [-0.2, 1.2] 0.20 [-0.06, 0.46]  0.180 
PCS Rumination# & 3.9 (3.9) 4.0 (4.1) -0.1 [-1.2, 1.0] -0.03 [-0.29, 0.24]  0.867 
PCS Helplessness# & 6.0 (4.9) 4.9 (5.1) 1.1 [-0.3, 2.5] 0.22 [-0.04, 0.48]  0.137 
Clinical PCS n (%)^ 21 (15.3%) 3 (3.2%)  12% [0.05, 0.19] ^ 0.003 
HADS-Total /42# & 10.04 (6.7) 7.45 (6.9) 2.60 [0.65, 4.55] 0.38 [0.12, 0.65]  0.009 
HADS-A /21# & 5.3 (3.9) 4.8 (4.0) 0.5 [-0.6, 1.6] 0.13 [-0.14, 0.39] 0.392 
Anxious n (%)^ 41 (29.9%) 8 (8.5%)  21% [0.12, 0.31]^ <0.001 
HADS-D /21# & 4.8 (3.6) 2.6 (3.7) 2.1 [1.1, 3.2] 0.60 [0.33, 0.87]  <0.001 
Depressed n (%)^ 41 (29.9%) 2 (2.1%)  28% [0.20, 0.36] ^ <0.001 
FAAM-ADL % #& 66.3 (15.2) 92.2 (15.6) -25.90 [-32.0, -19.77] -1.67 [-2.09, -1.25] <0.001 
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PSEQ-2 /12 # 8.7 (3.1) NA NA NA NA 
High PSEQ n (%)^  98 (71.5%) NA NA NA NA 
TSK-11 /44 # 27.7 (7) NA NA NA NA 
# Interval data reported as mean (SD) and point estimates of effect reported as standardised mean difference (SMD;95% CI). 
^ Dichotomised/binary data presented as frequency (%) and RD (risk difference).  
† Skewed continuous variables presented as median (interquartile range) and effect scores reported as the Mann-Whitney U test r. 
& Analysis adjusted for age, sex and pain excluding ankle 
Abbreviations: n=number; HADS= The Hospital Anxiety and Depression Scale; FAAM-ADL= The Foot and Ankle Ability Measure Activities of Daily 
Living subscale, PSEQ-2= 2-Item Short Pain Self-Efficacy Questionnaire; PCS=pain Catastrophizing Scale; TSK-11=Tampa Scale of Kinesiophobia, 
NA=not applicable. 
Analysis for FAAM based on 70 symptomatic and 51 controls due to missing data. 
PSEQ and TSK-11 were only assessed in symptomatic participants. 
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7.3.2 Factors associated with pain and function 
Correlation levels among different variables are reported in Table 7.2. Spearman’s 
correlation indicated that sex and age were not associated with pain or function (p>0.5) and 
therefore were not included in the regression analyses. 
Table 7.2: Spearman’s correlation product among different variables. 
Spearman's rho Ankle pain FAAM ADL PCS PSEQ-2 HADS-D TSK-11 HADS-A Sex 
FAAM ADL 
-0.596** 
(0.00)        
PCS 
0.579** 
(0.00) 
-0.607** 
(0.00)       
PSEQ-2 
-0.505** 
(0.00) 
0.827** 
(0.00) 
-0.645** 
(0.00)      
HADS-D 
0.431** 
(0.00) 
-0.599** 
(0.00) 
0.674** 
(0.00) 
-0.630** 
(0.00)     
TSK-11 
0.410** 
(0.00) 
-0.574** 
(0.00) 
0.608** 
(0.00) 
-0.551** 
(0.00) 
0.525** 
(0.00)    
HADS-A 
0.402** 
(0.00) 
-0.415** 
(0.00) 
0.630** 
(0.00) 
-0.463** 
(0.00) 
0.615** 
(0.00) 
0.411** 
(0.00)   
Sex 
0.13 
(0.12) 
-0.22 
(0.07) 
0.06 
(0.48) 
-0.05 
(0.58) 
-0.03 
(0.73) 
-0.06 
(0.50) 
0.16 
(0.06)  
Age 
0.02 
(0.78) 
-0.06 
(0.65) 
-0.03 
(0.72) 
-0.173* 
(0.04) 
-0.03 
(0.73) 
-0.06 
(0.51) 
-0.197* 
(0.02) 
-0.08 
(0.37) 
** Correlation is significant at the 0.01 level (2-tailed). 
* Correlation is significant at the 0.05 level (2-tailed). 
P=Sig. (2-tailed) 
All variables n=137 except for FAAM ADL based on n=70 due to missing data. 
 
Multiple regression indicated that depression (p=1.0), anxiety (p=0.622), pain self-
efficacy (p=0.532) and kinesiophobia (p=0. 230) did not significantly affect ankle pain scores. 
Pain catastrophizing as a whole (=-0.511, p<0.001) was the independent variable associated 
with ankle pain, where an increase in catastrophizing was a predictor of increased ankle pain. 
The final model explained 26% of the total variance in ankle pain (Table 7.3). 
Regression analysis with self-reported function (FAAM-ADL) as the dependent variable 
revealed that pain self-efficacy (=-0.554, p<0.001) was positively associated with function, 
while ankle pain (=-0.274, p<0.001), and kinesiophobia (=-0.229, p=0.005) were negatively 
associated with function. Pain catastrophizing (p=0.98), anxiety (p=0.53) and depression 
(p=0.213) were not associated with function. The final model explained 74% of the total 
variance in reported function (Table 7.4).  
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Table 7.3: Multiple linear regression model with ankle pain as the dependent variable 
Significant predictor variables Standardized β weight P value R2 
PCS 0.511 0.000 0.261 
Variables not retained in the model    Changes in R2 
HADS-D 0.000 1.0 0.000 
HADS-A  0.049 0.622 -0.001 
PSEQ-2 -0.061 0.532 -0.002 
TSK-11 0.116 0.230 -0.008 
Analysis based on a sample of 137 participants due to missing FAAM-ADL data. 
PSEQ-2= 2-Item Short Pain Self-Efficacy Questionnaire; HADS= The Hospital Anxiety and Depression Scale; 
TSK-11=Tampa Scale of Kinesiophobia; PCS=pain Catastrophizing Scale. 
 
 
Table 7.4: Multiple linear regression model with self-reported function (FAAM-ADL) as the dependent 
variable 
Significant predictor variables Standardized β weight P value R2 
PSEQ-2 0.28 0.00 0.738 
TSK-11 -0.26 0.00  
Worst ankle pain  -0.38 0.00  
Variables not retained in the model    Change in R2 
PCS -0.003 0.977 0.000 
HADS-A 0.055 0.526 -0.002 
HADS-D -0.106 0.213 -0.006 
Analysis based on a sample of 70participants due to missing FAAM-ADL data. 
PSEQ-2= 2-Item Short Pain Self-Efficacy Questionnaire; FAAM-ADL= The Foot and Ankle Ability Measure-
activities of daily living subscale; HADS= The Hospital Anxiety and Depression Scale; TSK-11=Tampa Scale of 
Kinesiophobia; PCS=pain Catastrophizing Scale. 
 
7.4 Discussion 
The present study aimed to identify whether psychological characteristics of 
individuals with symptomatic ankle problems differed from that of controls and to determine 
associations between psychological features, function and ankle pain. Results indicate that 
individuals with ankle symptoms report higher levels of depressive symptoms than individuals 
without such symptoms, and they are more likely to have clinical levels of pain 
catastrophizing, anxiety and depression than controls. Regression analysis showed that ankle 
pain severity and kinesiophobia were negatively associated with self-reported ADL function, 
and that pain self-efficacy was positively associated with self-reported ADL function. Further, 
pain catastrophizing was positively associated with ankle pain severity.  
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There is limited data from previous studies to compare the psychological 
characteristics of individuals with symptomatic ankle problems with the present study. 
Although HADS scores for depression in our study participants with ankle symptoms were 
within normal values, the symptomatic group presented with higher scores and a higher risk 
of reporting anxiety and depression than controls. The mean HADS depression and anxiety 
scores in individuals with ankle symptoms in our study were similar to previously reported 
values for hip and knee OA 414 and chronic knee pain 257,415. This is important as anxiety and 
depression are reported to adversely affect QoL in individuals with chronic foot and ankle 
diseases, including ankle OA 408.  
While clinical pain catastrophizing was more common in symptomatic than control 
participants, only a small percentage of symptomatic individuals in our study (15.3%) 
presented with clinical pain catastrophizing. There was no difference in pain catastrophizing 
scores between symptomatic and controls, and the mean pain catastrophizing score for 
participants with chronic ankle symptoms was lower than that reported for other chronic pain 
populations 415,416. It is possible that high pain self-efficacy in participants with chronic ankle 
problems may have contributed to the lower levels of pain catastrophizing in our study 
population.  
As pain self-efficacy and kinesiophobia are only appropriate to assess in symptomatic 
individuals, these data were not compared between the symptomatic and control groups in 
this study and thus data can only be discussed in relation to previous literature. Self-efficacy is 
a positive emotion defined as an individual’s confidence in his/her ability to attain a specific 
goal or outcome 417. Pain self-efficacy is therefore the confidence to attain the goals despite 
the presence of pain 418. High mean pain self-efficacy scores and the majority of symptomatic 
individuals (71.5%) presenting with high pain self-efficacy suggest a desirable level of 
confidence in functioning, despite the presence of pain. This may represent an 
accommodation to ankle impairments overtime, an adaptation or a shifting focus away from 
pain and impairments. Evidence from a systematic review has concluded that higher self-
efficacy in individuals with chronic pain conditions is associated with better function and 
activity participation, and less disability and depressive symptoms 419. Thus, high pain self-
efficacy may be an important coping mechanism in individuals with chronic ankle problems. It 
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is also possible that individuals with higher pain self-efficacy may push themselves harder, 
which may lead to provocation of symptoms. While the cross-sectional design limits 
conclusions of causal relationships, further research into pain self-efficacy in individuals with 
chronic ankle symptoms is warranted.  
While no cut off scores for identifying high kinesiophobia has been established for 
the TSK-11, authors of a recent study suggested that a score of greater than or equal to 35 
indicates high kinesiophobia 420. Based on this cut-off value, 16.8% of the symptomatic 
participants in this current study presented with high kinesiophobia. One previous study 
looked at kinesiophobia in a cohort study of 85 individuals with mixed foot and ankle 
pathologies (such as lateral and syndesmotic ankle sprains, fractures, tendonitis, strains, heel 
pain, instability, general ankle pain and OA) attending a physiotherapy clinic. Individuals with 
ankle symptoms from our study had higher kinesiophobia and higher pain severity than this 
previous work 421. The higher pain in our sample may explain the higher kinesiophobia 
reported. It is also possible that ankle symptoms may be associated with more kinesiophobia 
than foot problems as only 2% (n=2) of the heterogenous sample had ankle pain.  
Self-reported ADL function was significantly lower in individuals with ankle symptoms 
than controls, and severity of ankle pain, kinesiophobia and pain self-efficacy were related to 
function, explaining 74% of the variance in function in this population. These findings are 
consistent with research reporting a relationship between kinesiophobia, pain intensity and 
self-reported function in individuals with symptomatic hip and knee OA 422, and studies that 
identified an inverse correlation between kinesiophobia and ADL activities and disability in 
individuals with an anterior cruciate ligament rupture 423 and low back pain 202, respectively. 
Findings from a cross-sectional survey revealed a strong association between self-reported 
function and health-related QoL in individuals with chronic ankle symptoms, with those with 
lower ADL function (measured with the FAAM-ADL) reporting lower QoL 424. This suggests 
that there may also be a relationship between ankle pain severity, kinesiophobia, pain self-
efficacy and QoL in individuals with ankle symptoms and that the symptomatic cohort in our 
study may have had lower QoL compared to the controls. This reinforces the importance of 
assessing these characteristics when managing individuals with chronic ankle pain and 
stiffness.  
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Perhaps unsurprisingly, our study data identified a relationship between greater pain 
catastrophizing and higher severity of ankle pain. This is consistent with previous research 
that reported a relationship between pain catastrophizing and pain intensity 415,425,426,427, but 
not self-reported function 428. Thus, pain catastrophizing should be assessed in individuals 
with chronic ankle symptoms, particularly those with high pain severity.  
This study has some limitations that must be acknowledged. First, online methods 
were used for participant recruitment and data acquisition. This may have introduced a 
selection bias by limiting participation to internet users. Second, the cross-sectional design 
prevents inferences regarding causality or changes of psychological features with changes in 
symptoms. Further longitudinal evaluation of psychological impairments is needed in order to 
understand the prospective and longitudinal effect of depression, kinesiophobia, pain self-
efficacy on QoL and objective functional outcomes in this population. Third, the use of self-
report methods may be associated with response bias and potential error in the participant's 
interpretation of the questions. Fourth, participants in this study presented with ankle pain 
and/or stiffness but were not diagnosed with a specific pathology. Based on previous research 
and our data from a laboratory study, these symptoms are thought to represent ankle OA. We 
have shown that 93.9% of participants (n=33) with ankle pain and/or stiffness lasting for at 
least three months have radiographic OA of a grade of 2 or greater on the Kellgren and 
Lawrence scale. The association between symptom and radiographic degeneration has also 
been identified at the knee 52. X-rays to confirm the presence of ankle OA were not possible 
for this study due to the large sample size and diverse geographical locations of participants. 
Findings from this study indicate that individuals with symptomatic ankle conditions 
present with higher depression scores and greater risk of depression, anxiety and clinical 
catastrophizing than controls, and that pain severity, pain self-efficacy and kinesiophobia are 
associated with the self-reported function. These data suggest that clinicians should assess for 
psychological impairments in individuals with chronic ankle problems and consider the need 
for an interdisciplinary approach to management. There is evidence from a randomised 
controlled trial that recognition and treatment of comorbid depression have the potential to 
improve pain, function and QoL outcomes in individuals with chronic painful arthritis 429. 
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Research to determine the effect of detection and management of psychological impairments 
on physical and functional outcomes in individuals with chronic ankle problems is warranted.  
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Chapter 8 Work limitation and function among working individuals 
with symptomatic ankle problems compared to controls: Cross-
sectional survey 
8.1 Introduction 
Chronic musculoskeletal pain is a prevalent problem affecting 11-24% of European 
populations 430,431. The negative impact of chronic pain on QoL is well documented 407,152,208. 
Chronic pain has also been reported to negatively impact on work performance 432 and 
attendance 433. A Finnish study of 1.2 million employees identified that musculoskeletal 
conditions (OA, disc disorders and rheumatoid arthritis) were associated with long episodes of 
sick leave 433. A myriad of factors can influence employment and work participation, such as 
depressive symptoms 434, lower self-efficacy 435, physical work conditions and work stress 436, 
work ergonomics 437 feeling of control at work 438, and multiple pain sites 439. 
In the young, active population, employment is a vital dimension in overall QoL 440,441. 
Work is a mean for individuals to shape their personal identity and social status 442, and be 
financially independent. Musculoskeletal conditions are the principal causes of disability in 
people in their working years 443. Research indicates that individuals with chronic 
musculoskeletal conditions want to remain involved in productive work 444. Working 
individuals with chronic health conditions value work, as it provides them with financial 
independence, social contact and opportunities to contribute to society 445 
Chronic ankle pain is a prevalent musculoskeletal concern among adults aged 50–64 
years 3 and may have significant implications for people who are working and caring for 
families, particularly as the population is living 446, and possibly remaining in the workforce, 
longer. Ankle symptoms are associated with a range of physical and QoL impairments 381 
which could negatively impact work capacity. Thus, it is critical to understand the work 
limitations experienced by individuals with chronic ankle symptoms and factors that may 
influence work capacity in this population. 
This study aimed to assess work limitations experienced by individuals with ankle 
symptoms and compare function, psychological stress, pain self-efficacy and kinesiophobia 
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between individuals with ankle symptoms and controls who are involved in paid or unpaid 
work. In addition, this study aimed to investigate potential differences in these outcomes 
between working and non-working individuals with ankle symptoms and identify factors 
associated with work limitation. 
8.2 Methods 
A cross-sectional online survey of individuals with and without ankle pain and/or 
stiffness was implemented to identify differences in work limitation, self-reported function 
and psychological features between individuals with ankle symptoms and controls and 
between working and non-working individuals with ankle symptoms. The survey also aimed to 
identify factors associated with work limitation among working individuals with ankle 
symptoms.  
8.2.1 Participants 
Volunteers aged 18 to 82 years with and without persistent ankle pain and/or stiffness 
participated in this cross-sectional survey between March 2017 and February 2018. 
Participants were recruited via community advertisements placed in a local university staff 
and community newsletters, communications from National and State arthritis organisations, 
and on social media. Persistent ankle pain or stiffness was defined as pain or stiffness on most 
days for >3 months, and the presence of pain was defined as pain ≥2 out of 10 on an 11-point 
NRS with 0=’no pain” and 10=’worst pain imaginable’. Participants were defined as 
symptomatic if they experienced pain/aching in or around the ankle and/or stiffness or 
reduced movement of the ankle in the morning on most days for more than three months 
and did not report pain in any other body sites that was equal to or greater than that 
reported at the ankle. Participants were defined as controls if they did not experience any 
ankle pain or stiffness on most days for more than three months, and any reported ankle pain 
was <2 out of 10 in the last week. The study was approved by the institutional human 
research ethics committee and all participants provided informed consent.  
8.2.2 Data and measures 
General demographic (age and sex) and health information were assessed. Based on 
The Self-Administered Comorbidity Questionnaire 311, participants were asked if they 
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experienced any of 15 defined medical problems. The participant indicated if they receive 
treatment for the health problem and whether it limited their activities.  
The 12 item Workplace Ability Limitation Scale (WALS) was used to measure the 
extent to which the presence of ankle symptoms interfere with the performance of workplace 
activities. The WALS has high internal consistency and construct validity in people with 
arthritis 333. A four-point Likert scale (0=No difficulty to 3=Not able to do) is used to rate each 
item. There are also options to indicate that the item is “not applicable to my job” or 
“difficulty unrelated to ankle”, both of which result in a score of 0 for that item. Responses for 
all answers are summed for a total score ranging from (0–36). Higher scores indicate greater 
workplace activity limitations. Scores of 0-4 indicate little work difficulty, scores of 5-8 reflect 
moderate disability related to workplace adaptations, and scores >9 indicate considerable 
workplace disability 334. 
The daily Living function was assessed using the 21-item Activities of Daily Living sub-
scale of the Foot and Ankle Ability Measure (FAAM-ADL) 317. Excellent test-retest reliability 
and internal consistency for the FAAM-ADL have been reported 317. A 5-point Likert scale (0-4) 
ranging from 4=No difficulty to 0=Unable to do is used to rate each item. A “NA” (not 
applicable) option was available to indicate activities limited by factors other than foot or 
ankle problems. Items rated as “NA” are excluded from scoring, resulting in a lower total 
number of possible points. The total score (sum of responses) is converted to a percentage. 
Higher scores indicate a better level of function.  
Psychological distress was assessed using The Hospital Anxiety and Depression Scale 
(HADS) 331 which has seven anxiety (HADS-A) and seven depression (HADS-D) related items. 
Participants select the most appropriate response about how they felt over the past 7 days. 
Each item is scored from 0-3. Scores are summed for the anxiety and depression subscales to 
obtain total subscale score ranging from 0 to 21. A score of 8/21 is identified as a cut-off point 
for the presence of anxiety or depression 332, with higher scores indicated greater anxiety or 
depression. The subscales are further classified as mild=8 to 10, moderate=11-15 and 
severe=≥16. This scale has been reported to be a good predictor of interview-diagnosed 
anxiety in a population with lower limb OA 211. The validity of the HADs in assessing the 
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symptom severity, anxiety disorders and depression in somatic, psychiatric and primary care 
patients and in the general population has also been reported 332.  
Pain-related fear of movement was assessed using the 11-item Tampa Scale of 
Kinesiophobia (TSK-11) 320. The TSK-11 has good internal consistency (Cronbach’s =0.79) and 
test-retest reliability (ICC=0.81). Participants select the most appropriate response on a 4-
point Likert scale (ranging from 1= Strongly disagree to 4= Strongly agree) to each statement. 
Responses to all items are summed to create a total score ranging from 0 to 44. Higher scores 
indicate a high degree of kinesiophobia.  
Pain self-efficacy was assessed using the 2-Item Short Pain Self-Efficacy Questionnaire 
(PSEQ-2) 335. The PSEQ-2 is highly correlated with that of the original PSEQ 335. Responses 
range from 0 (Not at all confident) to 6 (Completely confident) for each of the two items. The 
total score is the sum of responses from the two items. Scores range from 0 to 12, with scores 
of ≥8 indicating high self-efficacy. 
The Pain Catastrophizing Scale (PCS) was used to assess catastrophizing. The reliability 
and validity of the PCS have been established 336. The 13 items are rated on a scale from 0 
(Not at all) and 4 (All the time). A total score (range from 0–52) is a sum of all individual item 
responses. A total score of ≥30 is indicative of clinically relevant levels of catastrophizing 336. 
Number of musculoskeletal pain sites was assessed using a labeled body diagram. 
Participants rated the pain experienced during the past 7 days in 13 musculoskeletal sites 
including the ankle. The pain was rated using the 11-point NRS described previously, with 
participants advised to select 0 if no pain was experienced in the body site. The number of 
bodily pain sites is the sum of sites with a pain score of ≥2 out of 10 including the ankle. 
8.2.3 Statistical analysis  
A univariate analysis of covariance (ANCOVA) was used to compare differences in pain, 
work limitation, function, anxiety, depression and catastrophising between working 
individuals with ankle symptoms and controls. Pain self-efficacy and kinesiophobia where only 
assessed in symptomatic participants and were therefore only included in comparisons 
between working and non-working individual with ankle symptoms.  
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A second comparison (ANCOVA) for pain, number of pain sites, number of comorbid 
conditions, function, pain self-efficacy, kinesiophobia, anxiety, depression and pain 
catastrophising was undertaken between working and non-working individuals of the 
symptomatic ankle group. Age, sex and severity of pain in sites other than the ankle were 
controlled as covariates. Wilcoxon rank-sum (Mann-Whitney) tests were used to compare 
skewed continuous variables (pain scores, number of pain sites and number of comorbid 
conditions) between working individuals with ankle symptoms and controls and between 
working and non-working individuals of the symptomatic ankle group. From Mann-Whitney 
test output, a measure of effect size (r) was calculated by dividing the absolute standardized 
test statistic (Z) by the square root of the sample size (N) (r = Z / √N). Depression, anxiety 332, 
pain self-efficacy 335 and clinical catastrophizing 336 scores were dichotomized using cut-off 
scores as defined above. Chi-square tests were conducted to compare sex proportions, 
clinical catastrophizing and high PSEQ between groups.  
Results for continuous variables are reported in the table as mean and standard 
deviation (SD), as well as the between-group mean difference (MD) and standardized mean 
differences (SMD) with 95% confidence intervals (CI). Frequencies and percentages with risk 
differences (95% CI) are reported for categorical and binary data. Measures of effect sizes 
(SMD and r) are reported in the results section and are interpreted as trivial: 0.0-0.2, small: 
0.2-0.6, medium: 0.6-1.2, large: 1.2-2.0, very large: 2.0-4.0 and distinct:>4.0 347.  
Using data only from individuals with ankle symptoms, bivariate (nonlinear) 
relationships between (age, sex, HADS-A, TSK, HADS-D, PCS, ankle pain and WALS) was 
investigated using Spearman’s correlation coefficient (normal distribution not assumed). 
Hopkins recommendations were used to interpret correlation as very small (0.0-0.1), small 
(0.1 to 0.3), medium (0.3 to 0.5), large (0.5-0.7), very large (0.7-0.9) and nearly perfect (0.9-
1.0) 347. For all analyses, the alpha level was set at p ≤ 0.05.  
Associations between work limitation and other survey factors were assessed using a 
multiple regression (backward elimination) model with ankle pain, TSK-11, HADS-D, HADS-A, 
PSEQ-2, PCS, number of pain sites and comorbid conditions included as independent variables 
in the models. Independent variables were eligible for inclusion in the multiple regression 
model if they were significantly associated with work limitation at p ≤ 0.05. The regression 
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models were tested for multicollinearity. Variables were sequentially eliminated leaving only 
those with p<0.1. Statistical analysis was performed using IBM SPSS Statistics for Windows 
(Version 25.0. Armonk, NY: IBM Corp). 
8.3 Results 
Two hundred thirty-one individuals (154 females and 77 males) with a mean (SD, 
range) age of 54.2 (13.0, 18 to 82) years participated in this survey. A flow chart of 
recruitment and group allocation has been reported in chapter 7. Data were available from all 
participants except for the FAAM-ADL which was completed by 121 participants due to a late 
addition to the survey. Missing data were excluded pairwise on analysis. Only 65.5 % (n=90) of 
symptomatic participants and 55.3 % (n=52) of controls were involved in paid or unpaid 
employment. There were no differences in the type of occupations between groups (Table 
8.1). Among the employed respondents, 67.6 % (n=96) were females and mean age was 50.3 
(SD: 12.1, range: 18 to 77) years. 
Table 8.1: Characteristics of the working symptomatic and control participants  
Mean (Standard deviation) with between-group mean difference (MD) and point estimate of effect 
expressed as standardised mean difference (SMD) and its 95% confidence interval (CI) unless otherwise 
specified 
 
Outcome Symptomatic 
(n=90) 
Control  
(n=52) 
MD  
(95%CI) 
SMD  
(95%CI) 
p value 
WALS # & 7.2 (4.5) 2.1 (4.7) 5.1 [3.4,6.8] 1.11 [0.74, 1.47] <0.001 
WALS score levels, n (%) ^      
Little work disability  29 (32.2%) 51 (98.1%) -66% [-76, -56] ^   
Moderate work disability  25 (27.8%) 1 (1.9%) 26% [16, 36] ^   
Considerable work disability 36 (40%) 0 (0%) 40% [30, 50] ^   
Occupational grouping n (%) ^      
Technical 21 (23.3%) 11 (21.2%) 2% [-12, 16] ^   
Clerical/Administration 19 (21.1%) 15 (28.8%) -8% [-23, 7] ^   
Training -related & 
Management 
19 (21.1%) 9 (17.3%) 4% [-9, 17] ^   
Manual labour 9 (10%) 6 (11.5%) 4% [-5, 13] ^   
Allied health 9 (10%) 3 (5.8%) 4% [-5, 13] ^   
Academic 5 (5.6%) 4 (7.7%) -2% [-11, 7] ^   
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Catering & Services 5 (5.6%) 3 (5.8%) -0% [-8, 8] ^   
Research 3 (3.3%) 1 (1.9%) 1% [-4, 7] ^   
FAAM-ADL% # & 69.3 (13.6) 95.2 (14.1) -25.9 [-33.0,-
18.7] 
-1.86 [-2.43, -
1.29] 
<0.001 
Number of pain sites † 7 (3- 10) 1 (0- 3)  0.594† <0.001 
Ankle pain † 7 (5- 8) 0 (0- 0)  0.813† <0.001 
Pain excluding ankle † 5.5 (3- 7) 2 (0.3- 4)  0.486† <0.001 
comorbidity † 1.0 (0- 1) 0 (0- 0)  0.354† <0.001 
HADs total # & 9.3 (6.0) 7.1 (6.2) 2.3 [0.0,4.5] 0.36 [0.02, 0.70] 0.049 
HADS-A # & 5.2 (3.5) 4.8 (3.7) 0.4 [-0.9,1.7] 0.11 [-0.23, 0.45] 0.525 
Anxiety levels n (%)      
No anxiety  65 (72.2%) 48 (92.3%) -20% [-32, -8] ^   
Mild anxiety  12 (13.3%) 3 (5.8%) 8% [-2, 17] ^   
Moderate anxiety  10 (11.1%) 1 (1.9%) 9% [2, 17] ^   
Severe anxiety  3 (3.3%) 0 (0%) 3% [-1, 8] ^   
HADS-D # & 4.1 (3.3) 2.3 (3.5) 1.8 [0.6,3.1] 0.53 [0.18, 0.88] 0.004 
Depression levels n (%) ^      
No depression  73 (81.1%) 51 (98.1%) -17% [-26, -8] ^   
Mild depression  7 (7.8%) 1 (1.9%) 6% [-1, 13] ^   
Moderate depression  9 (10%) 0 (0%) 10% [3, 17] ^   
Severe depression 1 (1.1%) 0 (0%) 1% [-3, 5] ^   
PCS # & 11.5 (9.2) 9.7 (9.5) 1.8 [-1.6,5.3] 0.19 [-0.15, 0.53] 0.290 
Clinical catastrophising n (%) ^ 10 (11.1%) 1 (1.9%) 9% [2, 17] ^  0.048 
# Interval data reported as mean (SD) and point estimates of effect reported as standardised mean difference 
(SMD;95% CI). 
^ Dichotomised/binary data presented as frequency (%) and RD (risk difference).  
† Skewed continuous variables presented as median (interquartile range) and effect scores reported as the Mann-
Whitney U test r. 
& Analysis adjusted for age, sex and pain excluding ankle 
WALS= workplace ability limitation scale; FAAM-ADL= The Foot and Ankle Ability Measure-activities of daily living 
subscale; HADS= The Hospital Anxiety and Depression Scale; PCS=pain Catastrophizing Scale. Analysis of FAAM based 
on 46 symptomatic and 26 control participants. 
 
8.3.1 Comparison between working individuals with and without symptomatic ankle problems  
Working individuals with ankle symptoms were 68.9% (n=62) females with a mean 
(SD) age of 50.5 (11.6) years. Control participants who were working were 65.4% (n=34) 
female with a mean (SD) age of 50.0 (13.0) years. There were no differences in age (p=0.83) 
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or sex (p=0.67) between groups. Types of employment and study outcomes for symptomatic 
and control participants who reported being involved in paid or unpaid work are reported in 
Table 8-1. There was a large effect for lower ADL function in symptomatic participants than 
controls (SMD=1.9), and a moderate effect for higher work limitations in symptomatic 
individuals than controls (SMD=1.1). Two-thirds of the symptomatic group reported moderate 
to considerable work limitation. Individuals with ankle symptoms were 26% more likely to 
report moderate work limitation and 40% more likely report considerable work limitation 
than controls.  
A Mann-Whitney U test revealed medium effects for greater ankle pain (p <0.001, 
r=0.813), and number of pain sites (p <0.001, r=0.594), and small effects for greater pain in 
sites other than ankle (p<0.001, r=0.486) and number of comorbidities (U =3236, p<0.001, 
r=0.354) in symptomatic participants compared to controls. There were small effect for 
higher levels of psychological distress (HADS total score: SMD=0.36) and depression (HADS-D 
score; SMD=0.53) in individuals in the symptomatic group compared to controls, but no 
significant differences for anxiety (p=0.53). While no significant differences were identified 
between symptomatic and controls in total pain catastrophizing score (p=0.290), the 
symptomatic group were 9% more likely to present with clinical catastrophizing.  
8.3.2 Comparison between working and non-working individuals with ankle symptoms 
In the symptomatic group, 65.7% (n=90) of individuals participated in paid or unpaid 
work. No sex differences were identified between working (68.9% (n=62) female) and non-
working (63.8% (n=30) female) groups (p=0.55). Working individuals were moderately 
younger than those who were not working (mean (SD) 50.5 (11.6) vs 61.4 (11.1) years; 
SMD=0.95). Comparisons of outcomes between working and non-working individuals with 
ankle symptoms are reported in Table 8.2. 
There were moderate effects for higher function and pain self-efficacy, and lower 
depression scores in working individuals with ankle symptoms compared to those who were 
not working (all SMD>0.6). The non-working symptomatic group was 20% more likely to 
present with mild depression than the working group. There were small effects for greater 
pain both at the ankle (p =0.025, r = 0.191) and at other body sites (p = 0.019, r = 0.200), and 
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a greater number of comorbidities (p =0.005, r = 0.239) in non-working compared to working 
individuals with ankle symptoms. A small difference in pain catastrophysing (SMD=0.4) was 
identified with better outcomes reported by working than non-working symptomatic 
participants. A trivial, but significant difference for a greater number of pain site in non-
working compared to working individuals in the symptomatic groups (p =0.502, r = 0.057). No 
between-group differences were identified for anxiety (p=0.16) or kinesiophobia (p=0.66). 
Table 8.2: Characteristics of working and not working individuals in the symptomatic ankle group  
Mean (standard deviation) with between-group mean differences (MD) and point estimate of effect 
expressed as standardised mean difference (SMD) and 95% confidence interval (CI) unless otherwise 
indicated 
 
Outcome Symptomatic 
Working  
(n=90) 
Symptomatic 
Not working  
(n=47) 
Mean Difference 
(95%CI) 
SMD (95%CI) P value 
FAAM-ADL # &  64.3 (16.4) 54.5(16.7) 9.8 [1.1, 18.4] 0.59 [0.08, 1.09] 0.028 
Number of pain sites † 7 (3- 10) 6 (4- 11) -1.5 [-3.0, 0.1] 0.0573† 0.502 
Worst ankle pain † 7 (5- 8) 8 (6- 9) -1.1 [-2.2, -0.1] 0.191† 0.025 
Pain excluding ankle † 5.5 (3- 7) 7 (4- 8) -1.4 [-2.5, -0.3] 0.200† 0.019 
Multimorbidity † 1 (0- 1) 1 (0- 3) -0.8 [-1.4, -0.3] 0.239† 0.005 
PSEQ-2 # & 9.3 (2.8) 7.6 (2.9) 1.6 [0.6, 2.7] 0.60 [0.24, 0.96] 0.003 
High pain efficacy ^ 76 (84.4%) 22 (46.8%) 38% [22, 54]^   <0.001 
TSK-11 # & 27.5 (6.8) 28.1 (7.0) -0.6 [-3.2, 2.0] -0.09 [-0.44, 0.27] 0.663 
HADs total # & 10.6 (7.3) 14.2 (7.6) -3.7 [-6.5, -0.9] -0.48 [-0.84, -0.13] 0.011 
HADS-A # & 5.9 (4.2) 7.0 (4.3) -1.1 [-2.7, 0.5] -0.26 [-0.61, 0.10] 0.162 
Anxiety levels n (%) ^      
No anxiety  65 (72.2%) 31 (66%) 6% [-10, 23]^   
Mild anxiety  12 (13.3%) 4 (8.5%) 5% [-6, 15]^   
Moderate anxiety  10 (11.1%) 9 (19.1%) -8% [-21, 5]^   
Severe anxiety  3 (3.3%) 3 (6.4%) -3% [-11, 5]^   
HADS-D # & 4.7 (4.0) 7.2 (4.2) -2.5 [-4.1, -1.0] -0.61 [-0.97, -0.25] 0.001 
Depression levels n (%) ^      
No depression  73 (81.1%) 23 (48.9%) 32% [16, 49]^   
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Mild depression  7 (7.8%) 13 (27.7%) -20% [-34, -6]^   
Moderate depression 9 (10%) 9 (19.1%) -9% [-22, 4]^   
Severe depression  1 (1.1%) 2 (4.3%) -3% [-9, 3]^   
PCS# & 13.9 (10.6) 18.2 (11.0) -4.4 [-8.4, -0.3] -0.40 [-0.75, -0.04] 0.036 
Clinical catastrophising ^ 10 (11.1%) 11 (23.4%) -12% [-26, 1]^  0.058 
# Interval data reported as mean (SD) and point estimates of effect reported as standardised mean difference 
(SMD;95% CI). 
^ Dichotomised/binary data presented as frequency (%) and RD (risk difference).  
† Skewed continuous variables presented as median (interquartile range) and effect scores reported as the Mann-
Whitney U test r. 
& Analysis adjusted for age, sex and pain excluding ankle 
PSEQ-2= 2-Item Short Pain Self-Efficacy Questionnaire; FAAM-ADL= The Foot and Ankle Ability Measure-activities 
of daily living subscale; HADS= The Hospital Anxiety and Depression Scale; TSK-11=Tampa Scale of Kinesiophobia; 
PCS=pain Catastrophizing Scale.Analysis of FAAM based on 46 working and 24 not working participants. 
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Table 8.3: Correlation levels of each independent variable with WALS and other variables. 
Spearman's rho (p-value) WALS PSEQ-2 PCS HADS-D TSK-11 Ankle pain HADS-A 
Number of 
comorbidities 
Number of 
pain sites Sex 
PSEQ-2 -0.708** 
(0.00) 
         
PCS 0.602** 
(0.00) 
-0.640** 
(0.00) 
        
HADS-D 0.559** 
(0.00) 
-0.512** 
(0.00) 
0.614** 
(0.00) 
       
TSK-11 0.545** 
(0.00) 
-0.484** 
(0.00) 
0.573** 
(0.00) 
0.452** 
(0.00) 
      
Ankle pain- 0.444** 
(0.00) 
-0.455** 
(0.00) 
0.568** 
(0.00) 
0.421** 
(0.00) 
0.338** 
(0.00) 
     
HADS-A 0.412** 
(0.00) 
-0.410** 
(0.00) 
0.618** 
(0.00) 
0.565** 
(0.00) 
0.308** 
(0.00) 
0.366** 
(0.00) 
    
Number of comorbidities 0.412** 
(0.00) 
-0.230* 
(0.03) 
0.330** 
(0.00) 
0.17 
(0.11) 
0.16 
(0.12) 
0.362** 
(0.00) 
0.283** 
(0.01) 
   
Number of pain sites 0.410** 
(0.00) 
-0.304** 
(0.00) 
0.384** 
(0.00) 
0.301** 
(0.00) 
0.14 
(0.18) 
0.479** 
(0.00) 
0.408** 
(0.00) 
0.443** 
(0.00) 
  
Sex 0.12 
(0.25) 
-0.07 
(0.49) 
0.10 
(0.34) 
-0.03 
(0.81) 
-0.11 
(0.32) 
0.07 
(0.51) 
0.17 
(0.10) 
0.260* 
(0.01) 
-0.02 
(0.87) 
 
Age 0.02 
(0.84) 
-0.19 
(0.07) 
-0.03 
(0.75) 
-0.05 
(0.66) 
0.02 
(0.83) 
0.08 
(0.46) 
-0.08 
(0.44) 
0.09 
(0.42) 
-0.05 
(0.64) 
0.03 
(0.78) 
** Correlation is significant at the 0.01 level (2-tailed). 
* Correlation is significant at the 0.05 level (2-tailed). 
 N= 90, p= Sig. (2-tailed) 
WALS= workplace ability limitation scale; PSEQ-2= 2-Item Short Pain Self-Efficacy Questionnaire; HADS-D= Depression; HADS-A= Anxiety; TSK-11=Tampa Scale 
of Kinesiophobia; PCS=pain Catastrophizing Scale. 
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8.3.3 Factors associated with work limitations 
The correlations between different variables are presented in Table 8.3. Spearman’s 
correlation indicated that age (p=0.84) and sex (p=0.25) were not associated with work 
limitations (WALS scores). Regression revealed that pain self-efficacy (PSEQ) was negatively 
associated with work limitation, while depression (HADS-D), and kinesiophobia (TSK-11) were 
positively associated with work limitations in the backward regression model. Pain self-
efficacy recorded the highest beta value (=0.2382, p<0.001) followed by TSK-11 (=-0.196, 
p=0.036) and then HADS-D (=0.192, p=0.041). Lower pain self-efficacy and higher depression 
and kinesiophobia were associated with greater work limitations. This model explained 55% 
of the total variance in work limitation (Table 8.4).  
Table 8.4: Multiple linear regression model with WALS as the dependent variable 
Significant predictor variables Standardized β weight p-value R2 
PSEQ -0.382 0.000 0.55 
TSK 0.196 0.036  
HADS-D 0.192 0.041  
Number of pain areas 0.150 0.082  
Number of comorbidities 0.140 0.097  
Variables not retained in the model    Change in R2 
PCS 0.031 0.813 0.000 
Ankle pain  0.029 0.761 -0.001 
HADS-A  -0.055 0.579 -0.002 
Analysis based on a sample of 90 participants 
PSEQ-2= 2-Item Short Pain Self-Efficacy Questionnaire; HADS= The Hospital Anxiety and Depression 
Scale; TSK-11=Tampa Scale of Kinesiophobia; PCS=pain Catastrophizing Scale. 
 
8.4 Discussion 
This study aimed to compare work limitation, psychological stress and self-reported 
function between individuals with persistent ankle pain and or stiffness and controls involved 
in paid or unpaid work. Our data indicate that individuals with ankle pain and stiffness 
reported higher work limitation, higher levels of depression and lower function than controls. 
Total WALS scores in individuals with ankle symptoms suggest moderate work disability. 
These scores are similar to WALS scores (mean (SD) 6.4 (4.4)) reported for individuals with OA 
and inflammatory arthritis, which were associated with workplace modification 334. It is 
alarming that most of the symptomatic respondents in our study were not in manual labour. 
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Besides, 67.8% of them reported moderate to considerable work limitations, compared to 
only 1.9% of controls reporting moderate work limitations.  
Three factors were significantly associated with work limitations: pain self-efficacy, 
depression, and kinesiophobia. These findings are supported by previous research in other 
populations. Previous research found that decreased kinesiophobia was associated with 
increased work ability among participants with persistent pain who were involved in a 
cognitive behavioral rehabilitation programme 447.  
Associations between lower self-efficacy, the presence of depressive symptoms and 
unemployment have been reported in individuals with chronic persistent musculoskeletal 
pain presenting to rheumatology clinic 435,200. Research has suggested two types of coping 
responses in individuals with pain: confrontation, which is an adaptive response linked to self-
efficacy, and avoidance, which is a non-adaptive response 174. Research on chronic back pain 
448 reported that self-efficacy, which is an example of an adaptive response, mediates the 
relationship between pain-related fear and disability and was a stronger predictor of disability 
than fear. This is important because self-efficacy is a central factor that drives how individuals 
decide their actions and determine how to deal with challenges and impediments based on 
their perception of their potential capabilities 449. Conceptually, individuals with adaptive 
responses exhibit resilience and attempt to deal with pain, rather than avoiding pain. This 
makes them less susceptible to functional decline. For example, higher pain self-efficacy was 
related to lower disability and depression in retired adults with persistent pain 450. In contrast 
to this, avoidance responses are associated with avoiding painful experiences and activities, 
which lead to a range of physical and psychological consequences 174. In chronic pain, 
avoidance stems from a belief that exposure to certain activity is a threat that will increase 
suffering from pain 176. With this in mind, individuals who are fearful enter into a loop of 
avoidance, inactivity, pain, limited participation and disability 175,176  
Research has shown individuals (n=290) with depression and depressive symptoms 
present with work limitations, and significant missed days 451. Enrolment to rehabilitation 
directed to improve depression yielded positive outcomes in form of less missed days and 
work disability 451. Interestingly, while the severity of ankle pain was associated with work 
limitations in univariate analysis, it was not retained in the linear regression model. One 
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possible explanation for this could be that the majority of our sample (60%) presented with 
an ankle pain intensity of ≥7 out of 10. Thus, there may not have been sufficient variability in 
pain intensity in our sample. Further, as ankle pain is strongly associated with other 
psychological factors, such as pain self-efficacy and catastrophizing, it may mediate 
relationships between work limitations and these other variables. 
There is growing evidence of the beneficial effects of work and employment on 
wellbeing 442. Employment can be viewed as an indicator of the wellbeing and functional 
ability. Comparisons between working and non-working participants with symptomatic ankle 
problems identified that working individuals in the symptomatic group were older and 
reported higher pain self-efficacy, lower depression, and less comorbid conditions and 
catastrophizing than non-working symptomatic participants. This is in line with research 
showing individuals who were off work as a result of hip OA were older and had poorer 
physical function and more functional limitations from comorbidities compared to individuals 
with hip OA who were still working 452. Similar findings were reported in research including 
working and non-working individuals with rheumatoid arthritis, the study reported that the 
non-working individuals reported worse pain scores than the working participants 453. 
Findings from our study and previous work reinforce the importance of working on 
psychological wellbeing and self-efficacy in individuals with chronic health conditions. We, 
however, should not overlook that the non-working group was older and their unemployment 
may be related to age rather than symptoms 454. However, we did not find a relationship 
between age and work limitations among working individuals.  
The FAAM- ADL scores suggest a reduced function in individuals with ankle symptoms 
compared to controls and among non-working symptomatic participants compared to 
working symptomatic participants. Findings from an earlier cross-sectional survey revealed a 
strong association between lower self-reported function (using the FAAM-ADL) and poorer 
QoL in individuals with chronic ankle symptoms 424. Although QoL was not assessed in the 
present study, previous data suggest that non-working individuals with ankle symptoms may 
have poorer QoL than individuals with ankle symptoms who are working.  
A previous study that investigated how individuals with chronic musculoskeletal pain 
remained working showed that those who were still working scored higher on self-efficacy 
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and utilised self-management approaches 455. In light of the finding of decreased pain self-
efficacy in non-working individuals with symptomatic ankle problem and the relationship 
between pain self-efficacy and work limitations in our study, teaching self-management 
approaches and educating these individuals about their pain may be important to help them 
remain at work. As evidence suggests that individuals with chronic health conditions want to 
remain involved in productive work 444 and that work is important for psychological health 
440,441, further research is needed to investigate strategies to assist with this. There is evidence 
that exercising in the workplace improves work ability, pain, physical function and depressive 
symptoms in workers with knee or hip OA 456. There may be a role for workplace exercise in 
addressing work limitations and psychological health in individuals with ankle symptoms. 
Other examples of strategies that could improve the ability of these individuals to remain at 
work involve cognitive behavioral therapy to empower individuals and teaching self-
management, or a workplace assessment to inform environmental or process modifications. 
Workplace modifications could include changes to physical set-up or job responsibilities, 
implementation of assistive devices or technology, or reorganization of work and rest time, 
structuring of job processes, and the use of assistive devices and equipment. Most of these 
suggestions would likely require expenses from the employer. Thus, cost-benefit analysis is 
warranted to show employers suggestions that may help those with chronic joint pain (who 
often have higher work limitations 457) to remain at work. 
The application of our findings is limited by the reliance on self-report which may have 
resulted in inaccurate reporting. Further, the cross-sectional study design limits conclusions of 
causal relationships between different variables and reduced work ability. While we have 
accounted for age, sex, pain in areas other than the ankle and multi-morbidity, the reasons 
for not working among the non-working participants were not investigated. Thus, we are 
unable to comment if not working is related to ankle pain or other factors. Individuals with 
ankle symptoms reported having a greater number of comorbidities and body pain sites. 
These characteristics may have contributed to the work and functional limitations 
experienced by this group. Previous research has shown that individuals with multiple pain 
areas present with impaired ADL 435,458 and lower work capacity 439. Further, individuals with 
multiple areas of pain have more frequent health consultation and use of anti-inflammatory 
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and analgesic medication than individuals with no pain 459,460. These features may be 
associated with impaired work ability and/or interrupted work time, which may have led to 
greater work limitations. 
It is important to note that, in order to obtain a full picture of the work disability 
among individuals with ankle symptoms, personal and environmental factors must also be 
considered. For example, a number of work-related factors, such as work stress 436, work 
ergonomics 437, work control 438 have been shown to explain a substantial part of 
occupational differences in sickness absence due to musculoskeletal diseases. Some of these 
factors may be important predictors that were not measured in our model. Our study has not 
investigated the house hold income, the need to work for financial motives, family stressors, 
type of work involvement (full or part-time), the number of hours, or productivity. A lucid 
understanding of the various factors specific to this population that influence work disability 
is vital and may help explain some of the variances. Future research should aim to include a 
balanced cohort of working individuals across the different types of work. Further research is 
needed to examine the impact of family, societal and financial stressors, working hours and 
job control on reported work limitation.  
In conclusion, this study highlights the presence of workplace activity limitations in 
individuals with ankle symptoms, and the relationship between depression, kinesiophobia, 
pain self-efficacy and work limitations in these individuals. Individuals with ankle problems 
who remained in the workplace were significantly younger with less pain in the ankle and in 
other body sites and higher function and pain self-efficacy compared to non-working 
symptomatic individuals. Total psychological stress, depression and catastrophizing were 
significantly lower among the working than non-working symptomatic individuals. The 
relationship between these factors and the decision to stop working has not been 
investigated. Future research could examine former work limitations and related factors in 
those who are no longer working to promote understanding of the reason for ceasing work in 
this population. 
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Chapter 9 Falls, falls self-efficacy and balance confidence in adults with 
ankle symptoms compared to controls: A cross-sectional survey study 
9.1 Introduction 
Falls are a major public health concern around the world 324. Falls can result in serious 
injuries, loss of independence, functional decline, restricted activity, increased health care 
utilization, hospitalization, admission to a nursing facility, and death 461-466. Although falls 
occur across the lifespan 467, they are more common among older adults with one in three 
adults 65 years of age and older falling annually 468. Chronic joint pain is associated with an 
increased risk of falls 373, greater fear of falling 469, and greater pain severity is linked to lower 
balance confidence in older adults 470. Persistent knee 471 and hip 472 pain have specifically 
been identified as falls risk factors. Although high levels of chronic ankle pain are prevalent 3 
153,173, the incidence of falls and fear of falling has not been investigated in individuals with 
chronic ankle pain. It remains unclear whether persistent ankle pain is also a risk factor for 
falling.  
Many factors (balance and gait impairments, limited mobility, fear of falling, muscle 
weakness and use of multiple medications 473) have been suggested to increase falls risk in 
adults 474. A systematic review 338 has identified a number of physical impairments in 
individuals with ankle OA (impaired balance, decreased muscle strength and reduced joint 
motion) that are commonly associated with falls 188,189,270,475;168,191. Further, individuals with 
ankle joint symptoms walked with a slower speed 476-479 and a shorter stride length 149,476,477 
compared to controls. In light of these impairments and the evidence of a relation between 
persistent joint pain and the risk of falling 182-184, individuals with ankle joint pain may be at an 
increased risk of falling.  
A recent cross-sectional laboratory study demonstrated that ankle pain and stiffness 
had a greater impact on physical impairments and function 381 than radiographic evidence of 
ankle joint degeneration. It was identified that individuals with ankle symptoms present with 
lower QoL, self-reported function, muscle strength and ankle range of motion and slower 
ambulatory function compared to asymptomatic individuals. The presence of radiographic OA 
without symptoms was not associated with any physical impairments or deficits in function or 
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QoL 381. As this data suggests that impairments associated with falls are present in individuals 
with ankle pain and stiffness, rather than those with radiographic signs of joint pathology, it 
may be important to investigate falls specifically in those with symptoms.  
Thus the primary aim of this study was to compare the self-reported history of falls 
(including frequency of falls, associated injuries, and hospitalization), falls self-efficacy and 
balance confidence in adults with and without persistent ankle symptoms. A secondary aim of 
this study was to identify factors associated with the frequency of falling in adults with and 
without persistent ankle symptoms. 
 
9.2 Methods  
9.2.1 Participants 
Adult volunteers (18 to 82 years of age) participated in this online cross-sectional 
survey between March 2017 and February 2018. Participants were recruited via community 
advertisements placed in university and community newsletters, communications from 
National and State arthritis organizations, and social media (targeting volunteers from 
different Australian states). Participants were eligible for inclusion in the symptomatic group if 
they experienced pain/aching in or around the ankle and/or stiffness or reduced movement 
of ankle in the morning on most days for more than three months and did not report pain 
equal to or greater than that reported at the ankle in any other body site. Inclusion criteria for 
the control group were no ankle pain and/or stiffness on most days for more than three 
months, and ankle pain less than two out of ten in the last week (reported on an 11-point NRS 
anchored with the ‘No pain’ at 0 and ‘Worst pain imaginable’ at 10). The study was approved 
by the institutional human research ethics committee and all participants provided informed 
consent.  
9.2.2 Outcome measures 
Participants completed an online survey to obtain information on general 
demographics (age, and sex), falls history, falls efficacy, balance confidence, function, and 
health status (comorbid conditions and pain). 
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Falls history in the last 12 months was determined by the question: “In the last 12 
months, have you had any falls?” A fall was defined as “an event which results in a person 
coming to rest inadvertently on the ground or floor or other lower level” 324. Participants 
were categorised as fallers (an individual who fell at least once over the last 12 months 325) or 
non-fallers. Participants indicated the number of falls they experienced in the past 12 months 
by selecting on of the options including 0, 1, 2, 3, 4, 5 or more. Fallers indicated if they 
sustained an injury from falling, the type of injury experienced (i.e. bruises, cuts/grazes, 
sprain/strain, broken bones, dislocation), and if any fall resulted in hospitalization. 
 The Falls Efficacy Scale-International (FES-I) was used to determine how concerned a 
participant was about the possibility of falling during the performance of 16 different physical 
and social activities inside and outside the home 326. The level of concern was measured on a 
four-point Likert scale ranging from 1 (not at all concerned) to 4 (very concerned) 326. The 
total (summed) score ranged from 16 to 64, with a higher score indicating a greater level of 
concern about falling (i.e. lower falls self-efficacy). Previous publications have categorised the 
level of concern about falling as: low (scores of 16-19), moderate (scores of 20-27) and high 
(scores of 28–64) 327. This instrument has excellent internal and test-retest reliability 
(Cronbach's alpha=0.96, ICC=0.96) 326.  
The Activities-Specific Balance Confidence (ABC) Scale was used to measure balance 
confidence during activities of daily living. Participants were asked to indicate their level of 
self-confidence when performing a range of 16 activities without losing balance or becoming 
unsteady. Activities ranged from walking around the house to walking on icy sidewalks. 
Confidence was rated on a scale ranging from 0% (not confident at all) to 100% (completely 
confident) with answers provided in 10% increments 328. A total score for the scale was 
obtained by calculating the average score/percentage per question (the sum of individual 
question scores divided by 16). Scores ranged from 0 to 100%, with higher scores indicating 
better balance confidence. The ABC has been shown to have good test-retest reliability 
(ICC=0.88) and strong internal consistency (Cronbach's alpha=0.9) 480. 
The 21-item activities of the daily living subscale of the Foot and Ankle Ability Measure 
(FAAM-ADL) were used to assess function 317. Each item was scored on a 5-point Likert scale 
ranging from ‘no difficulty’ (4) to ‘unable to do’ (0). A “not applicable” option was available to 
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indicate activities limited by factors other than foot or ankle problems, with those items 
removed from scoring. The total score (sum of responses) was converted to a percentage (0-
100%), with a higher percentage indicating a higher level of function. This questionnaire has 
excellent test-retest reliability and internal consistency 317.  
The severity of ankle pain was measured using an 11-point NRS as described above. 
Participants were asked to indicate the worst pain experienced during the past 7 days. Pain in 
12 other bodily regions (identified on a body chart) was also recorded using a NRS. The 
number of bodily regions (including the ankle) with pain ≥2 out of 10 were summed as a 
measure of the number of pain sites (score ranging from 0 to 13).  
A modified version of the Self-Administered Comorbidity Questionnaire (SCQ) was 
used to collect data on comorbid health conditions 311. Participants indicated if they 
experienced any of the following 15 medical problems: heart disease, high blood pressure, 
lung disease, diabetes, ulcer or stomach disease, kidney disease, liver disease, anaemia or 
other blood disease, cancer, depression, auto-immune disease, back pain, rheumatoid 
arthritis, gouty arthritis, and OA other than ankle. Participants were also asked if they 
received treatment for any of those defined health problems and whether those health 
problems limited their activities. The number of comorbidities that participants reported 
receiving treatment for were summed (scores ranging from 0-15). This was calculated as an 
indication of multi-morbidity 312.  
9.2.3 Data and statistical analysis  
Survey data was reviewed for completion and participants who did not complete the 
questions on falls history, falls self-efficacy (FES-I) and balance confidence (ABC scale) were 
followed up by email and invited to provide the missing data. Participants who did not 
subsequently complete these questions were excluded from the study.  
Statistical analysis was performed using IBM SPSS Statistics for Windows (Version 25.0. 
Armonk, NY: IBM Corp). Age was compared between groups using an independent t-test. A 
univariate analysis of covariance (ANCOVA) was used to compare differences in falls self-
efficacy, balance confidence, and ADL function between symptomatic individuals and 
asymptomatic controls. Age, sex and severity of pain in body areas other than the ankle were 
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included as covariates to control for their confounding influence on the dependant variables. 
Wilcoxon rank-sum (Mann-Whitney) test was used to compare the number of bodily pain 
sites, the severity of pain, and number of comorbid conditions (multi-morbidity) between 
symptomatic individuals and asymptomatic controls. The effect size (r) from Wilcoxon rank-
sum (Mann-Whitney) tests were calculated by dividing the Z statistic by the square root of 
sample size 413. Chi-square tests were conducted to compare categorical and binary variables 
(sex, falls status, number of falls, falls-related injuries, hospitalization, categories of concern 
about falling and balance confidence) between groups. Data are presented in Table 9-1 as 
mean, standard deviation (SD), mean difference (MD) and point estimate of effect expressed 
as SMDs and their 95% confidence intervals (CI) for continuous variables. For categorical and 
binary variables, frequency (percentages) with risk differences (CI) are presented (Table 9-1). 
Effect sizes were interpreted as trivial: 0.0-0.2, small: 0.2-0.6, medium: 0.6-1.2, large: 1.2-2.0, 
very large: 2.0-4.0 and distinct: > 4.0 347. 
The bivariate nonlinear relationship between dependent and independent variables 
was investigated using Spearman’s correlation coefficient (normal distribution not assumed). 
Correlation was interpreted as low (0.1 to 0.3), moderate (0.3 to 0.5), high (0.5-0.7) and very 
high (0.7-0.9) 347. For all analyses, the alpha level was set at p ≤ 0.05. Backward elimination 
regression models were conducted to investigate factors associated with falls status (i.e. 
being a faller compared to non-faller coded as faller=1, non-faller=0) and number of falls. The 
independent variables included in the bivariate correlations were age, sex, falls self-efficacy, 
balance confidence, ADL function, worst ankle pain, worst pain excluding the ankle, number 
of morbidities, and depression. Depression data was obtained as a binary outcome from the 
Self-Administered Comorbidity Questionnaire and was entered into the model coded as 1=Yes 
and 0=No. Group was also entered into the model through a dummy coded variable (i.e., 
symptomatic=1 and control=0). The multiple regression model was tested for 
multicollinearity. Variables were sequentially eliminated leaving only those with p<0.1.  
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9.3 Results 
9.3.1 Participant demographics  
A total of 282 surveys were received with 56 surveys excluded due to incomplete 
survey data (n=31), ankle pain was not the most severe area of pain (n=17), duplicate entries 
(n=5), individuals in the control group with ankle pain>1/10 (n=2) and age (n=1). The survey 
was completed by 226 participants (134 symptomatic participants and 92 controls).  
Characteristics of symptomatic and control participants are reported in Table 9.1. 
Mean (SD) age of study participants was 54.28 (12.86) with 152 females and 74 males. There 
were significant moderate differences in ankle pain (p <0.001, r =0.86) and pain excluding 
ankle (p <0.001, r =0.57) between groups. The median (interquartile range, IQR) severity of 
ankle pain in symptomatic participants was 7 (5- 9) vs 0 (0- 0). The symptomatic group 
reported greater pain intensity in body sites other than the ankle (6 (3- 8) vs 2 (0- 3)). The 
symptomatic group reported moderately higher number of musculoskeletal pain sites (7 (4- 
10) vs 1 (0- 3) (p <0.001, r =0.69)), higher number of comorbidities (1 (0- 2) vs 0 (0- 1) (p 
<0.001, r =0.37)) and lower ADL function (SMD= 1.6) compared to controls. Reported 
morbidities are listed in Table 9.2.  
9.3.2 Falls related outcomes 
More than 220 falls were reported by survey participants. Nearly half (48.7%; n=110) 
of all participants reported one or more falls in the last 12 months. Among fallers, 40.5% 
sustained a fall-related injury. The most commonly reported injuries associated with falling 
were bruises and cuts and grazes (45.5%)  
There were significantly more fallers (individuals with one or more fall; p<0.001) with 
a greater number of falls in the symptomatic group than the control group. One-third (34%) 
of symptomatic individuals reported more than two falls in the previous 12 months compared 
to 4.2% in the control group. In the symptomatic group, 47.7 % of fallers sustained a falls-
related injury compared to 12.5 % of controls (p=0.002). Most injury categories and 
hospitalisation due to a fall were more common in symptomatic than control participants. 
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Table 9.1: Fall and fall-related outcomes compared between symptomatic and Control groups 
Mean (Standard deviation, n) of characteristics of the symptomatic and Control groups, between-group mean differences and point estimate of effect 
expressed as standardized mean difference and its 95% confidence interval (95% CI) unless otherwise stated 
Group characteristic Symptomatic 
 
Control 
 
MD (95%CI) SMD (95%CI) p value 
Age years 54.2 (12.3, 134) 54.5 (13.7, 92) 0.3 [-3.2, 3.7] -0.02 [-0.29, 0.24] 0.87 
Female (%)  91 (67.9%) 61 (66%) 2% [-11, 14]^  0.80 
Number of bodily pain sites /13 6.9 (3.2,134) 1.4 (3.2,92) 0.69†  <0.001 
Worst ankle pain /10 6.7 (1.9, 134) 0.02 (1.9,92) 0.86†  <0.001 
Worst pain excluding ankle /10 5.5 (2.4, 134) 2.0 (2.4, 92) 0.57†  <0.001 
Multimorbidity/15 1.3(1.2,134) 0.4 (1.2,92) 0.37†  <0.001 
FAAM-ADL % * 67.1 (14.9, 69) 91.5 (15.4, 51) -24.4 [-30.5, -18.3] -1.60 [-2.02, -1.19] <0.001 
Falls related outcomes  
Number of fallers  86 (64.2%) 24 (26.1%) 38% [26, 50] ^  <0.001 
Number of falls (%)  
One fall 33(38.4%) 17 (70.8%) -32% [-53, -12]^   
Two falls 24 (27.9%) 6 (25%) 3% [-17, 23]^   
Three falls 16 (18.6%) 0 (0%) 19% [9, 29]^   
Four falls 8 (9.3%) 0 (0%) 9% [1, 18]^   
Five or more falls 5 (5.8%) 1 (4.2%) 2% [-8, 11]^   
Number of injured fallers 41 (47.7%) 3 (12.5%) 35% [18, 52] ^  0.002 
ABC % * 78.4 (19.9,134) 88.4 (20.7,92) -10.0 [-15.9, -4.1] -0.49 [-0.76, -0.22] 0.001 
FES-I 16-64 * 24.3 (7.9, 134) 21.4 (8.2, 92) 2.9 [0.5, 5.2] 0.36 [0.09, 0.63] 0.017 
Concern about falling      
High concern  44 (32.8%) 1 (1.1%) 32% [24, 40] ^   
Moderate concern 52 (38.8%) 12 (13%) 26% [15, 37] ^   
Low concern  38 (28.4%) 79 (85.9%) -58% [-68, -47] ^   
Number of fallers with fall-related injuries (%)  
Bruises, Cuts/grazes 47 (54.7%) 3 (12.5%) 42% [25, 59] ^   
Sprain/strain 16 (18.6%) 1 (4.2%) 14% [3, 26] ^   
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Fractures/dislocation 14 (16.3%) 0 (0%) 16% [7, 26]^   
Hospitalisation 13 (31.7%) 0 (0%) 32% [-4, 67] ^   
Dichotomised/binary data presented as frequency (%) and RD^ (95% confidence interval)  
*Adjusted for age, sex and severity of pain excluding ankle. 
† Effect sizes based on Wilcoxon rank-sum (Mann-Whitney) tests, calculated by dividing the absolute Standardised test statistic z by the 
square root of the number. 
Abbreviations: ABC=The Activities-Specific Balance Confidence Scale, FES-I=The Falls Efficacy Scale-International, FAAM-ADL= The Foot and 
Ankle Ability Measure-activities of daily living subscale. 
FAAM data based on 51 control and 69 symptomatic due to a late addition to the survey 
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Table 9.2: Number (%) of each comorbid condition reported by symptomatic and asymptomatic 
participants 
Conditions  Symptomatic group Control group 
High blood pressure 30 (22.4%) 14 (15.2%) 
Osteoarthritis other than ankle  30 (22.4%) 1 (1.1%) 
Back pain 30 (22.4%) 3 (3.3%) 
Depression 22 (16.4%) 9 (9.8%) 
Rheumatoid arthritis 15 (11.2%)  
Auto-immune disease 14 (10.4%) 3 (3.3%) 
Ulcer or stomach disease 9 (6.7%)  
Diabetes 5 (3.7%)  
Cancer 5 (3.7%)  
Lung disease 5 (3.7%)  
Gouty arthritis  4 (3%)  
Anaemia or other blood disease 3 (2.2%) 1 (1.1) 
Heart disease 3 (2.2%) 5 (5.4%) 
kidney disease 2 (1.5%)  
Liver disease 1 (0.7%)  
 
Fear of falling (FES-I) was higher with small effect in the symptomatic group compared 
to the control group (SMD=0.36). Individuals in the symptomatic group were 32% more likely 
to report a high concern about falling and 26% more likely to report moderate concern than 
the control group (Table 9-1). Symptomatic participants reported lower balance confidence 
(ABC scale) with a small effect compared to controls (SMD=0.49).  
9.3.3 Outcomes associated with falls status  
Bivariate correlation between falls status (being a faller or non-faller), FAAM-ADL, 
ankle pain, pain sites excluding the ankle, number of pain sites, number of morbidities, 
depression, group, ABC, FES-I, age and sex are reported in Appendix 11. Spearman’s rho 
correlation showed that sex and age were not significantly associated with falls status and 
were therefore not included in the regression model. To avoid multicollinearity, the number 
of pain sites was excluded from the model due to high correlation with ankle pain and pain in 
sites excluding the ankle. All other variables were included in the regression model with each 
variable removed sequentially leaving only FES-I (=0.313, p=0.001) and group (=0.233, 
p=0.012) (Table 9.3). 
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Table 9.3: Multiple linear regression model with fall status (coded as faller=1, non-faller=0) as the 
dependent variable 
Significant predictor variables Standardized β weight p-value R2 
FES-I 0.313 0.001 0.218 
Group (Ref. – control) 0.233 0.012 
Variables not retained in the model    Change in R2 
Worst ankle pain -0.88 0.73 -0.001 
ABC -0.072 0.61 -0.002 
Pain excluding ankle 0.076 0.56 -0.002 
Comorbidities 0.076 0.49 -0.003 
Depression 0.045 0.60 -0.002 
FAAM-ADL  -0.184 0.29 -0.008 
ABC=The Activities-Specific Balance Confidence Scale, FES-I=The Falls Efficacy Scale-International, 
FAAM-ADL= The Foot and Ankle Ability Measure-activities of daily living subscale 
 
9.3.4 Outcomes associated with the number of falls 
Correlation levels between the number of falls, FAAM-ADL, ankle pain, pain excluding 
ankle, number of pain sites, number of morbidities depression, group, ABC, FES-I, age, and sex 
are reported in Appendix 12. Spearman’s correlation indicated that sex (p=0.6) and age 
(p=0.7) were not associated with the number of falls. Because a high correlation was 
identified between the number of pain sites and ankle pain and pain excluding ankle, the 
number of pain sites was excluded from the regression model.  
All other variables were included in the initial regression model. Depression, group, 
comorbidities, pain excluding the ankle, ABC and FAAM-ADL were all removed from the 
model because p-values were >0.1. The FES-I had the greatest contribution to the number of 
falls (=0.3, p=0.001) followed by worst ankle pain in the last week (=0.3, p=0.006). This 
model explained 30% of the total variance in the number of falls (Table 9.4). 
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Table 9.4: Multiple linear regression model with the number of falls as the dependent variable 
Significant predictor variables Standardized β weight p-value R2 
FES-I 0.331 0.001 0.295 
Worst ankle pain 0.275 0.006 
Variables not retained in the model    Change in R2 
Depression 0.051 0.59 -0.002 
Group (Ref. – control) 0.089 0.60 -0.002 
Comorbidities -0.067 0.47 -0.003 
Pain excluding ankle 0.096 0.47 -0.003 
ABC -0.112 0.40 -0.004 
FAAM-ADL 0.174 0.35 -0.005 
ABC=The Activities-Specific Balance Confidence Scale, FES-I=The Falls Efficacy Scale-
International, FAAM-ADL= The Foot and Ankle Ability Measure-activities of daily living 
subscale 
 
9.4 Discussion 
Falls is a major problem that has not been investigated in individuals with ankle 
symptoms. This study aimed to compare the self-reported history of falls, fear of falling and 
balance confidence between adults with and without ankle symptoms. Our data indicate that 
individuals with persistent ankle symptoms are more likely to experience a fall than 
individuals without ankle symptoms. Our study also identified that independent of age, 
individuals with symptomatic ankle problems experience a greater number of falls and a 
greater number of injurious falls compared to asymptomatic controls. Symptomatic 
participants reported being hospitalised related to a fall with greater frequency than controls. 
The finding that nearly half of the fallers suffered an injury and nearly one third required 
hospitalisation as a result of falling suggests that falls may be a serious issue among 
individuals with ankle pain and stiffness. 
As most research on falls has focused on older adults it is difficult to compare our falls 
data (from individuals with a mean age of 54 years) to that from other studies. Although 
almost half of our study participants were fallers, only 26% of individuals in our control group 
fell in the last 12 months. Our control data is similar to that of a previous study which 
reported a 12-month falls rate of 20% in individuals aged 20–87 years 481. Other studies have 
reported that 55% of older adults with chronic pain experienced a fall in the previous 18 
month period 373 and 59 % of individuals with rheumatoid arthritis experiences a fall in the 
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previous 12 month period 482. This is similar to our finding that 64% of individual with ankle 
symptoms experienced a fall in the previous year.  
This study assessed fear of fall and balance confidence which stand for two different 
fall-related psychological constructs 483.The FES-I measures concern about falling- fear of 
falling- which illustrate anxiety and depression characteristics 484,485. On the other hand, the 
ABC assesses balance confidence which is related to self-efficacy 486 and does not directly 
address fear. Further, the ABC includes a broader range of functional activities than the FES-I. 
Individuals with chronic ankle problems had a greater fear of falling and lower balance 
confidence compared to controls. Those characteristics have been linked to an increased risk 
of falls in other populations 487,488. Among our participants, falls status (being a faller or non-
faller) and the number of falls was related to fear of falling. Fear of falling may be associated 
with altered movement strategies, such as muscular coactivation 489 and altered gait 490,491, 
which may increase the risk of falling 492. Falls status was also associated with whether 
individuals had ankle pain and stiffness (compared to no ankle symptoms) and the number of 
falls was associated with higher intensity of ankle pain. The presence of pain 373 and more 
severe pain has been associated with an increased risk of falls in older adults 373. Because age 
was not retained in our regression analyses, our data suggest that individuals with ankle 
symptoms and higher severity of ankle pain are at increased risk of falls regardless of age.  
There are a number of possible reasons why individuals with ankle pain and stiffness 
may experience a high prevalence and number of falls. Ankle symptoms are associated with 
impairments in muscle strength, ankle range of motion and ambulatory function 381. There is 
evidence of balance deficits in individuals with ankle OA 338. Muscle weakness and decreased 
balance have been linked to falls in previous studies 187,493; 494,495. Because the risk of falling 
increases with an increasing number of falls risk factors 463, together these factors may lead to 
a significant increase in falls risk in individuals with chronic ankle problems. A slower 
ambulatory function has been identified as an important predisposing factor for falling 463 and 
has been observed in individuals with chronic ankle symptoms 381. Further research should 
investigate the relation between the level of physical ambulatory deficits and the risk of falls 
in this population. Our data suggest that individuals with ankle pain and stiffness are also 
more likely to experience multi-morbidity compared to controls. Many of the health 
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conditions reported by the symptomatic group, such as OA 496, back pain 497, depression 
498,499, rheumatoid arthritis 500, and anaemia 501 in this study are associated with an increased 
risk of falls 497-502. These comorbid conditions may also contribute to lower physical function 
and decreased QoL in this population 503,504.  
Data from this study suggest the need to incorporate falls risk assessment into clinical 
assessment of individuals with chronic ankle symptoms to allow timely identification of 
modifiable risk of falls and implementation of falls prevention interventions. Although multi-
morbidities was not associated with falls in regression modeling, due to the high number of 
comorbidities reported by individuals with chronic ankle problems, a multi-disciplinary 
management approach may be important. Implementation of cognitive-behavioral therapies 
to reduce the fear of falling and improve self-efficacy has been shown to be effective in 
reducing falls in previous research 505-507. In light of the association between fear of falling and 
falls risk in individuals with ankle symptoms, a cognitive-behavioral therapy may be a 
beneficial intervention to moderate the fear of falling and enhance self-efficacy for this 
population and should be investigated in future studies. 
Although impairments linked to increased falls risk have been identified in individuals 
with chronic ankle symptoms, studies have not investigated the association between specific 
impairments and falls in this population. This warrants further investigation to attempt to 
determine key falls-related impairments that can be targeted in the management of ankle 
problems. Furthermore, research on the effects of falls prevention programs on ambulatory 
and ADL function, fear of falling, related impairments, and falls in this population is 
warranted. 
Although this study provides important information related to falls in individuals with 
ankle symptoms, there are limitations that need to be taken into consideration. First, the 
study was retrospective and relied on recall to report falls, the number of falls and fall-related 
injuries experienced in the past 12 months. Prospective studies could be designed to confirm 
these findings. Second, the online method of the survey may have limited participation to 
internet users. Third, the presence of other sites of bodily pain is a potential confounder in 
this study, even though analyses were adjusted accordingly. Fourth, the survey did not 
enquire about medication use. There is evidence to suggest an association between some 
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medications and risk for falls 508. Data was also not collected on previous falls (i.e. prior to the 
12-month window), the location of falls and circumstances surrounding a fall, which may be 
helpful to identify behaviors and circumstances associated with falling. Finally, as the risk of 
fall increases with age, it is possible that this study would yield different results if only those 
50-82 years old were examined. However, this study aimed to examine falls and falls related 
variables in individuals with ankle symptoms. Since ankle symptoms/ problems are prevalent 
in a wider age group, analyses were undertaken while controlling for the effect of age. 
The population investigated in this study were individuals with and without chronic 
ankle symptoms. This group was chosen because our previous research has identified that 
physical impairments and functional deficits were related to symptoms of pain and stiffness 
rather than radiographic joint pathology at the ankle 381. We have shown that 93.9% of the 
participants with ankle pain and stiffness lasting for at least three months have radiographic 
OA of ≥ a grade of 2 on the Kellgren and Lawrence scale (definite osteophytes with mild-
severe joint space narrowing 280). This is not that dissimilar to findings at the knee 52. This 
suggests that the symptomatic group in this study is likely to have symptomatic radiographic 
ankle OA, and our findings can likely be extrapolated to that population. Further research 
could examine the links between pain, symptoms and radiographic findings in the ankle and 
falls.  
9.5 Conclusion 
Individuals with chronic ankle symptoms have an increased risk of falling and 
sustaining an injury from a fall compared to asymptomatic controls. Fear of falling and the 
presence and severity of ankle pain are also important to consider due to their relationship 
with the number of falls experienced. 
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Chapter 10 General Discussion  
The overall objective of this thesis was to promote a better understanding of the 
impairments characterizing individuals with ankle symptoms and OA. In order to capture a 
broad range of information on the impact of ankle pain and OA, laboratory studies and 
surveys were used. These complementary methods facilitated the collection of data on 
objective measures and data from the participant perspective. The series of studies included 
in this thesis explored the impact of ankle symptoms and OA in relation to elements of the 
ICF. Interpretation of the results and the specific discussion of each study is presented within 
the respective chapters. This chapter summarises the thesis in relation to its objectives, 
clinical and research implications, as well as outlining methodological considerations. 
10.1 Summary of thesis findings in relation to the objectives 
The first objective of this thesis was to systematically review available evidence of 
physical impairments in individuals with ankle OA. Study 1 (see Chapter 3) systematically 
reviewed the literature to identify studies of physical impairments in individuals with ankle 
OA. The review identified eight studies, three of which were included in meta-analyses. The 
review provided a synthesis and quality appraisal of the included studies. Meta-analyses 
revealed large impairments of ankle sagittal plane range of motion (ROM) on the affected 
compared to the unaffected side in ankle OA and less sagittal plane torque in ankle OA 
compared to controls. Evidence from single studies identified deficits in frontal plane ROM 
and strength, talar translation and rotation on arthrometry, balance and electromyography of 
ankle joint muscles, abnormal bony alignments and greater fatty infiltrate in all calf muscle 
compartments in individuals with ankle OA. The review highlighted the scarcity of research in 
relation to impairments characterising individuals with ankle OA. One of the key limitations 
was lack of generalization of findings as most studies used convenience samples of 
participants with end stage ankle OA who may not be representative of the broader ankle OA 
population. The findings from the systematic review informed the development of the 
laboratory study (Study 2).  
A cross-sectional laboratory study was conducted to build on findings from the 
systematic review. Study 2 aimed to further understand physical impairments in individuals 
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with ankle OA, and the relationships between physical measures and patient-reported 
outcomes (Chapter 5). This study addressed the second thesis objective. Participants 
underwent a clinical and radiographic assessment of the ankle which facilitated comparisons 
of the following three groups: 1) symptomatic individuals with radiographic evidence of OA, 
2) asymptomatic individuals with radiographic evidence of ankle OA and 3) asymptomatic 
controls with no evidence of radiographic OA. This study examined well-characterised groups 
and utilised three ankle specific measures (CAIT, FAAM and AOS) when comparing patient-
reported outcomes between groups. As self-report measures reflect an individual’s perceived 
ability which may differ from their actual functional ability 509,510, this study collected data on 
physical function by means of self-report and functional performance tests to account for the 
limitation of using only self-reported measures of function. This study also explored the 
relationships between QoL, self-reported function and physical measures (thesis objective 2).  
Symptomatic individuals with ankle OA reported greater pain, instability, and disability 
as well as lower self-reported function compared to asymptomatic individuals. Significant 
deficits in muscle strength, DF ROM, and ambulatory function were identified in the 
symptomatic individuals with ankle OA compared to the asymptomatic individuals with and 
without ankle OA. This data builds on evidence from the systematic review (Chapter 3), 
confirming multi-directional strength deficits and identifying that deficits in DF ROM 
contribute to the total deficit in sagittal plane ankle ROM. While the identification of these 
impairments is important, the understanding of what mechanisms underlie these deficits is 
also important. Further research is needed to determine what factors contributed to the 
deficit in DF ROM and the lower torque production identified in this population.  
The ability to ambulate independently can have a number of health benefits and 
consequences 511. Together, lower torque production and limited ROM identified in the 
symptomatic group can impair the normal function of which ambulation is a central 
component. There is evidence to indicate that ankle strength may influence performance in 
functional tests including walking speed 353 and stair tests 354,355. Likewise, reduced ankle DF 
has been associated with impaired gait, compromised balance and function 165-169.  
Despite the availability of clinically applicable functional tests, previous research had 
not examined timed level walking and stair negotiation specifically in a population with ankle 
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OA. One previous study 512 measured the functional level of individuals with ankle OA 
scheduled for ankle surgery using an activity monitor for two weeks. The study results showed 
individuals with ankle OA walked a smaller number of steps per day compared with 
population norms. Not only did the assessed population in that study represent the severe 
end stage of ankle OA, but also the population norms were extracted from previous research 
on the knee and hip OA 513 that did not specify the size or characteristics of the comparator 
group. We, therefore, do not know whether age or sex are comparable between the assessed 
groups. From the laboratory study in this thesis, slower walking speed and stair 
ascent/descent identified in the symptomatic OA group and the association between these 
tests and function and QoL suggest the importance of including these outcomes when 
assessing individuals with ankle symptoms, and when addressing deficits in the management 
of symptomatic ankle OA.  
Radiographic joint degeneration was identified in 41 asymptomatic individuals (i.e. 
no ankle pain or stiffness) and in 13 asymptomatic ankles (i.e. the unaffected side in the 
symptomatic group). This suggests as previously shown at the knee 340, that radiographic joint 
degeneration does not necessarily equate to symptoms. A comparison of physical and 
patient-reported outcome measures between the two asymptomatic groups (i.e. 
asymptomatic OA and asymptomatic non-OA) revealed no significant differences. This 
absence of differences between the two asymptomatic groups adds to the existing body of 
evidence that the presence of symptoms but not joint degeneration is the relevant 
determinant of impairments 64-66. These findings also highlight the need to assess and treat 
based on symptoms and queries the relevance of radiographs in isolation when managing 
ankle OA. 
Chronic ankle symptoms are a common musculoskeletal concern with an estimated 
prevalence of 9%-20% of adults cited in the literature 2-5. It can be caused by different 
aetiologies including sprains, strains, fractures, dislocations, rheumatoid arthritis and OA 514. A 
substantial body of literature has established that persistent pain is associated with a number 
of outcomes investigated in this thesis including fear of falling 469, lower balance confidence 
470 fear avoidance 515, depressive and anxiety symptoms 516, and impaired QoL 152. However, 
to our knowledge, psychological stress, falls and falls related outcomes and work limitation 
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has not been analysed among a population with persistent ankle pain in comparison with 
control group. 
Questionnaires and surveys are common methods of collecting information about a 
population of interest 517,518. An online survey method was used (see chapters 6-9) to address 
thesis objectives (3-6) relating to identifying differences in self-reported outcomes. This 
method has been shown to have comparable validity and reliability to a classical paper-based 
survey 519,520 and also it provides access to individuals in distant locations. The cross-sectional 
survey studies also explored factors associated with QoL, number of falls, the severity of ankle 
pain, self-reported function and work limitation. Since persistent pain is the main reason for 
seeking medical care 149, the survey studies focussed on the presence of ankle symptoms 
rather than radiographic evidence of ankle OA. Survey participants included individuals with 
chronic ankle symptoms (pain and/or stiffness lasting >3 months) 2 and asymptomatic 
individuals with no persistent ankle symptoms.  
General findings from the survey studies 4-6 (chapters 6-9) reinforce the impact that 
ankle symptoms have on an individual, it revealed that aside from ankle pain, the 
symptomatic individuals reported worse pain elsewhere and presented with more pain sites 
and comorbidities when compared to the controls. It is also evident from the survey studies 
that the symptoms brought about by ankle problems impinge functioning, mental health, and 
work ability further diminishing the QoL.  
Similar to findings from the cross-sectional laboratory study, survey participants with 
persistent ankle symptoms reported worse scores for self-reported function, pain and 
disability, ankle instability, and QoL but not physical activity when compared to controls (see 
chapter 6). Individuals with ankle symptoms also reported higher depressive symptoms in 
comparison to the control (see chapter 7). The majority of symptomatic individuals (71.5%) 
presented with high pain self-efficacy and only a small proportion (16.8%) of the symptomatic 
participants presented with high kinesiophobia. Previous research reported that 
Kinesiophobia and self-efficacy were significantly correlated with function in individuals with 
knee OA 521. A similar correlation between kinesiophobia and function has been reported in 
research involving individuals with ruptured anterior cruciate ligament 423 and back pain 202. In 
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the same way, regression analysis of our survey data showed that ankle pain, pain self-
efficacy and kinesiophobia were associated with self-reported ADL function.  
It is not surprising that individuals with ankle symptoms reported higher work 
limitations than the controls; as 67% of the symptomatic reported moderate to considerable 
work limitations compared to 1.9% of the control (see chapter 8). The negative impact of 
chronic pain on work participation has been reported in the literature 432,433. The symptomatic 
group also reported higher levels of depression, lower function and were 9% more likely to 
present with clinical catastrophizing than controls. Symptomatic individuals with ankle pain 
who remained in the workforce were significantly younger with less pain in the ankle and 
elsewhere, had fewer comorbid conditions and higher function and pain self-efficacy than 
those with ankle symptoms who were not working. These findings are consistent with findings 
identified in a hip OA population 452. Further, the total psychological stress, depression and 
catastrophizing were significantly lower among the working than non-working symptomatic 
individuals. While these findings highlight the beneficial effects of work and employment 
reported in research on wellbeing 442. It is not clear if unemployment is owing to age, ankle 
symptoms and related impairments, or that the nonworking group may have experienced 
more pain from the ankle or from comorbidities than the working population and depicted 
worse outcomes. 
Comparison between symptomatic individuals with ankle pain and/or stiffness and 
asymptomatic controls revealed more falls, greater fear of falling, lower balance confidence 
and function in the symptomatic group when compared to controls (see chapter 9). This study 
also identified that nearly half of the symptomatic fallers suffered a fall-related injury and 
nearly one third required hospitalisation as a result of a fall. Previous research indicated that 
a history of fall is among the most predictive risk factors for future falls 487. Further, the 
presence of depressive symptoms was associated with a marked increase in the risk of falls in 
older adults 522. This same sample in study 4 (see chapter 7) has been found to present with 
higher depression scores and a higher risk of reporting anxiety and depression than controls. 
This places individuals with ankle symptoms at high risk of fall and if we use the fall history to 
denote high-risk individuals, our data suggest that 64% of the symptomatic individuals can 
be considered at high risk of falls as they reported at least one fall in the last 12 months. 
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These findings underscore that falls may be a serious issue among individuals with ankle 
symptoms and underline the importance of preventing falls and its negative consequences in 
this population.  
10.2 Methodological consideration and limitation 
This thesis used a number of methods (systematic review and cross-sectional studies) 
to address the aims, as well as an assortment of designs (including meta-analysis, exploratory 
laboratory and survey, and correlation). This section provides an overview of some 
methodological considerations and limitations pertaining to the different studies of this thesis 
10.2.1 Systematic review 
The search strategy used for the systematic reviews included within this thesis 
(Chapter 3), was completed by a single investigator (MM), which may have introduced a risk 
of selection bias or missing potential studies. However, this potential bias was minimized by 
systematically searching for publications using pre-established search terms, and 
inclusion/exclusion criteria. The included studies were limited in their methodological quality 
which might impact on the robustness of the conclusions drawn from the systematic review. 
Granting all this, the review highlighted the gaps in the literature pertaining to ankle OA 
research and provided a summarised appraisal of current knowledge. 
10.2.2 Cross-sectional laboratory study 
All clinical examinations and data collection was completed by a single investigator. 
This approach can introduce the possibility for bias, as the investigator could not be blinded 
to the group allocation (Symptomatic OA vs. asymptomatic OA or asymptomatic controls) 
during data collection. De-identified x-rays were assessed for presence and grade of OA by 
two independent assessors whom inter-rater agreement was substantial. A standard eligibility 
criterion was employed in the recruitment to eliminate the inclusion of individuals with 
diseases or medical conditions that are known to limit the ability to participate in daily activity 
or exercise, this led to a more homogenous group. While this is a strength of the study design, 
it is established that that OA coincides with other comorbid diseases. Since individuals with 
comorbid conditions were excluded from the laboratory study this limits the ability to 
generalize these findings to the wider ankle OA population. This research was strengthened 
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by the inclusion of controls of the same age, and sex, and with no history of back or lower 
limb injuries (Chapter 4) which limit potential confounders when analyzing the data and 
strengthens the validity of the research findings. The laboratory study was also limited by the 
number of missing imaging of the asymptomatic ankle. This factor limited our ability to draw 
any conclusions on physical asymmetry due to radiographic OA in those symptomatic 
individuals with evidence of OA on one side. 
External validity may have been affected by the participant's awareness of their 
participation in these exploratory research studies and motivation to participate. Participants 
may have been eager to stress their pain experience and show it as a burden or reluctant to 
report how their symptoms affect the different investigated variables 523,524. This may have 
influenced their answers on surveys or affected the extent of effort shown on functional 
performance test in laboratory studies. Further, OA is characterized by remission and 
fluctuation of symptoms and performance-based measures are limited in that they reflect a 
single point of time 525.  
10.2.3 Cross-sectional survey studies  
Data for this survey was collected using an online survey platform, this may have 
caused a selection bias as internet using population may represent only a percentage of the 
target population. The application of our findings is limited by the cross-sectional design of 
these studies. Although self-reported OA is frequently used in arthritis research (i.e. other 
studies have ascertained the presence of OA by self-report 184,526-529), self-report relies upon 
an individual’s recall regarding x-ray findings which may introduce a potential error based on 
their understanding of their diagnosis. Hence, the focus of comparison in the survey studies 
was based on the presence of symptoms rather than radiographic OA.  
While the symptomatic sample in these studies is not a confirmed ankle OA 
population, the sample presents with classical OA symptoms for more than 3 months on most 
days. There is evidence from research on symptomatic knee pain that radiographic knee OA 
was common in those who had >3 months 52,530 of knee pain in the past year (12 months) and 
>90 days of pain in the past 6 months 52. Further, data from our cross-sectional laboratory 
study revealed that most participants who presented with ankle symptoms had also evidence 
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of radiographic ankle OA, also results of patient-reported outcomes from the laboratory study 
(chapter 4) are no different than that of survey 1 (chapter 5). Based on that and after 
analysing the rest of survey data (chapters 6, 7 and 8) we have some confidence that the 
surveyed population is likely represents symptomatic ankle OA at least clinically if not 
radiographically because results were in line and consistent with research finding from other 
weight-bearing OA. Nevertheless, these studies are exploratory, and its results should be 
regarded as preliminary until a replicate study is conducted in a population with a confirmed 
diagnosis of ankle OA. 
Data related to falls frequency and falls related injury were collected retrospectively 
requiring the participant to indicate a number of falls over the last 12 months. This method 
will likely under-report falls 531. Evidence shows a decline in the ability to reliably and 
accurately self-report a fall event with age 532 and revealed that long-term tracking methods > 
3 months result in inaccurate fall reports 532,533. The same concern applies when assessing 
injury history including a number of ankle sprains and fractures as the ability to accurately 
recall this information vary among participants and potentially be a source of error. 
When assessing work limitation, we have accounted for age, sex, and pain other than 
the ankle, but the reasons for unemployment among the non-working participants were not 
investigated. Given that, we are unable to comment if unemployment is related to ankle pain 
and related impairments, unemployment negative effects or that individuals who are non-
working may have been sicker than the working population and depicted worse outcomes.  
10.3 Clinical implications from this thesis 
As ankle injury/trauma is the major risk factor for the development of OA, 
programmes to prevent the onset or delay the progression to OA are warranted. This may be 
achieved by preventing ankle sprains through prophylactic measures (activity appropriate 
footwear, optimisation of ankle passive restraints, external restraints and bracing as well as 
postural stability enhancement) 169,534-536. Likewise, early recognition of ankle injuries by 
identifying individuals at risk for OA following ankle injury/trauma, avoiding re-injury 537 and 
targeting potentially modifiable factors such as post-injury treatment approach, joint 
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mechanics, fitness and strength, BMI and behavioral characteristics (i.e. physical activity and 
return to sport) 538 can assist in limiting the progression to OA. 
A key finding from this thesis is confirming the influence of symptoms reported from 
research on pain and musculoskeletal conditions, this thesis highlights that ankle symptoms 
impact on physical and psychological wellbeing and place individuals with ankle symptoms at 
high risk of falling. An important implication therefore, is to develop management 
(educational, psychological, behavioural, and physical) strategies that help in modifying the 
pain which is the hallmark of musculoskeletal conditions. It is also vital for health care 
providers to specifically target the limitations identified from this thesis and other scientific 
evidence when managing individuals with ankle symptoms and OA.  
Individuals with ankle OA may benefit from the implementation of the international 
recommendations for management of knee and hip OA 539. For example, education about the 
condition, management objectives and options is a key recommendation that can be used 
with ankle OA population to improve pain 540, disability 540, QoL 541, coping and self-efficacy 
540. Exercise of different forms makes a corner stone of the clinical practice guidelines for hip 
and knee OA and can also be utilised for managing ankle symptoms and OA. Given that ankle 
dorsiflexor and plantar flexor strength is correlated with walking speed 353, stair tests 354 and 
stair ascent 355 and that increased muscle strength can improve function 356, there may be a 
role for strengthening exercises in the management of individuals with ankle symptoms to 
prevent declines in function and QoL. 
Since individuals with chronic ankle symptoms are more likely to fall and become 
injured as a result of fall than those without chronic ankle symptoms, there is unquestionable 
benefit to incorporate fall risk assessments in the assessment of individuals with ankle 
symptoms to allow timely identification of risk of falls especially the modifiable factors (such 
as fear of falling, strength, balance, and range of movement) that can be used in the fall 
prevention interventions. Besides, well-tailored exercises (such as balance, functional, 
strength/resistance, three-dimensional, flexibility, and aerobic endurance) 542 according to the 
level of fall risk play an important role in the prevention of falls and its consequences.  
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Our data showed that individuals with persistent ankle symptoms reported higher 
depression than the control group and depression is associated with heightened pain, 
increased functional disability 211 and reduced QoL 215,543. The number of falls in the 
symptomatic population was also related to fear of fall. These findings imply that screening 
for psychological distress might be useful to identify those cases who require psychological 
support and assistance in adapting to ankle symptoms. A multidisciplinary approach 
integrating the medical and psychological management to prepare the chronic pain patients 
to better deal with the burdens of symptoms/OA are warranted. Therapies that utilize 
support groups and integrate cognitive-behavioral approaches and gradual exposure to 
feared activities may play role in preventing consequences of pain-related fear, fear of falling 
and psychological impairments. The effectiveness of these approaches in improving activity 
levels and preventing falls has been reported 506. 
Disability and QoL are intertwined and can be influenced by a number of factors (see 
chapter 2). Previous research has shown that comorbidities are associated with lower QoL 
503,544 and physical function 215,504, and account for the higher risk of falling 545. Since the 
symptomatic group presented with significant multimorbidity compared to controls, this 
further underscores the importance of a multidisciplinary approach to care for all relevant 
morbidities. Further, in light of the relationship between obesity and pain, disability and QoL 
and the effect of weight loss intervention on these outcomes 398,400, providing weight loss 
interventions which are among the key recommendations for managing hip and knee OA may 
be important in the management of this population. Since FAAM-ADL scores were shown to 
be a good representation of QoL; FAAM-ADL could be used as an outcome measure to 
determine ADL function and QoL.  
10.4 Implications for future research 
The findings presented in this thesis could be developed in future research for 
example, the laboratory study cohort was a highly selected group of participants with no 
comorbid pain and conditions. This had the advantage of ensuring that findings could not be 
due to other than ankle OA. However, further research is a requisite to determine whether 
these findings can be generalised to the broader ankle OA population who often have some 
degree of pain elsewhere and other comorbid conditions. There is a body of evidence already 
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available on the risk of falls, but more research is needed to identify these in populations with 
ankle symptoms and OA. For example, previous research identified physical impairments 
(including balance, muscle strength and joint motion) as risk factors for falls 188,495. Research 
focusing on how these physical impairments contribute to occurrence and frequency of fall in 
a population with ankle symptoms and confirmed ankle OA is needed.  
This thesis also identified self-efficacy, pain intensity and pain-related fear as 
determinants of self-reported function, there is no information available as to the 
contribution of self-efficacy and fear of movement to objectively measured physical function 
in a population with ankle pain or OA. Since self-reported function showed best association 
with QoL, future research may examine the contribution of self-efficacy to objectively 
measured physical performance and determine the relationship between self-efficacy and 
QoL in a population with ankle symptoms.  
Although ankle joint is a common English term that refers to the joint between foot 
and leg and broadly to the ankle region, a limitation that must be acknowledged was the 
absence of a shared definition of ankle joint with survey participants. This may have caused 
an ambiguity and possible confusion and may have resulted in the inclusion of cases with pain 
in neighbouring body areas such as midfoot. For more clarity, using a highlighted or labeled 
body diagram to define the intended anatomical body site when recruiting future survey 
participants is warranted.  
The study on work limitation has not investigated the type of work involvement (full or 
part-time), the number of hours, and the productivity loss. Some important personal and 
environmental factors in relation to work such as postural constraints, and occupational 
hazards were beyond the scope of this study and were not measured in our model. Research 
is needed to understand the various factors specific to the population with persistent ankle 
pain that influence work disability and the effect of modifying these factors on the reported 
work disability.  
This thesis did not collect data on the falls prior to the 12-month, venues of falls and 
circumstances preceding a fall, such knowledge is warranted to identify high-risk situations 
and behaviours, and to develop targeted fall prevention strategies. Prospective research of 
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individuals with clinical OA symptoms (pain and stiffness) with and without radiographic 
evidence of OA, may help identify whether radiographic evidence of OA, as opposed to 
clinical symptoms is valuable tool to explain falls in this population. Research suggests that 
retrospective recall can yield inaccurate reports of fall 532,533. To precisely estimate the 
frequency of falls, prospective fall ascertainment methods such as post cards 546 calendars 547 
or diaries 548,549 on weekly or monthly intervals 532,550 should be utilised in future research. In 
the same way, self-reported measurement of physical activity used in this thesis may have 
yielded overestimation due to its limited sensitivity to low or moderate activity and weak 
specificity to accurately estimate physical activity compared with objective measures of 
activity. Hence, future studies may validate and assess physical activity in a population with 
ankle symptoms with objective measures such as activity monitors and differentiate between 
the types of activities performed.  
The multitude of deficits identified in individuals with ankle symptoms and OA 
reinforces the impact this condition has on an individual. There are few studies and no clinical 
recommendations to guide management of ankle symptoms and OA. A 2015 systematic 
review of conservative management of ankle OA determined that the quality of evidence is 
poor and there are insufficient data to inform ankle OA management 551. Well-designed 
research into the management of ankle OA with consideration of the impairments and key 
outcomes identified in this thesis is needed. Furthermore, research on the effects of 
therapeutic programs targeting the modifiable physical risk factors such as muscle strength, 
dorsiflexion ROM and gait outcomes on falls and fall efficacy in a population with 
symptomatic ankle problems and OA is warranted. Longitudinal studies to determine if 
targeting early radiographic ankle OA can slow or prevent OA progression are also needed. 
10.5 Conclusion 
This PhD thesis determined the function, disability, and health profile of individuals 
with ankle pain and /or stiffness and confirmed ankle OA through a systematic review of 
previous research, cross-sectional laboratory and survey studies. This thesis has 
demonstrated that individuals with symptomatic ankle OA present with impairments in 
ambulatory function, ROM, muscle strength and endurance compared to asymptomatic 
individuals. No differences in these outcomes between individuals with and without 
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radiographic OA who did not have ankle symptoms were identified. This suggests that the 
presence of symptoms of pain and stiffness have a greater influence on function and 
impairments than signs of radiographic joint disease at the ankle. Further, survey results 
indicate that persistent ankle pain and stiffness negatively impact on disability, QoL and 
function and is associated with limitations at work, increased falls and psychological 
impairments. For more directed investigations of the effect of interventions for this 
population, further research is needed to better understand the mediators of the 
impairments, psychological distress and QoL identified in populations with ankle pain and OA. 
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Appendices 
Appendix 1 
Search terms 
tibiotalar OR talofibular OR talotibial OR talocrural OR talocalcaneal OR ankle 
AND 
osteoarthritis OR osteoarthrosis OR -arthritis OR osteo-arthrosis OR arthrosis 
AND 
“force plate” OR muscle OR kinematic OR kinematics OR kinetics OR kinetic OR kinesthe* OR valgus 
OR varus 
OR atrophy OR isometric OR isotonic OR isokinetic OR strength OR weakness OR dynamometer OR 
power OR force OR endurance OR speed OR fatigue OR contraction OR EMG OR latency OR 
electromyograph* OR activation OR laxity OR stiffness OR displacement OR “anterior drawer” OR 
motion OR “range of movement” 
OR dorsiflex* OR plantarflex* OR inver* OR ever* OR supinat* OR pronat* OR flex OR flexor* OR 
flexion OR extens* OR adduct* OR abduct* OR “reaction time” OR “joint position” OR sensorimotor 
OR “movement detection” OR accelerometer OR “stride length” OR cadence OR stability OR control 
OR arthrometer OR balance OR proprioception OR postur* OR coordinate* OR “center of mass” OR 
“centre of mass” OR “center of pressure” OR “centre of pressure” OR gait OR walk* OR locomot* OR 
step OR steps OR stepping OR hop 
OR hops or hopping OR jump* OR run OR instability 
 
Not terms 
Cadaver OR cadaveric OR rabbit OR rat OR rats OR mouse OR mice OR Paediatric OR pediatric OR 
juvenile OR child OR children OR “Cruciate ligament” OR Cruciate OR “Collateral ligament” OR 
meniscus OR menisci OR hip OR patellofemoral OR Diabetic OR diabetes OR Rheumatic OR 
“rheumatoid arthritis” OR Rheumatologic 
OR rheumatism OR Hallux OR "hallux rigidus" OR "hallux valgus" OR "hallux limitus" OR "hallux varus" 
OR Cancer or tumor 
 
Databases search algorithm 
-------------------------------------------------------------------------------------------------------------------------  
Search in PubMed 
1. Main search terms linked with “AND”  
2. “NOT” review in “publication type” search field  
3. Combining the NOT term sets resulted in higher numbers hence the option to search each set of 
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terms independently.  
4. “NOT” term sets searched independently in “title/abstract” search field:  
 
Cadaver OR cadaveric OR rabbit OR rat OR rats OR mouse 
OR mice Paediatric OR pediatric OR juvenile OR child OR 
children 
“Cruciate ligament” OR Cruciate OR “Collateral ligament” OR meniscus OR menisci OR hip OR 
patellofemoral 
Diabetic OR diabetes 
Rheumatic OR “rheumatoid arthritis” OR Rheumatologic OR rheumatism 
Hallux OR "hallux rigidus" OR "hallux valgus" OR "hallux limitus" OR "hallux 
varus" Cancer or tumor 
-------------------------------------------------------------------------------------------------------------------------  
Search in SPORDiscus 
Notes: 
1. Relevant search fields for our set of NOT terms were either in title, subjects (descriptor) or 
abstract.  
2. I removed the term review from “title” (subject field).  
3. Experimented removing the terms from titles and again from abstracts and identified the 
difference.  
4. Removing the terms from abstracts included all terms that were removed from titles. Hence 
NOT terms were removed from abstracts (subject field)  
-----------------------------------------------------------------------------------------------------------------  
Search in CINAHL 
Notes: 
1. Search fields are different in CINAHL with an option to select human in the “search option” 
table as well as the option to search “publication type” in the search field.  
2. I removed the term review from “publication type” (search field).  
3. Experimented removing the terms from titles and again from abstracts and identified the 
difference.  
4. Removing the terms from abstracts included all terms that were removed from titles. Hence 
NOT terms were removed from abstracts (subject field)  
-----------------------------------------------------------------------------------------------------------------  
Search in EMBACE 
Notes: 
1. There are no specific search fields to select from.  
2. The main Boolean operators listed are AND and OR.  
3. I searched for the different sets of main terms independently then I combined them with AND.  
4. When I typed the# presenting the combined main searches followed by NOT terms e.g. #4 
NOT Cadaver OR cadaveric OR rabbit OR rat OR rats OR mouse OR mice, the numbers were 
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higher instead of being lower.  
5. I then searched for the different sets of NOT terms separately.  
6. Within the entry box I typed the # presenting the combined main searches followed it with 
NOT and the # representing search results for each set of NOT terms.  
7. Same results was achieved by typing # presenting the combined main searches followed by 
NOT and all NOT terms in brackets.  
8. NOT and the # representing search results for each set of NOT terms.  
-----------------------------------------------------------------------------------------------------------------   
Search in Web of Science 
Notes: 
1. Relevant search fields for our set of NOT terms were either in title or topic.  
a. Search main terms linked with “AND”  
b. “NOT” in title:  
• Cadaver OR cadaveric OR rabbit OR rat OR rats OR mouse OR mice  
• Paediatric OR pediatric OR juvenile OR child OR children  
• “Cruciate ligament” OR Cruciate OR “Collateral ligament” OR meniscus OR menisci OR hip OR  
patellofemoral 
• Diabetic OR diabetes  
• Rheumatic OR “rheumatoid arthritis” OR Rheumatologic OR rheumatism  
• Hallux OR "hallux rigidus" OR "hallux valgus" OR "hallux limitus" OR "hallux varus"  
2. Refining to web of science subject category and document type is possible only after the 
search is done.  
Review, letter, meeting abstracts, book chapters, editorial material, reprints and proceedings paper 
(document types) were excluded from the results. 
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Appendix 2 
Item statement Epidemiological appraisal instrument H
ay
as
h
i e
t 
al
., 
20
08
 
H
u
b
b
ar
d
 e
t 
al
, 2
00
9
 
Le
e 
et
 a
l.,
 2
01
1
 
Le
e 
et
 a
l.,
 2
01
3
 
N
ü
es
ch
 e
t 
al
 2
01
2
 
V
al
d
er
ra
b
an
o
 e
t 
al
., 
20
06
 
W
ie
w
io
rs
ki
 e
t 
al
., 
20
12
 
W
ik
st
ro
m
 &
 A
n
d
er
so
n,
 2
01
3
 
1. Is the hypothesis/aim/objective of the study clearly described?               1 
2. Are all the exposure variables clearly described?                
3. Are the main outcomes clearly described?                
4. Is the study design clearly described?                
5. Is the source of subject population clearly described?                
6. Are the eligibility criteria for subject selection clearly described                
7. Are the participation rate(s) reported? Are ascertainments of record availability described?                
8. Are the characteristics of study participants described?                
9. Have the characteristics of subjects lost after entry into the study or subjects not participating from 
among the eligible population been described? Have the details of unavailable records been described? 
               
11. Are the important covariates and confounders described in terms of individual variables?                
13. Are the statistical methods clearly described?                
14. Are the main findings of the study clearly described?               1 
15. Does the study provide estimates of the random variability in the data for the main outcomes (i.e. 
confidence intervals, standard deviations)? 
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16. Does the study provide estimates of the statistical parameters (e.g. regression coefficients or 
parameter estimates such as odds ratio or mean differences)? 
               
17. Are sample size calculations performed and reported?                
18. Is the comparison/reference group comparable to the exposed group?                
19. Is the participation rate adequate? Is the ascertainment of record availability adequate?                
20. Are the study subjects from different groups recruited over the same period of time?                
21. Are subject losses or unavailable records after entry into the study taken into account?                
25. Are the exposure variables reliable?                
26. Are the exposure variables valid?                
27. Are the methods of assessing the exposure variables similar for each group?                
29. Are the observers blinded to subject groupings when the exposure assessment was made or the 
disease status of subjects when conducting exposure assessment? 
               
31. Are the main outcome measures reliable?                
32. Are the main outcome measures valid?               1 
33. Are the methods of assessing the outcome variables standard across all groups?               1 
34. Are the observations taken over the same time for all groups?                
35. Is prior history of disease and/or injury collected and included in the analysis?                
36. Is there adequate adjustment for covariates and confounders in terms of individual variables in the 
analyses? 
               
40. Are outcome data reported by levels of exposure?                
41. Are the outcome/exposure data reported by subgroups of subjects?                
42. Can the study results be applied to the eligible population?                
43. Can the study results be applied to other relevant populations?                
Quality score (0-1) 0.56 0.33 0.39 0.36 0.35 0.36 0.41 0.30 
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Appendix 3 
 
Table A 3.2: Adopted stages for the current systematic review 
Stage Description 
Mild  Early sclerosis, minimum joint space narrowing and osteophyte formation 
Moderate  Moderate narrowing and osteophyte formation 
Advanced Obliteration of the entire joint space, subchondral bone contact /ankylosis 
 
 
  
Table A3.1: stages of ankle OA in two classification systems and the adopted stages for the current systematic review 
 
Stages Morrey and Wiedeman classification 54  
 
Modified Takakura classification 116(from Lee et al 2011241) Adopted grouping 
0 Normal -  
1 Minimum narrowing and osteophyte formation Early sclerosis and formation of osteophytes, No joint space narrowing  Mild OA 
2 Moderate narrowing and osteophyte formation Narrowing of the medial joint space Moderate OA 
3  Gross deformity and ankylosis a. Obliteration of the medial joint space with subchondral bone contact limited to the 
medial malleolus 
Advanced OA 
 - b. b. Subchondral bone contact extending to the roof of the dome of the talus 
4 - Obliteration of the entire joint space, resulting in bone contact throughout the ankle 
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Appendix 4 
Physical outcomes compared between the affected side in people with ankle OA versus the unaffected side or healthy control. 
Outcome Stage of 
OA 
Affected side in 
ankle OA 
Mean (SD, n) 
Unaffected side 
in ankle OA 
Mean (SD, n) 
Between sides 
SMD [CI] 
Healthy control 
Mean (SD, n) 
Affected side v 
control 
SMD [CI] 
Unaffected side vs 
control 
SMD [CI] 
TMM (◦) 241 
 
Moderate  24.9 (2.8, 68) 
 
  22.6 (6.1, 80) 
 
0.47 [0.14, 0.80]  
Advanced  28.78 (8.58, 87)   22.6 (6.1, 80) 
 
0.82 [0.50, 1.14]  
TTS (◦) 238 
 
 
Mild  85.3 (2.6, 26) 
 
 
  87.2 (2.8, 62) 
 
 
-0.69 [-1.16, -0.22] 
 
 
Moderate  82.7 (3.5, 39) 
 
 
  87.2 (2.8, 62) 
 
-1.45 [-1.90, -1.00]  
 Advanced  77.44 (7.6, 68)   87.2 (2.8, 62) 
 
-1.66 [-2.07, -1.26]  
Talar tilt (◦) 241 
 
Moderate  2.5 (2.8, 68)   0 (0, 80)   
Advanced  5.4 (5.3, 87)   0 (0, 80)   
TPC (◦) 238 
 
Mild  88.2 (6.1, 26) 
 
 
  88.3 (5.8, 62) 
 
-0.02 [-0.47, 0.44] 
 
 
 Moderate  91.0 (8.7, 39) 
 
 
  88.3 (5.8, 62) 
 
0.38 [-0.02, 0.78]  
 Advanced  84.1 (10.9, 68)   88.3 (5.8, 62) 
 
-0.47 [-0.82, -0.12]  
SIA (◦) 238 
 
 
Mild  2.9 (7.0, 26) 
 
 
  1.5 (5.9, 62) 
 
0.22 [-0.24, 0.68] 
 
 
 Moderate  8.0 (8.6, 39) 
 
 
  1.5 (5.9, 62) 0.91 [0.49, 1.33] 
 
 
 Advanced  6.6 (9.0, 68)   1.5 (5.9, 62) -10.93 [-12.33, -9.54]  
TAS (◦) 238 
 
Moderate  84.5 (3.1,39)   87.4 (2.7,62) -1.01 [-1.43, -0.58]  
Advanced  82.7 (3.7,68)   87.4 (2.7,62) -1.43 [-1.82, -1.05]  
TAS (◦) 241 Moderate  86.9 (2.4,68)   88.9 (2.4,80) -0.83 [-1.17, -0.49]  
 Advanced  84.9 (4.4,87)   88.9 (2.4,80) -1.09 [-1.41, -0.76]  
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TLS (◦) 238 
 
Moderate  80.4 (3.2,39)   81.13 (2.8,62) -0.24 [-0.65, 0.16]  
Advanced  78.4 (5.2,68)   81.13 (2.8,62) -0.64 [-0.99, -0.29]  
TLS (◦) 241 
 
Moderate  76.8 (3.5,68)   79.8 (3.8,80) -0.81 [-1.15, -0.48]  
 Advanced 72.4 (4.8,87)   79.8 (3.8,80) -1.69 [-2.05, -1.34]  
Hind foot alignment (◦) 241 
 
Moderate  0.5 (8.1, 68)   -0.5 (5.4, 80) 0.15 [-0.18, 0.47]  
Advanced  5.3 (8.63, 87)   -0.5 (5.4, 80) 0.79 [0.48, 1.11]  
Calcaneal alignment (°) † 145 
 
Moderate+ 
Advanced 
3.0 (8.9, 15) 
 
7.0 (3.55, 15) 
 
 
-0.57 [-1.31, 0.16] 4.6 (1.24, 15) -0.25 [-0.96, 0.47]  
Tibiotalar ratio 240 Advanced 28.3 (2.47, 104) 
 
 
  35.0 (3.0, 50) 
 
-2.51 [-2.95, -2.07]  
Total range of movement (◦)        
Inversion /Eversion 145 Moderate+ 
Advanced 
19.7 (11.1, 15) 
 
43.3 (10.97, 15) 
 
 
-2.08 [-2.99, -1.17] 50.7 (8.4, 15) 
 
-3.07 [-4.16, -1.97] -0.74 [-1.48, 0.01] 
Dorsiflexion/plantar flexion 145 Moderate+ 
Advanced 
16.0 (7.6, 15) 
 
56.7 (5.23, 15) -6.07 [-7.87, -4.27] 58.7 (5.2, 15) 
 
-6.39 [-8.27, -4.52] -0.37 [-1.10, 0.35] 
Dorsiflexion/plantar flexion 239  18.1 (9.15, 21) 56.0 (6.25, 21) -4.75 [-5.97, -3.52]    
Mechanical stability         
Anterior displacement (mm) 146  
 
 7.1 (1.9, 8) 10.6 (1.5, 8) 
 
 
-1.93 [-3.18, -0.69] 11.2 (1.8, 8) 
 
 
-2.09 [-3.38, -0.81] -0.34 [-1.33, 0.65] 
Posterior displacement (mm) 146   4.6 (1.3, 8) 5.0 (1.3, 8) 
 
 
-0.29 [-1.28, 0.70] 
 
4.9 (0.58, 8) -0.28 [-1.27, 0.70] 0.09 [-0.89, 1.07] 
Inversion rotation (°) 146   21.6 (6.4, 8) 
 
 
31.1 (4.5, 8) 
 
 
-1.62 [-2.80, -0.45] 33.0 (2.1, 8) 
 
 
-2.26 [-3.60, -0.93] -0.51 [-1.51, 0.49] 
Eversion rotation (°) 146   9.4 (2.8, 8) 
 
 
15.2 (5.1, 8) 
 
-1.33 [-2.45, -0.22] 21.3 (5.6, 8) 
 
 
-2.54 [-3.95, -1.13] -1.08 [-2.15, -0.01] 
Calf circumference (cm)        
Calf circumference (cm) 155 
 
 38.19 (2.36,12) 39.42 (2.74,12) -0.46 [-1.28, 0.35] 38.29 (2.67, 12) -0.04 [-0.84, 0.76] 0.41 [-0.40, 1.22] 
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Calf circumference (cm) 145 Moderate+ 
Advanced 
32.7 (3.45, 15) 34.8 (3.44, 15) -0.59 [-1.33, 0.14] 33.6 (2.8, 15) -0.28 [-1.00, 0.44] 0.37 [-0.35, 1.10] 
Calf circumference (cm) 239 Moderate+ 
Advanced 
33.2 (2.65, 21) 35.3 (2.76, 21) -0.76 [-1.39, -0.13]    
CSA (cm²)        
Anterior tibial group 239 
 
Moderate+ 
Advanced 
10.3 (2.6, 21) 
 
 
11.0 (2.9, 21) -0.25 [-0.86, 0.36]    
Peroneal muscle group 239 
 
Moderate+ 
advanced 
5.8 (1.7, 21) 6.5 (1.5, 21) 
 
-0.43 [-1.04, 0.18]    
Deep posterior muscles 239 Moderate+ 
Advanced 
4.5 (1.3, 21) 
 
5.4 (1.5, 21) 
 
-0.63 [-1.25, -0.01]    
Gastroc. med. muscle 239 Moderate+ 
Advanced 
12.0 (3.3, 21) 
 
 
13.3 (3.5, 21) 
 
-0.37 [-0.99, 0.24]    
Gastroc. Lat. muscle 239 Moderate+ 
Advanced 
5.7 (2.0, 21) 
 
 
6.7 (2.0, 21) -0.49 [-1.11, 0.12]    
Soleus muscle 239 Moderate+ 
Advanced 
18.6 (5.4, 21) 
 
 
24.7 (6.0, 21) -1.05 [-1.70, -0.40] 
 
   
Anatomical calf CSA 239 Moderate+ 
Advanced 
57 (13.4, 21) 67.5 (11.9, 21) -0.81 [-1.44, -0.18]    
Fatty infiltration        
Anterior tibial group 239 
 
Moderate+ 
Advanced 
1.3 (0.8, 21) 0.4 (0.5, 21) 1.25 [0.58, 1.92]    
Peroneal muscle group 239 
 
Moderate+ 
Advanced 
1.4 (0.6, 21) 0.5 (0.5, 21) 1.60 [0.90, 2.30]    
Deep posterior muscles 239 Moderate+ 
Advanced 
1.4 (0.8, 21) 0.2 (0.4, 21) 1.86 [1.13, 2.60]    
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Gastroc. med. muscle 239 
 
Moderate+ 
Advanced 
1.3 (0.5, 21) 0.6 (0.6, 21) 1.24 [0.58, 1.91]    
Gastroc. Lat. muscle 239 
 
Moderate+ 
Advanced 
1.1 (0.7, 21) 0.4 (0.5, 21) 1.13 [0.47, 1.78]    
Soleus muscle 239 Moderate+ 
Advanced 
2.5 (0.5, 21) 0.8 (0.6, 21) 3.02 [2.11, 3.93]    
Maximal isometric torque        
Dorsiflexion 145 Moderate+ 
Advanced 
16.4 (4.9, 15) 25.9 (8.2, 15) -1.37 [-2.17, -0.56] 27.1 (9.4, 15 -1.39 [-2.20, -0.58] -0.13 [-0.85, 0.58] 
Dorsiflexion 155 
 
 11.1 (7.96,12)   26.3 (13.86,12) -1.30 [-2.19, -0.40]  
Plantarflexion 145 Moderate+ 
Advanced 
15.8 (7.6, 15) 25.6 (7.4, 15) -1.27 [-2.07, -0.48] 30.7 (15.5, 15) -1.19 [-1.97, -0.40] -0.41 [-1.13, 0.32] 
Plantarflexion 155 
 
 20.9 (7.62, 12)   36.9 (13.51, 12) -1.41 [-2.32, -0.50]  
Isometric strength (N.m/kg)        
Plantar flexion 146  0.18 (0.09, 8) 
 
 
0.22 (0.07, 8) 
 
 
-0.47 [-1.47, 0.53] 0.39 (0.1, 8) 
 
-2.09 [-3.37, -0.80] -1.86 [-3.09, -0.63] 
Dorsiflexion 146 
 
 0.16 (0.05, 8) 
 
 
0.2 (0.06, 8) 
 
 
-0.68 [-1.70, 0.33] 0.36 (0.1, 8) 
 
-2.39 [-3.76, -1.02] -1.83 [-3.06, -0.61] 
Inversion 146 
 
 0.09 (0.03, 8) 
 
 
0.14 (0.04, 8) 
 
-1.34 [-2.45, -0.22] 0.22 (0.04, 8) -3.48 [-5.17, -1.78] 
 
-1.89 [-3.13, -0.65] 
Eversion 146 
 
 0.1 (0.03, 8) 0.14 (0.03, 8) -1.26 [-2.36, -0.16] 0.22 (0.04, 8) -3.21 [-4.82, -1.60] -2.14 [-3.44, -0.84] 
Muscle EMG Amplitude (µV)        
Anterior tibial muscle 145 Moderate+ 
Advanced 
39.8 (21.9, 15) 67.8 (53.4, 15) -0.67 [-1.41, 0.07] 62.6 (43.4, 15) -0.65 [-1.38, 0.09] 0.10 [-0.61, 0.82] 
Medial gastrocnemius 145 Moderate+ 
Advanced 
6.9 (10.9, 15) 20.2 (23.0, 15) -0.72 [-1.46, 0.02] 24.7 (19.0, 15) -1.12 [-1.90, -0.34] -0.21 [-0.93, 0.51] 
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Peroneus longus 145 Moderate+ 
Advanced 
14.1 (19.4, 15) 26.9 (25.3, 15) -0.55 [-1.28, 0.18] 33.0 (43.3, 15) -0.55 [-1.28, 0.18] -0.17 [-0.88, 0.55] 
Soleus 145 Moderate+ 
Advanced 
19.9 (55.6, 15) 17.9 (25.1, 15) 0.05 [-0.67, 0.76] 25.7 (29.4, 15) -0.13 [-0.84, 0.59] -0.28 [-1.00, 0.44] 
Muscle EMG Frequency (Hz)        
Anterior tibial muscle 145 Moderate+ 
Advanced 
119.4 (31.8, 15) 142 (29.1, 15) -0.72 [-1.46, 0.02] 144.9 (26.1, 15) -0.85 [-1.61, -0.10] -0.10 [-0.82, 0.61] 
Medial gastrocnemius 145 Moderate+ 
Advanced 
159.2 (19.9, 15) 186.5 (26.7, 15) -1.13 [-1.91, -0.35] 184.8 (23.8, 15) -1.14 [-1.91, -0.36] 0.07 [-0.65, 0.78] 
Peroneus longus 145 Moderate+ 
Advanced 
147.5 (35.4, 15) 176.1 (31.7, 15) -0.83 [-1.58, -0.08] 159.8 (28.6, 15) -0.37 [-1.09, 0.35] 0.53 [-0.20, 1.26] 
Soleus 145 Moderate+ 
Advanced 
124.2 (33.1, 15) 150.1 (21.0, 15) -0.91 [-1.67, -0.15] 146.8 (32.6, 15) -0.67 [-1.41, 0.07] 0.12 [-0.60, 0.83] 
Static balance variables.        
COP total displacement (mm) 146   219.5 (193.6, 8) 
 
 
  27.0 (6.6, 8) 
 
 
1.33 [0.21, 2.44]  
COP total velocity (mm/s) 146   36.8 (16.4, 8) 
 
 
  11.4 (2.1, 8) 
 
 
2.05 [0.78, 3.33]  
COP ML displacement (mm) 146   2.8 (4.5, 8) 
 
 
  0.88 (0.55, 8) 
 
 
0.57 [-0.44, 1.57]  
COP AP displacement (mm) 146   1.9 (2.2, 8) 
 
 
  0.35 (0.4, 8) 
 
 
0.93 [-0.12, 1.97]  
COP ML velocity (mm/s) 146   0.53 (0.61, 8) 
 
 
  0.01 (0.09, 8) 
 
 
1.13 [0.05, 2.21]  
COP AP velocity (mm/s) 146   0.68 (0.83, 8)   0.15 (0.13, 8) 
 
0.84 [-0.19, 1.88]  
AP sway (cm) 147  3.94 (1.36, 5)   2.31 (0.25, 5) 1.51 [0.01, 3.01]  
ML Sway (cm) 147  2.14 (1.03, 5)   1.02 (0.21,5) 1.36 [-0.10, 2.82]  
†Alignment was measured with goniometer in standing. 
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Abbreviations and definitions: SD=standard deviation; SMD=standardized mean difference; CI=confidence interval ;TMM (◦)=The angle between the distal third of the tibial shaft 
and the medial malleolar joint surface ; Hind foot alignment (◦)=the angle between tibial and calcaneal axes; TTS (◦)=The angles between the tibial shaft the articular surface of 
the talar dome ; TPC (◦)=The angle between the tibial shaft axis and the articular surface of the posterior facet of the calcaneus; TAS (◦)=The angle between the tibial shaft and 
tibial articular surface in the frontal plane on weight-bearing x-ray ; TLS (◦)=The angle between the tibial shaft axis and the articular surface of the tibial shaft in the sagittal plane 
on weight-bearing x-ray; SIA= angle between the articular surface of the talar dome and the posterior facet of the calcaneus; Tibiotalar ratio= ratio into which the mid-longitudinal 
axis of the tibial shaft divides the longitudinal talar length; CSA=cross sectional area; EMG=electromyography; Anterior tibial muscle group= (tibialis anterior, extensor digitorum 
and hallucis longus); Gastroc.med.muscle= Gastrocnemius medialis muscle; Gastroc Lat.muscle= Gastrocnemius lateralis muscle; Deep dorsal muscle group = (tibialis posterior, 
flexor digitorum longus, and flexor hallucis longus); Peroneal muscle group= (peroneus longus and brevis); AP= Anterior-posterior; ML= Medial-lateral. 
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Appendix 7 
Test-retest reliability for physical measures 
  Sample (n ankles) ICC  95% CI SEM MDC 
Maximum isometric dorsiflexion strength-Knee flexion (N) 10 (10 ankles) 0.93 0.759 to 0.982 8.50 23.56 
Maximum isometric inversion strength-Knee flexion (N) 10 (10 ankles) 0.96 0.861 to 0.990 8.38 23.23 
Maximum isometric eversion strength-Knee flexion (N) 10 (10 ankles) 0.96 0.868 to 0.991 7.76 21.51 
Maximum isometric plantarflexion-Knee flexion (N) 10 (10 ankles) 0.97 0.895 to 0.993 22.30 61.81 
Maximum isometric plantarflexion-Knee Extension (N) 10 (10 ankles) 0.98 0.923 to 0.995 20.40 56.54 
Stair ascent and descent (sec) 10 0.93 0.764 to 0.982 0.39 1.09 
Timed 10-m walk (sec) 10 0.60 0.034 to 0.883 0.29 0.81 
DF ROM (mm) 10 (10 ankles) 1.00 0.987 to 0.999 1.08 2.98 
Foot posture index (score -12 to +12) 10 (20 ankles) 0.84 0.620 to 0.935 0.72 2.00 
AP-PA displacement (mm) 10 (10 ankles) 0.91 0.703 to 0.977 1.24 3.43 
Inversion-Eversion rotation (◦) 10 (10 ankles) 0.99 0.98 to 1.00 2.12 5.87 
Dorsal arch height-weight-bearing (mm) 5 (10 ankles) 0.89 0.78 to 0.96 0.7 1.9 
Dorsal arch height -non weight-bearing (mm) 5 (10 ankles) 0.98 0.95 to 0.99 0.81 1.9 
Midfoot width- weight-bearing (mm) 5 (10 ankles) 0.99 0.98 to 1.00 0.5 1.4 
Midfoot width-non-weight-bearing (mm) 5 (10 ankles) 0.97 0.95 to 0.98 1.1 3.1 
ICC = intraclass correlation coefficient; CI = confidence interval; SEM = standard error of measurement; MDC=minimal detectable change (at 95% confidence 
limit) 
All measures were taken seven days apart by a single examiner 
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Appendix 8 
Past fracture, ankle sprain history and Kellgren–Lawrence grades n(%) of the study groups and risk difference between groups 
 Frequency and percentage for each group Risk difference (95% confidence interval) 
Characteristic  Symptomatic OA 
n=31 
Asymptomatic OA 
n=41 
Asymptomatic non-OA 
n=24 
Symptomatic 
vs 
Asymptomatic 
Symptomatic OA  
vs  
Asymptomatic OA 
Asymptomatic OA  
vs  
Asymptomatic non-OA 
Past fracture  13(50.0%)* 0 (0%) 0 (0%) 50% [31, 69] 50% [31, 69] 0% [-6, 6] 
Ankle sprains    
No sprain  13 (50.0%)* 30 (75%) 19 (79.2%) 30% [-52, -9] 23% [-47, 0] 18% [0, 35] 
One sprain  2 (7.6%)* 6 (14.6%) 2 (8.3%) 5% [-18, 8] 7% [-22, 8] 6% [-9, 22] 
Two sprains  1 (3.8%)* 0 (0%) 0 (0%) 4% [-5, 13] 4% [-5, 13] 0% [-6, 6] 
Three sprains  1 (3.8%)* 3 (7.3%) 0 (0%) 1% [-10, 8] 3% [-14, 7] 7% [-3, 17] 
> 3 sprains  9 (34.6%)* 0 (0%) 1 (4.2%) 33% [15, 52] 35% [16, 53] 4% [-14, 6] 
Kellgren–Lawrence    
Grade 0 0 (0%) 0 (0%) 3 (12.5%) 5% [-12, 2] 0% [-5, 5] 13% [-26, 1] 
Grade 1  0 (0%) 0 (0%) 21 (87.5%) 32% [-44, -20] 0% [-5, 5] 88% [-100, -74] 
Grade 2  17 (54.8%) 27 (65.9%) 0 (0%) 9% [-30, 11] 11% [-34, 12] 66% [50, 81] 
Grade 3  8 (25.8%) 13 (31.7%) 0 (0%) 6% [-12, 24] 6% [-27, 15] 32% [17, 47] 
Grade 4  6 (19.4%) 1 (2.4%) 0 (0%) 18% [4, 32] 17% [2, 32] 2% [-5, 10] 
*Data on fracture and sprains based on 26 responses from the symptomatic OA, 31 asymptomatic OA and 41 asymptomatic non-OA. 
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Appendix 9 
Correlation levels between the different physical outcomes, quality of life and function  
Spearman's rho Group 
10-m. 
walk 
Stair 
descen
t 
Stair 
ascent 
DF 
ROM 
PF-
knee 
Flex 
Inv-
knee 
Flex 
Ever-
knee 
Flex 
DF-
knee 
Flex 
PF-
knee 
Ext 
Heel 
raises  FPI 
DAHDI
FF 
MFWDI
FF FMM 
Total 
AP 
displac
ement 
 Total 
rotatio
n 
FAAM 
ADL 
10-m. walk 0.32**                                   
Sig. (2-tailed) 0.00                                   
N 95                                   
Stair descent 0.21* 0.61**                                 
Sig. (2-tailed) 0.05 0.00                                 
N 93 93                                 
Stair ascent 0.17 0.65** 0.91**                               
Sig. (2-tailed) 0.11 0.00 0.00                               
N 93 93 93                               
DF ROM -0.56** -0.13 -0.14 -0.13                             
Sig. (2-tailed) 0.00 0.20 0.18 0.22                             
N 96 95 93 93                             
PF-knee Flex -0.48** -0.30** -0.35** -0.31** 0.40**                           
Sig. (2-tailed) 0.00 0.00 0.00 0.00 0.00                           
N 96 95 93 93 96                           
Inv- knee Flex -0.57** -0.39** -0.42** -0.37** 0.49** 0.71**                         
Sig. (2-tailed) 0.00 0.00 0.00 0.00 0.00 0.00                         
N 96 95 93 93 96 96                         
Ever- knee Flex -0.56** -0.29** -0.37** -0.32** 0.43** 0.73** 0.76**                       
Sig. (2-tailed) 0.00 0.00 0.00 0.00 0.00 0.00 0.00                       
N 96 95 93 93 96 96 96                       
DF in knee Flex -0.56** -0.38** -0.37** -0.33** 0.57** 0.66** 0.69** 0.71**                     
Sig. (2-tailed) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00                     
N 96 95 93 93 96 96 96 96                     
PF in knee Ext -0.55** -0.35** -0.48** -0.42** 0.39** 0.71** 0.74** 0.76** 0.66**                   
Sig. (2-tailed) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00                   
N 95 95 93 93 95 95 95 95 95                   
Heel raises  -0.44** -0.37** -0.26* -0.25* 0.22* 0.44** 0.43** 0.49** 0.48** 0.50**                 
Sig. (2-tailed) 0.00 0.00 0.01 0.01 0.04 0.00 0.00 0.00 0.00 0.00                 
N 93 93 92 92 93 93 93 93 93 93                 
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FPI -0.11 0.11 -0.10 -0.11 .23* 0.12 0.14 0.15 0.10 0.09 0.01               
Sig. (2-tailed) 0.31 0.31 0.36 0.28 0.02 0.25 0.18 0.15 0.36 0.39 0.95               
N 95 94 92 92 95 95 95 95 95 94 92               
DAHDIFF -0.03 0.23* 0.21* 0.19 .23* -0.12 -0.16 -0.06 -0.09 -.20* -0.24* 0.31**             
Sig. (2-tailed) 0.75 0.03 0.05 0.07 0.02 0.25 0.13 0.56 0.40 0.05 0.02 0.00             
N 95 94 92 92 95 95 95 95 95 94 92 94             
MFWDIFF -0.09 0.08 0.04 0.04 0.18 0.11 0.13 0.29** 0.17 0.13 -0.03 0.31** 0.22*           
Sig. (2-tailed) 0.36 0.44 0.68 0.72 0.09 0.28 0.21 0.01 0.09 0.20 0.78 0.00 0.03           
N 95 94 92 92 95 95 95 95 95 94 92 94 95           
FMM -0.09 .212* 0.16 0.15 .27** 0.00 -0.03 0.11 0.05 -0.07 -0.18 0.39** 0.86** 0.64**         
Sig. (2-tailed) 0.39 0.04 0.13 0.14 0.01 0.98 0.77 0.29 0.64 0.49 0.08 0.00 0.00 0.00         
N 95 94 92 92 95 95 95 95 95 94 92 94 95 95         
Total AP 
displacement  -0.07 0.02 -0.02 0.04 0.34** -0.11 -0.07 -0.10 0.06 -0.09 0.04 0.04 0.01 -0.10 0.00       
Sig. (2-tailed) 0.53 0.86 0.89 0.67 0.00 0.30 0.52 0.32 0.56 0.39 0.72 0.68 0.92 0.32 0.99       
N 96 95 93 93 96 96 96 96 96 95 93 95 95 95 95       
 Total rotation -0.30** -0.01 0.13 0.14 0.51** 0.02 0.14 0.17 0.27** 0.09 0.00 0.26* 0.31** 0.31** 0.35** 0.43**     
Sig. (2-tailed) 0.00 0.93 0.22 0.18 0.00 0.82 0.16 0.09 0.01 0.40 0.99 0.01 0.00 0.00 0.00 0.00     
N 96 95 93 93 96 96 96 96 96 95 93 95 95 95 95 96     
FAAM ADL -0.85** -0.34** -0.31** -0.26* 0.47** 0.47** 0.54** 0.61** 0.56** 0.60** 0.50** 0.16 -0.02 0.18 0.10 0.07 0.220*   
Sig. (2-tailed) 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.14 0.88 0.10 0.36 0.50 0.04   
N 90 89 88 88 90 90 90 90 90 89 88 89 89 89 89 90 90   
AQoL-6D -0.47** -0.26* -0.34** -0.28* 0.42** 0.47** 0.49** 0.51** 0.52** 0.42** 0.26* 0.13 0.01 0.10 0.06 0.07 0.08 0.54** 
Sig. (2-tailed) 0.00 0.02 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.24 0.95 0.38 0.57 0.54 0.47 0.00 
N 86 85 84 84 86 86 86 86 86 85 84 85 85 85 85 86 86 86 
Abbreviations: N=number; FAAM=Foot and Ankle Ability Measure; AQoL-6D= The Assessment of Quality of Life questionnaire-6D; FMM=Foot mobility magnitude; DAHDIFF=dorsal arch height difference; 
MFWDIFF= mid-foot width difference; FPI= foot posture index ;AP=Anteroposterior; PF=Plantarflexion; DF=dorsiflexion; Inv=inversion; Ever=eversion; ROM=range of movement; Ext=extension; Flex=flexion 
** Correlation is significant at the 0.01 level (2-tailed). 
* Correlation is significant at the 0.05 level (2-tailed). 
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Appendix 10 
Nonparametric (Spearman’s rho) Correlations between variables 
Correlation 
Coefficient 
AQoL-Total score FAAM- ADL AOS-Disability AOS-Pain FAAM-Sport CAIT Group BMI Ankle stiffness Age 
FAAM- ADL 0.795  
(p<0.001,n = 380) 
 
         
AOS-Disability -0.793** 
(p<0.001,n=375) 
-0.942** 
(p<0.001,n=371 
        
AOS-Pain -0.756** 
(p<0.001,n=366) 
-0.899** 
(p<0.001,n=364) 
0.923** 
(p<0.001,n=369) 
       
FAAM-Sport 0.738** 
(p<0.001,n=378) 
0.926** 
(p<0.001,n=378) 
-0.905** 
(p<0.001,n=372) 
-0.828** 
(p<0.001,n=365) 
      
CAIT 0.714** 
(p<0.001,n=356) 
0.865** 
(p<0.001,n= 346) 
-0.842** 
(p<0.001,n=341) 
-0.810** 
(p<0.001,n=332) 
0.855** 
(p<0.001,n=344) 
     
Group -0.409** 
(p<0.001,n=391) 
-0.551** 
(p<0.001,n=383) 
0.539** 
(p<0.001,n=378) 
0.552** 
(p<0.001,n=369 
-0.548** 
(p<0.001,n=381) 
-0.689** 
(p<0.001,n= 357) 
    
BMI -0.464** 
(p<0.001,n=387) 
-0.507** 
(p<0.001,n=379) 
0.514** 
(p<0.001,n=374) 
0.459** 
(p<0.001,n=365) 
-0.476** 
(p<0.001,n=377) 
-0.506** 
(p<0.001,n=353) 
0.368** 
(p<0.001,n=390) 
   
Ankle stiffness -0.404** 
(p<0.001,n=266) 
-0.489** 
(p<0.001,n=269) 
0.497** 
(p<0.001,n=269) 
0.498** 
(p<0.001,n=269) 
-0.405** 
(p<0.001,n=269) 
-0.267** 
(p<0.001,n=232) 
-0.233** 
(p<0.001,n=269) 
0.136* 
(p=0.03,n=265) 
  
Age -0.10 
(p=0.05,n=391) 
-0.144** 
(p=0.01,n=383) 
0.108* 
(p=0.04,n=378) 
0.10 
(p=0.07,n=369) 
-0.09 
(p=0.07,n=381) 
-0.03 
(p=0.63,n=357) 
-0.145** 
(p<0.001,n=394) 
0.06 
(p=0.22,n=390) 
0.123* 
(p=0.04,n=269) 
 
Sex 0.06 
(p=0.26,n=391) 
0.137** 
(p=0.01,n=383) 
-0.09 
(p=0.07,n=378) 
0.133* 
(p=0.01,n=369) 
0.129* 
(p=0.01,n=381) 
0.114* 
(p=0.03,n=357) 
-0.197** 
(p<0.001,n=394) 
-0.10 
(p=0.06,n=390 
-0.04 
(p=0.57,n=269) 
0.125* 
(p=0.01,n=394) 
** Correlation is significant at the 0.01 level (2-tailed). 
* Correlation is significant at the 0.05 level (2-tailed). 
Abbreviations: p value/significance level; AOS=ankle osteoarthritis scale; FAAM=Foot and Ankle Ability Measure; AQoL-6D= The Assessment of Quality of Life; BMI= body mass index; CAIT= The CumberlandAnkle Instability 
Tool. 
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Appendix 11  
Correlation levels of each independent variable with fall status (coded as faller=1, non-faller=0) and other variables. 
Spearman's rho  
(p-value) 
Fallers FAAM ADL  FESI ABC Ankle pain Number of 
pain sites 
Pain excluding ankle Group Comorbidities Depression Age 
FAAM ADL -0.472** 
(0.00) 
          
FESI 0.443** 
(0.00) 
-0.697** 
(0.00) 
         
ABC -0.440** 
(0.00) 
0.747** 
(0.00) 
-0.842** 
(0.00) 
        
Ankle pain 0.407** 
(0.00) 
-0.913** 
(0.00) 
0.683** 
(0.00) 
-0.701** 
(0.00) 
       
Number of pain sites 0.385** 
(0.00) 
-0.748** 
(0.00) 
0.636** 
(0.00) 
-0.645** 
(0.00) 
0.750** 
(0.00) 
      
Pain excluding ankle 0.382** 
(0.00) 
-0.716** 
(0.00) 
0.640** 
(0.00) 
-0.651** 
(0.00) 
0.771** 
(0.00) 
0.822** 
(0.00) 
     
Group 0.374** 
(0.00) 
-0.875** 
(0.00) 
0.574** 
(0.00) 
-0.572** 
(0.00) 
0.864** 
(0.00) 
0.687** 
(0.00) 
0.575** 
(0.00) 
    
Comorbidities 0.252** 
(0.00) 
-0.450** 
(0.00) 
0.509** 
(0.00) 
-0.483** 
(0.00) 
0.440** 
(0.00) 
0.471** 
(0.00) 
0.463** 
(0.00) 
0.369** 
(0.00) 
   
Depression 0.152* 
(0.02) 
-0.202* 
(0.03) 
0.254** 
(0.00) 
-0.257** 
(0.00) 
0.187** 
(0.01) 
0.209** 
(0.00) 
0.261** 
(0.00) 
0.10 
(0.16) 
0.477** 
(0.00) 
  
Age 0.05 
(0.50) 
0.01 
(0.88) 
0.02 
(0.81) 
-0.07 
(0.29) 
-0.04 
(0.58) 
-0.13 
(0.05) 
-0.03 
(0.64) 
-0.05 
(0.45) 
0.13 
(0.06) 
0.04 
(0.57) 
 
Sex -0.04 
(0.58) 
-0.07 
(0.46) 
0.147* 
(0.03) 
-0.189** 
(0.00) 
0.05 
(0.43) 
0.13 
(0.06) 
0.134* 
(0.04) 
0.02 
(0.80) 
0.11 
(0.09) 
0.06 
(0.38) 
-0.04 
(0.54) 
** Correlation is significant at the 0.01 level (2-tailed). * Correlation is significant at the 0.05 level (2-tailed). 
Group (Ref. – asymptomatic).  
FES-I=The Falls Efficacy Scale-International, ABC=The Activities-Specific Balance Confidence Scale, FAAM-ADL= The Foot and Ankle Ability Measure-activities of daily living 
subscale 
All data based on full sample n=226 except FAAM ADL n=120 
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Appendix 12  
Correlation levels of each independent variable with number of falls and other variables. 
Spearman's rho  
(p-value) 
Number of 
falls 
FESI FAAM 
ADL 
ABC Ankle pain Pain 
excluding 
ankle 
Number of 
pain sites 
Group Comorbidities Depression Age 
FESI 0.510** 
(0.00) 
          
FAAM ADL -0.509** 
(0.00) 
-0.697** 
(0.00) 
         
ABC -0.502** 
(0.00) 
-0.842** 
(0.00) 
0.747** 
(0.00) 
        
Ankle pain 0.475** 
(0.00) 
0.683** 
(0.00) 
-0.913** 
(0.00) 
-0.701** 
(0.00) 
       
Pain excluding ankle 0.449** 
(0.00) 
0.640** 
(0.00) 
-0.716** 
(0.00) 
-0.651** 
(0.00) 
0.771** 
(0.00) 
      
Number of pain sites 0.448** 
(0.00) 
0.636** 
(0.00) 
-0.748** 
(0.00) 
-0.645** 
(0.00) 
0.750** 
(0.00) 
0.822** 
(0.00) 
     
Group 0.411** 
(0.00) 
0.574** 
(0.00) 
-0.875** 
(0.00) 
-0.572** 
(0.00) 
0.864** 
(0.00) 
0.575** 
(0.00) 
0.687** 
(0.00) 
    
Comorbidities 0.260** 
(0.00) 
0.509** 
(0.00) 
-0.450** 
(0.00) 
-0.483** 
(0.00) 
0.440** 
(0.00) 
0.463** 
(0.00) 
0.471** 
(0.00) 
0.369* 
(0.00)* 
   
Depression 0.167* 
(0.01) 
0.254** 
(0.00) 
-0.202* 
(0.03) 
-0.257** 
(0.00) 
0.187** 
(0.01) 
0.261** 
(0.00) 
0.209** 
(0.00) 
0.10 
(0.16) 
0.477** 
(0.00) 
  
Age 0.02 
(0.74) 
0.02 
(0.81) 
0.01 
(0.88) 
-0.07 
(0.29) 
-0.04 
(0.58) 
-0.03 
(0.64) 
-0.13 
(0.05) 
-0.05 
(0.45) 
0.13 
(0.06) 
0.04 
(0.57) 
 
Sex -0.03 
(0.63) 
0.147* 
(0.03) 
-0.07 
(0.46) 
-0.189** 
(0.00) 
0.05 
(0.43) 
0.134* 
(0.04) 
0.13 
(0.06) 
0.02 
(0.80) 
0.11 
(0.09) 
0.06 
(0.38) 
-0.04 
(0.54) 
p Sig. (2-tailed) 
* Correlation is significant at the 0.05 level (2-tailed); ** Correlation is significant at the 0.01 level (2-tailed). Group (Ref. – asymptomatic) 
FES-I=The Falls Efficacy Scale-International, FAAM-ADL= The Foot and Ankle Ability Measure-activities of daily living subscale ABC=The Activities-Specific Balance Confidence 
Scale. All data based on full sample n=226 except FAAM ADL n=120 
 
